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Introduction 1
1  INTRODUCTION
During my Ph.D. work I studied some of the mechanisms that regulate the complex
machinery of vesicular transport from the endoplasmic reticulum to the Golgi apparatus
in the single-celled eukaryote Saccharomyces cerevisiae.  I focused my attention on
certain proteins involved in vesicular budding, particularly on Sec24p family members.
In addition I studied proteins involved in tethering/docking processes, in particular a new
member of the Gyp family of GTPase activating proteins (GAP), Gyp5p, the preferred
substrate of which is the small Ras-like Ypt1 protein.
1.1  Intracellular protein transport in eukaryotic cells
Eukaryotic cells are subdivided into membrane-enclosed compartments called
organelles.  Each organelle is endowed with a specific subset of lipids and cellular
proteins according to its physiological specialization.  This has been known since the
introduction of electron microscopic analyses combined with cell fractionation studies
(de Duve, 1975; Palade, 1975).  Cellular life and differentiation depend on keeping the
integrity of the complex network of membranous compartments, however,
macromolecules also have to be transported from one compartment to another and into
and out of the cell.  In order to achieve this without compromising membrane integrity,
an efficient and elaborate transport machinery that ensures temporal and spatial
specificity has been developed (Fig. 1.1).  Secretory proteins are synthesized and
assembled in the endoplasmic reticulum (ER).  Then they pass through the Golgi
apparatus where they undergo a variety of carbohydrate and other modifications before
being delivered to their final destinations, such as the plasma membrane, endosomes or
the lysosome (vacuole).  A related pathway exists for the uptake of proteins and
extracellular fluids from the cell surface via endosomes to lysosomes and traffic can
occur in both directions along the two pathways (Fig. 1.1).  Retrograde transport
between endocytic and exocytic compartments ensures that the quantitative and
qualitative balance in the protein and lipid contents of the cell’s organelles is maintained.
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Since the pioneering work of George Palade (Palade, 1975) it has been known that
proteins get to their final destination in membrane-derived transport vesicles (for reviews
see Mellman and Warren, 2000; Rothman, 1994).  The vesicular protein transport
through the secretory and endocytic pathways is directional and tightly controlled
through the action of a variety of evolutionary conserved proteins (Bennett and Scheller,
1993; Ferro-Novick and Jahn, 1994; Kaiser and Schekman, 1990; Novick and Zerial,
1997).  In principle, the transport process "simply" requires the selective packaging of
cargo into a vesicle carrier and the transport, docking and fusion of the vesicle
intermediate with the appropriate target membrane.  This set of biochemical reactions
depends on a considerable array of proteins, lipids and enzyme complexes (coats,
SNAREs, GTPases, ATPases, kinases, phosphoinositides, etc.), some of which function
as structural components while others catalyze the assembly/disassembly of reaction
intermediates or regulate spatial and temporal aspects of the process.  The vesicular
transport can be separated into three steps: budding (see Section 1.3), tethering/docking,
and fusion of vesicles with the target membrane (see Section 1.4).
The three main classes of vesicles, classified on the basis of their protein coats,
are: COPII vesicles, which mediate ER to Golgi traffic (see 1.3.1); COPI vesicles, which
are responsible for retrograde traffic from the Golgi to the ER and for traffic between the
cisternae of the Golgi; and the clathrin-coated vesicles, which mediate various endocytic
and post-Golgi vesicular trafficking steps (for reviews see Kirchhausen, 2001; Scales et
al., 2000b).  The assembly of a protein coat provides not only the driving energy to
deform the vesicle membrane into a spherical shell but also an affinity matrix for the
selective partitioning of cargo molecules into the vesicle.  In addition to the coat proteins,
the budding process also involves monomeric GTPases of the dynamin and ARF family,
as well as adaptor proteins (for reviews see Aridor and Balch, 1996; Cosson and
Letourneur, 1997; Kirchhausen, 1999; Springer et al., 1999).  Once the cargo-
containing vesicles have pinched off from the donor organelle membrane, they must
be targeted to and fuse with the correct target membrane.  It is thought that vesicles
travel to their target membrane along cytoskeletal structures (Kamal and Goldstein,
2000).  Members of the SNARE, Ypt/Rab and Sec1 families of proteins appear to
direct and regulate these vesicle docking and fusion reactions (see Section 1.4).  In
addition, a regulatory function in vesicular trafficking has also been demonstrated for
phosphatidylinositol and its phosphorylated derivatives (for reviews see De Camilli et
al., 1996; Odorizzi et al., 2000).
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Protein transport to peroxisomes, mitochondria and chloroplasts differs
mechanistically from the vesicular transport discussed here (for reviews see Haucke
and Gottfried, 1997; Hettema et al., 1999; Schatz, 1996; Schleiff and Soll, 2000).
1.2  ER-Golgi transport
Transport of proteins between the endoplasmic reticulum and the Golgi
apparatus is mediated by COPII and COPI coated vesicles (Bannykh et al., 1996;
Bednarek et al., 1996).  In addition, there are many accessory proteins that facilitate
Fig 1.1  Vesicular protein transport pathways in a S. cerevisiae cell.  Filled arrows indicate
forward traffic, while open arrows indicate retrograde trafficking, dotted arrows indicate
hypothetical routes.  The known sites of action of Ypt GTPases are in white boxes and
those of syntaxins in gray boxes.  e.E.= early endosome, l.E.= late endosome, Plm= plasma
membrane.  Figure modified from (Götte et al., 2000).
 l. E.
e. E.
Plm
Vacuole
Golgi
ER
Vam3
Ypt1
Ypt31/32
Ypt51
Ypt51
Ypt7
Sec4
Ypt6
Ypt51
Pep12
Ufe1
Sed5
Tlg1/2
Tlg1/2
Sso1/2
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the forward movement of proteins from the ER and their uptake into transport
vesicles (for review see Herrmann et al., 1999).
The endoplasmic reticulum consists of an elaborate and dynamic tubular and
cisternal network that is continuous with the outer nuclear membrane. It is divided in
smooth and rough ER.  The rough ER is the place were proteins are assembled and it
can be considered the first station in the secretory pathway.  The Golgi apparatus is
typically represented as a series of stable compartments, cis-, medial-, trans-Golgi and
trans-Golgi-network (TGN), with transport vesicles serving as carriers of the secretory
cargo from one compartment to the next (in S. cerevisiae, the Golgi apparatus does
not form stacks of organelles but consists of individual cisternae interspersed
throughout the cytoplasm).  An alternative model considers the Golgi compartments as
transitory structures continuously undergoing renewal, and the Golgi apparatus is
viewed as a dynamic outgrowth of the ER (Fig. 1.2).  According to this "cisternal
maturation" hypothesis, COPII vesicles fuse to form the ERGIC (ER-Golgi intermediate
compartment) clusters, which coalesce to form a new cis-cisterna that progresses
through the stack, until it ultimately disintegrates into various types of transport carriers.
CLASSICAL VESICULAR       CISTERNAL MATURATION
         MODEL        MODEL
GOLGI
COMPLEX
ENDOPLASMIC
RETICULUM
ERGIC
Fig. 1.2  Schematic representation of the two proposed mechanisms for transport of secretory
cargo to and through the Golgi apparatus.  In the first model, the Golgi consist of stable
compartments, membrane-bounded carriers transport cargo molecules from ER to cis-Golgi
and between the different Golgi compartments.  In the second model, ER-derived
membranes coalesce to form a new cis-cisterna which then progresses through the stack,
carrying the secretory cargo forward, while  retrograde COPI vesicles recycle resident Golgi
proteins to younger cisternae.  ERGIC= ER-Golgi intermediate compartment
     = COPII              = COPI                = Clathrin
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While cisternae progress, carrying the secretory cargo forward, retrograde COPI
vesicles recycle resident Golgi proteins to younger cisternae.  In both models the
intermediate compartment (ERGIC) residing between the ER and the Golgi is
considered to be a dynamic structure that captures cargo released from the ER in COPII
vesicular carriers and promotes recycling by COPI vesicular carriers (Bannykh and
Balch, 1997). In yeast, there is no clear evidence for the existence of an intermediate
compartment and cis-Golgi is regarded as the first compartment after the ER.
Up to now, the dilemma of whether transport through the Golgi complex occurs
via vesicular transport or by cisternal maturation remains unsolved.  Nevertheless, in
both models COPII vesicles mediate the first transport step in the secretory pathway.
It is in fact generally accepted that most, if not all, of the forward vesicular traffic from
the ER to the Golgi involves COPII vesicles (Mellman and Warren, 2000; Pelham and
Rothman, 2000)
1.3  Budding
Once a protein is properly core-glycosylated, folded and assembled in the ER it
may be incorporated into COPII vesicles.  COPII-coated vesicles, as mentioned
before, represent the major, and perhaps the sole, vehicle for anterograde protein
traffic from the ER, and COPII components are involved in cargo selection and export
from the ER.
1.3.1  COPII-coated vesicles
COPII coat is composed of five cytosolic components: Sar1p, a small GTP-
binding protein (Barlowe et al., 1993; Nakano and Muramatsu, 1989), and the two
heterodimeric protein complexes Sec23p/Sec24p (Hicke et al., 1992; Yeung et al.,
1995a) and Sec13p/Sec31p (Salama et al., 1997; Salama et al., 1993).  By
morphological studies on yeast sec mutants and by cell-free assays (Baker et al.,
1988; Barlowe et al., 1994; Rexach and Schekman, 1991) it was demonstrated that
these five cytosolic proteins represent the minimal requirements for vesicular budding.
Several homologs of COPII components exist in yeast, in mammals (Table 1.1)
and in other organisms.
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Table 1.1  COPII components in yeast and mammals
Protein Main characteristics Yeast Mammals
Sar1p
~ 21 kDa
- GTPase. Sar1p (YPL218W) (190 aa)
(Nakano and Muramatsu,
1989; Oka et al., 1991)
mSar1Ap (198 aa)
mSar1Bp
(Kuge et al., 1994; Shen et
al., 1993)
Sec23p
~ 85 kDa
- GAP for Sar1p.
- Always in complex with
Sec24p.
- Sequence similarity
with Sec24p.
Sec23p (YPR181C) (768 aa)
(Hicke and Schekman, 1989;
Yoshihisa et al., 1993)
hSec23Ap (765 aa)
hSec23Bp (767 aa)
(Orci et al., 1991; Paccaud
et al., 1996)
Sec24p
~ 105 kDa
- Always in complex with
Sec23p.
- Putative Zinc binding
motif.
- Sequence similarity
with Sec23p.
Sec24 (YIL109C) (926 aa)
Sfb2p (YNL049C) (876 aa)
Sfb3p (YHR098C) (929 aa)
(Hicke et al., 1992; Kurihara
et al., 2000; Peng et al.,
2000; Roberg et al., 1999)
hSec24Ap (1078 aa)
hSec24Bp (1268 aa)
hSec24Cp (1094 aa)
hSec24Dp (1032 aa)
(Pagano et al., 1999; Tang et
al., 1999; Tani et al., 1999)
Sec13p
~ 34 kDa
- Always in complex with
Sec31p.
- six WD-40 repeat
motifs.
Sec13p (YLR208W) (297 aa)
Seh1p (YGL100W) (349 aa)
(Pryer et al., 1993; Saxena
et al., 1996; Siniossoglou et
al., 1996)
Sec13Rp (322 aa)
(Swaroop et al., 1994;
Tang et al., 1997)
Sec31p
~ 150 kDa
-phosphoprotein.
-Always in complex with
Sec13p.
-seven WD-40 repeats
near the N terminus.
Sec31p (YDL195W) (1273 aa)
(Salama et al., 1997)
Sec31Ap (1220 aa)
Sec31Bp (1179 aa)
(Tang et al., 2000).
The vesicle budding process starts (see Fig. 1.3) with the recruitment of Sar1p
to the ER (Yoshihisa et al., 1993).  Sar1p recruitment to membranes requires ATP.
This could allow the export machinery to respond to extracellular signaling pathways,
thus integrating the secretory pathway with the cellular physiology (Aridor and Balch,
2000).  At the ER membrane, Sar1p exchanges GDP for GTP under the influence of
a specific guanine nucleotide exchange factor, Sec12p, an integral membrane
glycoprotein (Barlowe and Schekman, 1993).  This activation step leads to the
recruitment of Sec23p/Sec24p from the cytosol to the membrane to form a ternary
complex that interacts with cargo and cargo receptors (Aridor et al., 1998; Kuehn et
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al., 1998; Springer and Schekman, 1998; Springer et al., 1999).  Finally the
Sec13p/Sec31p complex binds to initiate the formation of the budding vesicle.  Sec23p
is a GTPase activating protein for Sar1p (Yoshihisa et al., 1993).  GTP hydrolysis (step
preceding fusion) allows Sar1p to dissociate from the membrane, this would render
COPII components easily displaceable from the completed vesicle.  In fact, it is thought
that the vesicular coat has to be removed to allow fusion to take place.
Fig. 1.3  Scheme of COPII vesicle formation (modified from Schekman and Orci, 1996).
Cargo
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Cargo
Sec24
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GTP GTP
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  Sec23
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Cargo
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Direct interactions among COPII components have been shown by two-hybrid
analysis and in vitro binding assays.  The N-terminus of Sec24p binds to Sec23p
(Gimeno et al., 1996; Peng et al., 1999); Sec13p and the N-terminal region of Sec31p
interact with each other, while Sec23p and Sec24p interact with a central region of
Sec31p (Shaywitz et al., 1997), see Fig. 1.4.
In vivo, an additional gene, SEC16, is
important for budding and probably also for
cargo sorting, but it may not contribute
directly to vesicle morphogenesis.  Sec16p
is a large (240 kDa) peripheral membrane
protein that is tightly associated with the
cytosolic face of the ER.  It was shown to
interact genetically with all five COPII
proteins and to bind, through independent
domains, Sec23p, Sec24p and Sec31p.
Sec16p was proposed to organize and to
stabilize COPII coat assemblage (Espenshade et al., 1995; Shaywitz et al., 1997).
In vitro experiments using reconstituted COPII-coated vesicles from chemically
defined liposomes showed that the "binding sites" for coat proteins could be lipids
rather than membrane proteins, in particular the acidic phospholipids
phosphatidylinositol-4-phosphate (PIP) and phosphatidylinositol-4-5-bisphosphate
(PIP2) (Matsuoka et al., 1998b).  Acidic phospholipids present in a membrane in high
amounts favor the binding of coat proteins and the formation of buds and vesicles,
nevertheless it is not clear whether they represent the essential minimal components
of a biological process (Nickel et al., 1998).
Several experiments suggest that cargo is selected and actively concentrated into
COPII vesicles (Aridor et al., 1998; Balch et al., 1994; Bannykh et al., 1996; Campbell
and Schekman, 1997; Matsuoka et al., 1998a; Springer et al., 1999).  In particular, it was
demonstrated that Sar1p-GTP and Sec23p/Sec24p form a specific "prebudding"
complex with integral membrane proteins such as the SNAREs Bet1p and Bos1p and
with membrane proteins of the p24 family (such as Emp24p) in yeast (Kuehn et al.,
1998; Springer and Schekman, 1998) and with vesicular stomatitis virus glycoprotein
(VSV-G) in mammalian systems (Aridor et al., 1998).  Sec23p/Sec24p in the presence of
Sar1-GTP can also interact with cytosolic cargo such as the glycosylated pro-alpha
Sec16
 Sec24
 Sec 23
Sec31
Sec13
Fig. 1.4  Sec16p interactions with COPII
components as described in (Shaywitz
et al., 1997).
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factor (gpαF), probably with the help of membrane spanning receptors/adaptors (Kuehn
et al., 1998).  Furthermore, it was demonstrated that resident ER proteins (such as
Sec61p and Kar2p) are excluded from the prebudding complex (Kuehn et al., 1998;
Matsuoka et al., 1998b).  A direct interaction of Sec24p and the Golgi syntaxin Sed5p
suggests that it is mainly this COPII component that binds membrane cargo molecules
(Peng et al., 1999).  Proteins of the p24 family (type I transmembrane proteins) were
thought to be cargo receptor/adaptors that could serve as a link between lumenal cargo
molecules and coat proteins (Fiedler et al., 1996; Muniz et al., 2000; Schimmoller et al.,
1995; Stamnes et al., 1995).  It was recently demonstrated, however (with a strain
lacking all eight members of the p24 gene family) (Springer et al., 2000), that in S.
cerevisiae p24 proteins are not essential for vesicular transport.  Therefore, a possible
role as quality control factors, which restrict the entry of proteins into COPII vesicles, was
postulated for p24 proteins.  Recently, data have been published supporting the role of
the mannose specific lectin-like ERGIC-53 (a non-glycosylated type I membrane protein)
as a receptor facilitating the ER-to-ERGIC (ER-Golgi intermediate compartment)
transport of soluble glycoprotein cargo in mammalian cells (Appenzeller et al., 1999;
Hauri et al., 2000).  In addition, studies on mammalian cells have identified two sorting
motifs within the cytoplasmic domains of transmembrane cargo molecules which are
important for their efficient exit out of the ER: a di-acidic motif (Asp-X-Glu, where X
represents any amino acid) on the cytoplasmic tail of vesicular stomatitis virus
glycoprotein (Nishimura and Balch, 1997; Nishimura et al., 1999), and a double
phenylalanine motif (Phe-Phe) on the cytoplasmic tail of p24 proteins (Dominguez et al.,
1998) and ERGIC-53 (Hauri et al., 2000; Kappeler et al., 1997).  It was also demonstrated
that peptides containing the double phenylalanine motif were able to bind to several
proteins, among them the mammalian Sec23p/Sec24p complex (Dominguez et al.,
1998; Kappeler et al., 1997).  Furthermore, novel data from mammalian cells, suggest a
more active role of Sar1p in cargo sorting.  According to these researchers cargo capture
would happen in two integrated stages, the first of which would be supported by Sar1p
before the recruitment and the assembly of the coat complexes (Aridor et al., 2001).
1.3.2  The Sec24p family
In yeast, there are two close orthologues of Sec24p (Sfb2p and Sfb3p) that were
characterized during this work (Kurihara et al., 2000; Peng et al., 2000; Roberg et al.,
1999).  Whereas Sec24p is an essential protein, Sfb2p and Sfb3p are dispensable for
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cell viability.  As Sec24p, both Sfb2p and Sfb3p form stable complexes with Sec23p.
Interestingly, all three proteins harbor within the N-terminal region a domain with a
GATA-type zinc finger-like motif (CysX2CysX18CysX2Cys) (Mackay and Crossley, 1998;
Trainor et al., 1990).  In Table 1.2, the main characteristics of these proteins are listed.
Table 1.2  Main characteristics of S. cerevisiae Sec24 family proteins.
Sec24p
(ORF: YIL109C)
Sfb2p (Iss1p)
(ORF: YNL049C)
Sfb3p (Lst1p)
(ORF: YHR098C)
Length 926 aa 876 aa 929 aa
MW 103.6 kDa 98.9 kDa 103.9 kDa
Chromosome IX XIV VIII
pI 5.83 5.16 5.87
% identity with Sec24p 100% 56% 23.5%
% similarity with Sec24p 100% 71% 42%
Gene deletion phenotype Lethal no significant effect no significant effect
Protein interactions
(physical)
Sec23p, Sec31p,
Sec16p, Bet1p, Bos1p,
Sed5p, Pma1p
(Gimeno et al., 1996; Peng
et al., 1999; Shaywitz et al.,
1997; Shimoni et al., 2000;
Springer and Schekman,
1998; Yeung et al., 1995b).
Sec23p, Sed5p,
Sec16p
(Higashio et al., 2000;
Kurihara et al., 2000;
Peng et al., 2000)
Sec23p, Pma1p
(Peng et al., 2000;
Shimoni et al., 2000)
Synthetic lethal
interactions
BET1, SEC12, SEC13,
SEC16, SEC17, SEC18,
SEC22, SEC23, SFB3,
BET1
(Kurihara et al., 2000; Peng
et al., 2000)
BET1, SEC22
(Kurihara et al., 2000)
SEC12, SEC13,
SEC16, SEC23,
SEC24, SEC31.
(Peng et al., 2000;
Roberg et al., 1999;
Shimoni et al., 2000)
Database searches revealed a whole family of Sec24-related proteins from
many other organisms (three isoforms in S. pombe, two isoforms in C. elegans, three
isoforms in D. melanogaster, four isoforms in H. sapiens).
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1.4  Tethering, docking and fusion
The fusion of a transport vesicle with its target membrane involves two types of
events: first the transport vesicle must specifically recognize the correct target
membrane, then it has to fuse with that membrane.  Interaction of two membranes
can be considered a multi-stage process in which different protein complexes are
involved.  The first stage, during which the two membranes come close to each
other, has been termed "tethering".  Then follows the interaction of SNAREs (SNAP
receptors) on opposing membranes (see Section 1.4.1), and this strong interaction
(called "docking") ultimately leads to membrane fusion.  The docking/fusion process
is probably initiated by the binding of two soluble proteins, NSF (Sec18p in yeast)
and SNAP (Sec17p in yeast ), that open the cis-SNARE complexes (Ungermann et
al., 1998).  NSF (N-ethyl-maleimide sensitive factor) is a soluble ATPase (Beckers et
al., 1989; Block et al., 1988; Malhotra et al., 1988), SNAPs (no relation with SNAP-
25) are soluble NSF attachment proteins (Clary et al., 1990).
Many different "tethering components" involved at different transport steps have
recently been identified in yeast and mammalian cells (for review see Guo et al., 2000;
Waters and Pfeffer, 1999).  The use of multiple tethering factors is likely to ensure the
high selectivity and spatial and temporal regulation of membrane targeting.  Tethering
complexes and proteins implicated in ER-Golgi transport in yeast are: TRAPP (transport
protein particle, a ten subunits complex) (Barrowman et al., 2000; Sacher et al., 2000;
Sacher et al., 1998; Wang et al., 2000b), p115/Uso1p (Allan et al., 2000; Cao et al.,
1998; Sapperstein et al., 1996; Sapperstein et al., 1995), and Sec34p-Sec35p
(VanRheenen et al., 1998; VanRheenen et al., 1999).  In mammalian cells, the protein
p115 probably also acts at other transport steps (Nelson et al., 1998; Waters et al., 1992).
The intricate tethering/docking process is regulated by small Ras-like GTPases
termed Ypt in yeast or Rab in mammals (for reviews see Götte et al., 2000; Lazar et
al., 1997; Zerial and McBride, 2001) (see Section 1.4.2).  Ypt/Rab proteins might be
involved in recruiting tethering and docking factors (Allan et al., 2000; Cao et al.,
1998; Guo et al., 2000; Seals et al., 2000; Wickner and Haas, 2000) and/or in the
removal of inhibitors of SNARE complex assembly such as could be the proteins of
the Sec1 family (Lian et al., 1994; Lupashin and Waters, 1997; Sogaard et al., 1994).
The Sec1 family is another group of proteins important in fusion.  In yeast, there
are four proteins belonging to this family: Sec1p, Sly1p, Vps33p and Vps45p.  Sec1p
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acts exclusively at the plasma membrane.  It was demonstrated to bind to assembled
exocytic SNARE complexes in yeast (Carr et al., 1999).  In mammals, n-Sec1p binds
to the closed conformation of Syntaxin1A inhibiting it from interacting with other
SNAREs (Yang et al., 2000).  Sly1p participates in docking events of ER-derived
vesicles to the Golgi compartment; it binds to the Golgi syntaxin Sed5p (Grabowski
and Gallwitz, 1997).  The SLY1-20 mutant is a dominant allele that can suppress the
functional loss of YPT1 (Dascher et al., 1991; Ossig et al., 1991).  Vps45p is involved
in endosomal trafficking, and it was shown to bind to the syntaxin Tlg2p (Nichols et
al., 1998).  Vps33p is part of a large protein complex (C-VPS complex / HOPS)
involved in Golgi-to-vacuole protein transport and in homotypic vacuole fusion (Sato
et al., 2000; Seals et al., 2000).  The function of Sec1 proteins is not well understood
yet, they have been described both as activators and inhibitors of SNARE complex
assembly and membrane fusion (for review see Halachmi and Lev, 1996).
1.4.1  SNAREs
SNAREs (SNAP receptors) comprise distinct families of conserved
transmembrane or membrane-associated proteins that were independently discovered
in yeast, mammalian cells and neurons (for review see Bennett and Scheller, 1993;
Ferro-Novick and Jahn, 1994) and which are considered the core machinery for
membrane fusion (Weber et al., 1998).  They are grouped into three large families (the
names derive from the synaptic proteins first recognized to be SNAREs): the syntaxin
(Bennett et al., 1992), the SNAP-25 (synaptosomal-associated protein of 25 kDa)
(McMahon and Sudhof, 1995) and the VAMP/synaptobrevin family (VAMP= vesicle-
associated membrane protein) (Baumert et al., 1989; Trimble et al., 1988).  The term
SNARE was coined by J. Rothman and colleagues (Söllner et al., 1993b) to describe
entities which could bind soluble factors that had  previously been described to be
important components of the intracellular membrane fusion apparatus, namely NSF
(N-ethylmaleimide-sensitive fusion protein) and SNAP (soluble NSF attachment
protein; no relation to SNAP-25).  Based on their localization and overall structure,
SNAREs were initially classified into t-SNARES (SNAREs localized to target
membrane) and v-SNAREs (SNAREs localized to the membrane of a trafficking
vesicle) (Söllner et al., 1993a).  The Syntaxin and SNAP-25 families were originally
classified as t-SNAREs and the VAMP/synaptobrevin family as v-SNAREs.  Since
proteins related to SNAREs were also found in non-neuronal cells and were localized
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to specific subcellular compartments, Rothman and colleagues in 1993 formulated the
"SNARE hypothesis" (Rothman, 1994; Rothman and Warren, 1994; Söllner et al.,
1993b) on the basis of which SNAREs would provide a general mechanism for the
specific docking and fusion of transport vesicles (containing v-SNAREs) with their
target membranes (containing the cognate t-SNAREs).
Every cell expresses a large number of SNARE proteins that exhibit
characteristic subcellular distributions (see Fig. 1.1), suggesting that the fidelity of
vesicle trafficking might in part be determined by specific SNARE pairings.  However,
the promiscuity of SNARE pairing observed in vitro (Fasshauer et al., 1999; Grote and
Novick, 1999) and the fact that they shuttle between trafficking compartments
associated with transport vesicles (Wooding and Pelham, 1998) suggest that the
information for membrane compartment organization is not in the inherent ability of
SNAREs to form complexes.  This point remains quite controversial since several
researchers still support the idea of specificity by SNARE pairing.  These investigators
observed that whereas SNAREs pair almost randomly in solution they are not at all
promiscuous in the presence of lipid bilayers (McNew et al., 2000; Parlati et al., 2000;
Scales et al., 2000a).  SNAREs involved in ER-to-Golgi transport in yeast are Bos1p,
Bet1p, Sec22p and Sed5p (Cao and Barlowe, 2000; Parlati et al., 2000).
Structural and biochemical data highlighted the mechanism by which trans-SNARE
complexes catalyze the merging of lipid bilayers during intracellular membrane fusion.
SNAREs are coiled-coil proteins and during membrane fusion, four α-helices from proteins
on the vesicle and target membrane come together to form a stable, four-helix bundle (see
Fig. 1.5 ).  The trans-SNARE complex consists of syntaxin and SNAP25 family members
on the target membrane and a VAMP/synaptobrevin family member on the vesicle.
Fig. 1.5  Trans-SNARE complex formation and membrane fusion.  For vesicle fusion, three
SNAREs of the syntaxin (red) and the SNAP25 family (green) are required on the target
membrane and a VAMP family member  (blue) on the vesicle (modified from Scales et al, 2000a).
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The formation of the four-helix bundle may bring interacting membranes in close
enough opposition to facilitate, if not complete, bilayer fusion (Lin and Scheller, 1997;
Otto et al., 1997; Poirier et al., 1998; Sutton et al., 1998; Weber et al., 1998).
There is evidence that, at least in the case of vacuole-to-vacuole fusion, for the
terminal step of the fusion event to take place, a calcium signal that is sensed by
calmodulin is necessary (Peters and Mayer, 1998).  The action of protein
phosphatase-1 has been found to be essential for fusion, too (Peters et al., 1999).
The association of the four α-helices in the synaptic fusion complex structure
produces highly conserved layers of interacting amino acid side chains in the center of
the four-helix bundle, and on the basis of these features SNAREs were reclassified into
Q-SNAREs and R-SNAREs (Q= glutamine, R= arginine).  Fusion-competent SNARE
complexes generally consist of four-helix bundles composed of three Q-SNAREs and
one R-SNARE (Fasshauer et al., 1998; Ossig et al., 2000), however exceptions to
this rule have been described (Katz and Brennwald, 2000).
Because the core complex is extremely stable, cells have evolved a specialized
chaperone whose function is to dissociate the SNARE complex under the hydrolysis of
ATP.  This chaperone is the previously mentioned NSF (Sec18p in yeast) which acts in
conjunction with SNAP (Sec17p in yeast).  Both NSF and SNAP are structurally and
functionally conserved in evolution.  They are known to function at virtually all
intracellular transport steps (Rothman, 1994).  SNAP/Sec17p needs to bind to the
SNARE complex before NSF/Sec18p can bind.  Sec18p action also depends on the
heterodimeric protein complex LMA1 (a heterodimer composed of thioredoxin and the
proteinase inhibitor IB2) that is thought to stabilize SNARE proteins after their
separation (Barlowe, 1997; Xu et al., 1997; Xu et al., 1998).  Recent data suggest that
only cis-SNARE complexes (formed when SNAREs combine on the same membrane)
are disrupted by the action of the ATPase NSF, and that this would be necessary to
maintain a supply in cells of uncombined SNAREs for fusion (Wang et al., 2000a;
Weber et al., 2000).  For further reviews on SNARE proteins see (Chen and Scheller,
2001; Gerst, 1999; Jahn and Südhof, 1999; Pelham, 1999).
1.4.2  The Ypt/Rab family of small GTPases
Ypt/Rab proteins form the largest subfamily of the Ras superfamily of GTPases
(Götte et al., 2000; Novick and Zerial, 1997; Zerial and McBride, 2001).  The Ras-
superfamily includes more than 700 members in species from yeast to man and it can
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be divided into at least five subfamilies: the Ras, the Rho/Rac/Cdc42, the Ypt/Rab, the
Sar1/Arf, and the Ran families (Garcia-Ranea and Valencia, 1998; Kahn et al., 1992;
Matozaki et al., 2000).  Different members of these families play key roles in a variety
of cellular processes including signal transduction, cytoskeletal organization and
protein transport (Garcia-Ranea and Valencia, 1998; Zerial and Huber, 1995).  Like
heterotrimeric G proteins they act as molecular switches, where the "switching"
process relies on GTP hydrolysis (for review see Bourne et al., 1990; Kjeldgaard et al.,
1996; Sprang, 1997).
Ras and Ras-like proteins are related in size (approximately 200-230 amino
acids), secondary and tertiary structure (six-stranded β-sheet surrounded by α-helices)
and they share significant sequence identity and similar biochemical properties
(Bourne et al., 1990; Gamblin and Smerdon, 1998; Wittinghofer and Pai, 1991).  They
bind guanine nucleotides with high affinity and are endowed with a very slow intrinsic
GTPase activity.  The superfamily is characterized by a C-terminal cysteine motif
subject to post-translational modifications and by the presence of a set of highly
conserved regions, G1-G5 (loops between the secondary structure elements), that are
critical for GDP/GTP exchange, for GTP-induced conformational change and for GTP
hydrolysis  (Bourne et al., 1991; Valencia et al., 1991) (see Fig. 1.6).  The G1-region or
"P-loop" (residues 10-17 in p21ras, 15-22 in Ypt1p) is responsible for the binding of the
alpha- and beta- phosphate groups of GTP/GDP.  The G2-region or "effector region"
(residues 32-40 in p21ras, 37-45 in Ypt1p) is the part of the molecule which undergoes
the most extensive changes upon GTP hydrolysis (Schlichting et al., 1990) and is
thought to bind effector proteins (Becker et al., 1991; Sigal et al., 1986).  The
conserved threonine residue in this region binds a Mg2+ ion, essential for GTP
hydrolysis, that is coordinated to the oxygens of the β− and γ− phosphates of GTP.
Fig. 1.6  Schematic representation of the conserved G1-G5 (gray boxes) regions in members
of the Ras-superfamily and their involvement in the binding of guanine nucleotides.
Conserved sequence motifs for Ypt/Rab GTPases are shown at the top.
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The G3-region (residues 53-62 in p21ras, 59-68 in Ypt1p) binds the gamma-
phosphate of GTP, the glutamine in this region (Q61 in p21ras and Q67 in Ypt1p) is
critical for GTP hydrolysis.  The G4-region (residues 112-119 in p21ras, 117-124 in
Ypt1p) binds the guanine ring of GTP/GDP whereas the G5-region (residues 140-146
in p21ras, 147-153 in Ypt1p) is required for stabilization of the G4-interactions.  The C-
terminal cysteine-containing motif in Ypt/Rab proteins (Fig. 1.6) is post-translationally
modified with a lipid moiety (geranylgeranyl), which is necessary for insertion into the
membrane (Cox and Der, 1992; Peter et al., 1992).
Depending on the nucleotide being bound (GDP or GTP), Ras and Ras-like
GTPases adopt different conformations that allow them to interact with different effector
proteins.  The conformational changes, upon GTP hydrolysis, are mainly localized in two
distinct regions of the molecule, named "switch I" and "switch II". Switch I (residues 30-
38 in p21ras) overlaps with the effector region G2 while switch II (residues 60-76 in
p21ras) encompasses the G3-region (Milburn et al., 1990; Wittinghofer and Pai, 1991).
Ypt/Rab proteins are regulators of vesicular protein transport in both the
biosynthetic/secretory and endocytic pathways.  They are located on distinct cellular
compartments, and participate in molecular events that underlie the targeting and/or
docking/fusion of transport vesicles with their acceptor membrane (Schimmoller et al.,
1998; Zerial and McBride, 2001).  Ypt/Rab GTPases are thought to act prior to
SNAREs in vesicle docking.  There are many hints indicating that they act directly or
indirectly to promote SNARE-complex formation (Sogaard et al., 1994; VanRheenen et
al., 1999).  They might be involved in recruiting tethering and docking factors and/or in
the removal of inhibitors of SNARE complex assembly  (Allan et al., 2000; Cao et al.,
1998; Lupashin and Waters, 1997; Pfeffer, 1999; Seals et al., 2000).  There are also
studies that support an additional role of some Rab proteins in regulating the
movement of vesicles and organelles along the cytoskeleton (Echard et al., 1998;
Nielsen et al., 1999; Peranen et al., 1996; Pruyne et al., 1998; Schott et al., 1999).
Rab protein activity seems to be modulated by different effectors.  Several
proteins were actually identified as Rab effectors and the list is rapidly growing, among
them are: rabphilin3A, rabin3 and Rim for Rab3 (Brondyk et al., 1995; Shirataki et al.,
1993; Wang et al., 1997); rabaptin-5, rabaptin-5β and EEA1 for Rab5 (Gournier et al.,
1998; Simonsen et al., 1998; Stenmark et al., 1995); Rab8ip for Rab8 (Ren et al.,
1996); p40 for Rab9 (Diaz et al., 1997); Rab11BP for Rab11 (Zeng et al., 1999).
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Ypt/Rab GTPases and their involvement in membrane trafficking were first
discovered in yeast (Gallwitz et al., 1983; Salminen and Novick, 1987; Schmitt et al.,
1988; Segev et al., 1988).  In S. cerevisiae, there are 11 Ypt GTPases: Ypt1p,
Ypt31p, Ypt32p, Sec4p, Ypt51p, Ypt52p, Ypt53p, Ypt6p, Ypt7p, Ypt10p  and Ypt11p
(Fig. 1.1 shows the localization and sites of action of Ypt proteins in the yeast cell; for
review see Götte et al., 2000; Lazar et al., 1997).  Only the functional loss of those
involved in the biosynthetic pathways results in lethality, these proteins are: Ypt1p
(Schmitt et al., 1986), Ypt31p/Ypt32p (Benli et al., 1996), and Sec4p (Salminen and
Novick, 1987).  In mammalian cells, over 30  Rab proteins are known (for review see
Martinez and Goud, 1998; Novick and Zerial, 1997; Zerial and McBride, 2001).
Ypt/Rab proteins cycle between a GTP-bound (active) and GDP-bound
(inactive) form, and between a membrane-attached and a soluble form (see Fig. 1.7).
The soluble fraction of the proteins is complexed with a cytosolic protein, the GDP
dissociation inhibitor GDI (Gdi1p/Sec19p in yeast; mammalian cells express several
GDI isoforms) (Garrett et al., 1994).  GDI indiscriminately interacts with all types of
Ypt/Rab proteins (Ullrich et al., 1993).  It is able to solubilize the inactive, GDP-bound
Ypt protein from target membranes and thought to guide it to the correct donor
membrane (Garrett et al., 1994; Pfeffer et al., 1995).
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Fig. 1.7  Model of the Ypt GTPase cycle as described in [Götte, 2000 #38] (to be followed
clockwise from  middle left).  The inactive GDP-bound form of the Ypt protein is kept in a soluble
state by the GDP-dissociation inhibitor (GDI).  After docking to a putative membrane receptor
(R), GDI dissociates from transport GTPases.  Upon membrane binding, a guanine nucleotide
exchange factor (GEF) catalyzes GDP/GTP exchange.  The activated Ypt GTPase (Ypt*) most
likely acts in the assembly of a protein complex which facilitates membrane docking.  A GTPase
activating protein (GAP) accelerates the GTP hydrolysis and the GDP-bound form of the Ypt
can be solubilized by GDI and used in a new cycle.  s = soluble, m = membrane-bound.
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The mechanism by which the interaction with the correct membrane is achieved is
poorly understood, but it appears that the hypervariable C-terminus is involved in specific
membrane interaction (Brennwald and Novick, 1993; Chavrier et al., 1991).  In addition
hypothetical receptors could be important to mediate a correct membrane interaction
(Dirac-Svejstrup et al., 1997; Soldati et al., 1995; Ullrich et al., 1994).  The recently
described complex of Yip1p and Yif1p is a candidate membrane receptor for Ypt1 and
Ypt31/Ypt32 GTPases on Golgi compartments (Matern et al., 2000; Yang et al., 1998).
After membrane association, GDI dissociates from transport GTPases.  A GDI
displacement factor (GDF), with specific action on endosomal Rab proteins, was
isolated in mammalian cells (Dirac-Svejstrup et al., 1997).  Such a factor has not
been identified in yeast yet.  Once a GDP-bound GTPase associates with the
membrane, GDP has to be exchanged for GTP, in order to activate the protein
(Soldati et al., 1994; Ullrich et al., 1994).  The exchange reaction is catalyzed by a
guanine nucleotide exchange factor (GEF) (Cherfils and Chardin, 1999; Day et al.,
1998; Sprang and Coleman, 1998).  Known Ypt/Rab specific GEFs are Rabex-5 for
Rab5 (Horiuchi et al., 1997), Vps9p for Ypt51p (Hama et al., 1999) and Sec2p for
Sec4p (Walch-Solimena et al., 1997).  GEF activity for Ypt1p and Ypt31/32 appears
to reside in the 10-component TRAP complex (Jones et al., 2000; Wang et al.,
2000b) Ypt6p-GEF activity in the heterodimeric Ric1/Rgp1 complex (Siniossoglou et
al., 2000) and Vps39p, a component of the multi-protein complex C-VPS/HOPS,
stimulates the nucleotide exchange on Ypt7p (Wurmser et al., 2000).  Finally, when a
GTPase has fulfilled its function, GTP is hydrolyzed.  The Ypt’s weak intrinsic
GTPase activity (<0.01 min-1 at 30 °C; see Table 4.1) is accelerated many orders of
magnitude by GTPase activating proteins (GAPs).  In yeast, eight GAPs for Ypt/Rab
proteins have been identified (see Section 1.4.4).  In mammals, only two Rab-GAPs
are currently known: GAPCenA that prefers Rab6 as substrate (Cuif et al., 1999) and
Rab3-GAP that is specific for Rab3 subfamily members (Burstein and Macara, 1992;
Clabecq et al., 2000; Fukui et al., 1997). GAPCenA shares sequence similarity with
yeast Ypt/Rab-GAPs, but the sequence of Rab3-GAP seems to be totally different.
1.4.3  Ypt1p
Ypt1p is a 23 kDa GTP-binding protein (Gallwitz et al., 1983), and together with
Sec4p (Salminen and Novick, 1987) is the founding member of the Ypt/Rab family of
small GTPases.  After its discovery in yeast, Ypt1p homologues were found in mouse
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(Haubruck et al., 1987) and rat (Rab1p, the acronym Rab stays for rat brain) (Touchot et
al., 1987) and subsequently in many others species.  Ypt1p is predominantly localized to
Golgi membranes (Segev et al., 1988), the mammalian homolog Rab1p is found on ER
membranes, pre-Golgi intermediates, and early compartments of the Golgi complex
(Saraste et al., 1995).  Ypt1p acts in ER-to-Golgi transport and intra-Golgi transport
(Jedd et al., 1995).  As shown by the use of mutants (Becker et al., 1991; Schmitt et al.,
1988; Segev et al., 1988) and of cell-free transport systems (Rexach and Schekman,
1991; Segev, 1991), the GTPase is required for docking of ER-derived vesicles to Golgi
membranes.  There are data indicating a role of Ypt1p in recruiting the docking factor
Uso1p (Cao et al., 1998; Sapperstein et al., 1996).  This was also observed  in
mammalian cells, where it has been demonstrated that Rab1p recruits p115 (the
mammalian homolog of Uso1p) onto COPII vesicles where it interacts with a select set
of SNARE proteins (Allan et al., 2000).  Other in vitro transport studies indicated that
Ypt1p is functionally required on the Golgi acceptor membrane (Cao and Barlowe,
2000).  Genetic interactions between YPT1 and both SEC34 and SEC35 genes
(encoding for the proteins of the tethering Sec34p/Sec35p complex) have been also
documented (VanRheenen et al., 1998; VanRheenen et al., 1999).
Loss of Ypt1p function results in the accumulation of vesicles and ER
membranes and finally in cell death.  This phenotype can be suppressed by high
expression of the SNAREs Sec22p and Bet1p (Dascher et al., 1991).  The
suppressive effect is even stronger when there is co-overexpression of Bos1p with
either Sec22p (Lian et al., 1994) or Bet1p (Stone et al., 1997), all SNAREs involved
in ER-Golgi transport.  Furthermore, the loss of Ypt1p can be efficiently suppressed
by a dominant mutant allele of SLY1 (SLY1-20) (Dascher et al., 1991; Ossig et al.,
1991) that encodes a member of the Sec1p protein family (see Section 1.4).  These
and other experiments (Lupashin and Waters, 1997; Sogaard et al., 1994) showed
that Ypt1p is required to facilitate SNAREs complex formation.
To study the function of Ypt1p, several mutants created by site-directed
mutagenesis have been used; of special interest are single amino acid substitutions
within the conserved domains G4 (N121I) and G3 (Q67L).  The N121I substitution
turned out to be a dominant negative inhibitor of transport (Schmitt et al., 1988;
Schmitt et al., 1986) most likely because of its tight interaction with a still unknown
effector.  The Q67L mutation, in analogy to the equivalent substitution in Ras,
believed to lock Ypt1p in the active GTP-bound form, apparently does not induce any
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easily observable phenotype (Richardson et al., 1998).  From this, it was concluded
that GTP hydrolysis is not important for the GTPases function in transport, but this
view will be challenged by the data presented in this Ph.D. thesis.
1.4.4  The Gyp protein family
The slow intrinsic GTPase activity of Ypt/Rab GTPases (<0.01 min-1) has to be
accelerated by GAPs in order to allow the termination of the GTPases function and
the recycling of the regulators.  Ypt/Rab-GAP proteins were first identified in yeast by
high expression cloning and named Gyp (GAP for Ypt) (Strom et al., 1993; Vollmer
and Gallwitz, 1995).  Gyp proteins form a family with several structurally related
members.  This was predicted by a sophisticated computer search (Neuwald, 1997;
Neuwald et al., 1997), and subsequently proven by biochemical analysis (Albert and
Gallwitz, 1999; Albert and Gallwitz, 2000; Albert et al., 1999; Cuif et al., 1999).  To date,
there are eight yeast proteins proven to be Ypt/Rab-GAPs (Gyp1p-Gyp8p) (see Table
1.3).  In addition, there are other yeast proteins (the products of YMRO55c/BUB2,
YMR192w and YGL036w reading frames) that share sequence similarity with Gyp family
members.
Table 1.3  Yeast Ypt/Rab-GAPs.
GAP ORF Length MW(kDa) pI
Substrate
(main substrates
are underlined)
References
Gyp1p YOR070c 637 73.3 6.71
Sec4p, Ypt51p,
Ypt1p, Ypt7p.
(Albert et al., 1999;
Du et al., 1998; Rak
et al., 2000).
Gyp2p
(Mic1/Mdr1) YGR100w 950 109.23 5.25
Ypt6p, Sec4p. (Albert and Gallwitz,
1999).
Gyp3p
(Msb3) YNL293w 633 73 7.3
Sec4p, Ypt6p,
Ypt51p, Ypt31p
(Albert and Gallwitz,
1999).
Gyp4p
(Msb4) YOL112w 492 57.1 5.39
Ypt6p, Ypt7p,
Sec4p.
(Albert and Gallwitz,
2000).
Gyp5p YPL249c 894 101.8 4.73 Ypt1p, Sec4p. This work.
Gyp6p YJL044c 458 53.8 5.84 Ypt6p, Ypt7p. (Strom et al., 1993; Will
and Gallwitz, 2001)
Gyp7p YDL234c 746 87.3 5.02
Ypt7p, Ypt6p,
Ypt31p, Ypt32p.
(Albert et al., 1999;
Vollmer et al., 1999).
Gyp8p YFL027c 497 57.7 8.81
Ypt6p, Ypt1p,
Sec4p.
S. Albert unpublished
data.
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Gyp proteins share six conserved sequence motifs (A, B, C, D, E, F) (Neuwald,
1997) (Fig. 4.2).  These sequence motifs (present also in several proteins in different
eukaryotic organisms) are localized within the catalytic domain of Gyp proteins and will
be referred to as the “GYP domain”.  However, the GYP domain does not represent
the complete catalytic domain, additional sequences downstream of the conserved
motifs are required for GAP activity.  A detailed mutational analysis of the catalytically
active regions in Gyp1p and Gyp7p has revealed a conserved arginine residue in motif
B which is critical for the catalytic activity (Albert et al., 1999).  It was therefore
postulated that Ypt/Rab-GAPs exhibit an "arginine finger" mechanism of GTPase
accelerating activity similar to that previously described for Ras- and Rho-GAPs
(Ahmadian et al., 1997; Rittinger et al., 1997a; Rittinger et al., 1997b; Scheffzek et al.,
1997; Scheffzek et al., 1998).  According to the  "arginine finger hypothesis" GAP
supplies an arginine residue into the active site of the GTPase to favor GTP hydrolysis
and thereby to stabilize the transition state of the reaction (see Fig. 1.8).
Fig. 1.8  Scheme of the Ras/Rho GAP
complex from (Scheffzek et al., 1998).
The transition state is shown as having a
pentacoordinate γ-phosphate group due
to nucleophilic attack of a water molecule
(w). The catalytic arginine residue of GAP
"arginine finger", together with a "finger
loop", crosses the "gap" between the
proteins in order to neutralize developing
charges during the transition state of the
reaction and stabilize the critical catalytic
glutamine residue in Ras/Rho proteins
(Q61 in Ras and Q63 in Rho).  A
"secondary", positively charged residue, (Arg in Ras-GAP and Lys in Rho-GAP), stabilizes
the "finger loop".  GMP = guanosine monophosphate.
The crystal structure of the Gyp1p GAP-domain, recently solved (Fig. 1.9) (Rak
et al., 2000), revealed that the protein is purely α-helical (16 α-helixes) and V-
shaped.  In accordance with the biochemical data, the critical arginine (R343) is
positioned in the presumed GTPase-binding cleft where it could come into close
contact with the bound GTP.  It is interesting to note that while Ras- Rho- and
Pβ Pγ
 δ-
 δ- -
 +
Catalytic arginine
"finger arginine"
 Arg/LysArg
w
Mg2+
Gln
GMP
 Stabilizing
basic residue
GAP
Ras/Rho
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Ypt/Rab-GTPases are significantly related in primary and tertiary structure, the
corresponding GTPase- activating proteins are not at all related in primary structure
and display distinct folds, however, their overall structures are nearly exclusively α-
helical and their catalytic activities are based on same mechanistic principle (Barrett
et al., 1997; Rak et al., 2000; Scheffzek et al., 1996).
None of the eight yeast Ypt/Rab-GAPs studied so far is essential for cell viability
or, after gene deletion, results in a observable phenotype.  This might be due to
overlapping substrate specificity as all Gyp proteins accept more than one GTPase
as substrate (Table 1.3).
One of the aims of this work was the detailed characterization of a member of
the family of Ypt/Rab-GAPs, Gyp5p, the preferred substrate of which turned out to be
Ypt1p.  In addition, an attempt was made to explain the biological relevance of its
GAP activity within the living cell.
"D"
"A"
"C"
"B"
"E"
Fig. 1.9  The three-dimensional structure of Ypt-GAP of Gyp1p (from A. Rak et al, 2000).
The ribbon diagram displays the secondary structure elements and the catalytic active
arginine (Arg 343) in a ball-and-stick representation.  Regions of the conserved motifs A-F
are highlighted in green.
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2  MATERIALS
Bacterial and yeast strains, mammalian cell lines, plasmids, oligonucleotides
and antibodies are listed and described in Appendix (Chapter 7).
2.1  Growth media
2.1.1  Media components
Bacto-agar, bacto-peptone 140, bacto-yeast-extract, and bacto-yeast nitrogen
base w/o amino acids from Difco (Detroit, USA).  D-glucose, D-raffinose, D-galactose, D-
fructose, ammonium sulfate, potassium acetate and amino acids from SERVA
(Heidelberg, Germany).  Geneticin G418 Sulfate from Calbiochem (La Jolla, CA, USA),
Ampicillin Na-salt, kanamycin sulfate, chloramphenicol and tetracycline from SERVA,
Penicillin-Streptomycin from Gibco BRL. (Karlsruhe, Germany).  3-Amino-1,2,4-Triazole
(3-AT) and 5-Fluoroorotic acid (5-FOA) from Sigma-Aldrich (Deisenhofen, Germany).
Dulbecco’s Mod. Eagle Medium and Sodium Bicarbonate from Gibco BRL. (Karlsruhe,
Germany). Fetal Bovine Serum  F-7524 from Sigma (Deisenhofen, Germany)
2.1.2  Bacterial media
All media were autoclaved for 20 min at 120oC and stored at 4oC.  Solid media
were obtained adding bacto-agar at the final concentration of 1.5 % (w/v).
LB (Luria Bertani)   5 g/l Yeast extract
10 g/l Bacto-peptone
  5 g/l NaCl
  5 ml/l NaOH 1N
SOC 20 g/l Bacto-peptone
  5 g/l Yeast extract
  0.5 g/l NaCl
prior to use add: 10 ml/l 1M MgCl2 (filter sterilized)
 10 ml/l 1M MgSO4 (filter sterilized)
   1 ml/l 2M Glucose (filter sterilized)
Additives
0.1-1 mM IPTG
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Antibiotics: 100 µg/ml Ampicillin
  50 µg/ml Kanamycin
  30 µg/ml Chloramphenicol
  15 µg/ml Tetracycline
2.1.3  Yeast media
All media were autoclaved for 20 min at 120oC and stored at 4oC.  Solid media
were obtained adding bacto-agar at the final concentration of 2 % (w/v).
YEPG (YEPGal) 10 g/l Yeast extract
20 g/l Peptone 140
20 g/l D-glucose (D-galactose)
20 mg/l Uracil
20 mg/l Adenine sulphate
YEPG 0.1% 10 g/l Yeast extract
20 g/l Peptone 140
  1 g/l D-glucose
20 mg/l Uracil
20 mg/l Adenine sulphate
PM-glucose   1.7 g/l Yeast nitrogen base w/o amino acids
(PM-galactose)   5 g/l Peptone 140
(PM-raffinose)   5 g/l Ammonium sulfate
20 g/l D-glucose (D-galactose) (D-raffinose)
SD   1.7 g/l Yeast nitrogen base w/o amino acids
  5 g/l Ammonium sulfate
20 g/l D-glucose
SMM   1 g/l KH2PO4
  1 g/l NH4Cl
  0.2 g/l CaCl2
  0.6 g/l MgCl2
  0.5 g/l NaCl
  3 g/l Yeast extract
20 g/l Glucose
Additives
Amino acids: 20 mg/l Uracil
20 mg/l Adenine sulphate
20 mg/l L-tryptophan
20 mg/l L-histidine
30 mg/l L-leucine
30 mg/l L-Lysine/HCl
Antibiotics: 200 mg/l geneticin G418
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2.1.4  Mammalian cell media
DME 10% FCS (10 l) 1 Package Dulbecco’s Mod. Eagle Medium
37 g Sodium Bicarbonate
200 ml Penicillin-Streptomycin (10000 IU/ml)
1 l Foetal Bovine Serum
2.2  Frequently used buffers and solutions
TAE 50X 242 g/l Tris-base
57.1 ml/l Glacial acetic acid
18.612 g/l EDTA
DNA loading buffer 10X 30% (w/v) Ficoll
0.25% (w/v) Xylene Cyanol FF
0.25% (w/v) Bromophenol Blue
0.5 M EDTA, pH 8.0
30% Acrylamide-stock sol. 29.2%(w/v) Acrylamide
0.8% (w/v) Bisacrylamide
APS 10% (w/v)
Laemmli loading buf. 2X 0.1M Tris-HCl, pH 6.8
2% (w/v) SDS
2% (v/v) ß-Mercaptoethanol
20% (v/v) Glycerol
0.002%(w/v) Bromophenol Blue
SDS electrophoresis buf. 0.19 M Glycine
25 mM Tris-base
0.1% (w/v) SDS
Coomassie fixing sol. 25% (v/v) Isopropanol
10% (v/v) Glacial acetic acid
Coomassie staining sol. 10% (v/v) Glacial acetic acid
60 mg/l Coomassie brilliant blue R250
Western blot 20 mM Tris-base
transfer buffer 150 mM Glycine
20% (v/v) Methanol
Ponceau S solution 2.5 g/l Ponceau S
15% (v/v) Glacial acetic acid
40% (v/v) Methanol
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Western blot 10 mM Tris-HCl, pH 7.4
washing buffer A 0.9% (w/v) NaCl
0.05% (v/v) Tween 20
Western blot 0.2% (w/v) SDS
washing buffer B 0.9% (w/v) NaCl
0.5% (v/v) Triton X-100
0.5% (w/v) BSA
HPLC buffer 10 mM Tetrabutylammonium bromide
100 mM K2HPO4/KH2PO4, pH 6.5
0.2 mM NaN3
2-4% (v/v) Acetonitrile
GAP reaction buffer 50 mM Tris-HCl, pH 8.0
5 mM MgCl2
1 mM DTT
PBS 137 mM NaCl
2.7 mM KCl
4.3 mM Na2HPO4 7H2O
1.4 mM KH2PO4
pH 7.3
Phenol Phenol saturated with TE
0.1% (w/v) Hydroxychinoline
SSC 20X 3 M NaCl
0.3 M Na-citrate
TE 10 mM Tris-HCl, pH 7.4-8.0
1 mM EDTA, pH 8.0
TBS 100 mM Tris-HCl, pH 7.5
0.9% NaCl
Buffer 88 20 mM HEPES pH 7.0
0.25 M Sorbitol
0.15 M KOAc
5 mM MgOAc
2.3  Chemicals
All chemicals used were of analytical grade and were purchased from Boehringer
(Mannheim, Germany), Merck (Darmstadt, Germany), Sigma Deisenhofen, Germany)
or Serva (Heidelberg, Germany) unless otherwise stated.  Tran35S-label from ICN
(Meckenheim, Germany) and Amplify fluorografic reagent from Amersham
(Braunschweig, Germany).  Glutathione sepharose 4B, protein A sepharose fast flow
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and protein G sepharose fast flow were from Pharmacia (Freiburg, Germany).  Ni-NTA
agarose from QIAGEN (Hilden, Germany).  Bradford protein assay reagent and Chelex
100 resin from Bio-Rad (Munich, Germany).  Protease inhibitors cocktail tablets and
PefablocSC (4-2-Aminoethyl-benzenesulfonyl fluoride) from Roche (Mannheim,
Germany).  Prestained protein ladder BenchMark from Gibco Brl (Karlsruhe,
Germany), Rainbow protein marker from Amersham (Braunschweig, Germany).
2.4  Enzymes
Restriction endonucleases were from Boehringer (Mannheim, Germany), New
England Biolabs (Frankfurt, Germany), and Promega (Mannheim, Germany).  T4-
polymerase, T4-DNA ligase and RNase were from Boehringer (Mannheim,
Germany).  Taq DNA polymerase was from Perkin Elmer (New Jersey, USA), Deep
Vent DNA polymerase from Thermococcus litoralis was from New England Biolabs
(Frankfurt, Germany), Pfu DNA polymerase from Stratagene (Heidelberg, Germany).
Zymolyase 100T from Arthrobacter luteus was from Seikagaku Corp. (Tokyo, Japan),
Lyticase partially purified from Arthrobacter luteus was from Sigma (Deisenhofen,
Germany), ß-glucuronidase/arylsulfatase from Helix pomatia was from Boehringer
(Mannheim, Germany).  Thrombin was from Sigma (Deisenhofen, Germany).
2.5  Reaction systems, Kits
Plasmid DNA extraction from E. coli, DNA extraction from agarose gels and
purification of PCR products were performed with a QIAGEN Spin Miniprep or
Midiprep kit, a QIAquick Gel Extraction kit, a QIAquick PCR purification kit
respectively, from QIAGEN (Hilden, Germany).
ECL western blotting detection reagents, ECL direct nucleic acid labeling, 3’-
oligo-labeling and detection system, and Lumi-LightPLUS western blotting substrate
from Amersham-Buchler (Braunschweig, Germany).
QIAexpressionist (His-tag) from QIAGEN, GST-fusion system from Pharmacia
(Freiburg, Germany) and MBP-fusion system from New England Biolabs (Frankfurt,
Germany).
For Sequencing the Thermo Sequenase dye terminator cycle sequencing kit
from Amersham was used.
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2.6  Disposable supplies
Autoradiography films X-Omat from Kodak-Eastman (Rochester, New York, USA).
Nitrocellulose membrane filters BA 85 and Nylon membrane filters Nytran-N from
Schleicher and Schuell (Dassel, Germany).  Whatman 541 Filter and Whatman 3MM
paper from Whatman (Maidstone, UK).  Filtropur BT50 0.2µm 500ml from Sarstedt
(Nümbrect, Germany), non pyrogenetic 0.22 µm filter Millex-GS from Millipore (Molsheim,
France).  Centricon concentrators from Amicon (Beverly, USA), and membra-spin PES
columns  (membraPure, Bodenheim, Germany).  Reaction vials 0.5 ml, 1.5 ml and 2 ml
from Eppendorf (Hamburg, Germany).  Polypropylene Falcon vials 15 ml and 50 ml from
Becton –Dickinson (Heidelberg, Germany).  Petri dishes from Nunc (Wiesbaden,
Germany).  Electroporation cuvettes from Invitrogen (Leek, The Netherlands).  All other
materials including glassware were purchased from Schütt (Göttingen, Germany).
2.7  Laboratory gadgets
Centrifuges: Eppendorf bench centrifuge 5415 (Eppendorf, Hamburg, Germany),
Hereaus Laborfuge GL, Sorvall RC-5B with rotors HS-4, HB-4, GSA, SS-34 and SA600
(DuPont Instruments, Bad Homburg, Germany), Ultracentrifuges TL-100, L7, L8-M with
rotors TLA100.3 45Ti 70Ti SW40Ti and SW60 Ti (Beckman, Munich, Germany).
Electroporation chamber BioRad Gene-Pulser with pulse-controller from BioRad
Laboratories (Munich, Germany).  Gel dryer BioRad Slab Dryer 443 and 448 from BioRad
Laboratories (Munich, Germany).  Homogenizer Gaulin Micron Lab 40 “French Press”
from APV Gaulin (Lübeck, Germany).  HPLC (High performance liquid chromatography)
“System GOLD” from Beckman (Munich, Germany).  Incubators: Gyrotory Shaker and
controlled environment incubators from New Brunswick (Edison, NJ, USA).  Lumi-imager
from Boehringer (Mannheim, Germany).  Micromanipulator from Singer Instruments
(Watchet, GB).  Spectrophotometer Uvikon 860 from Kontron instruments (Eching,
Germany).  Microscopes: Zeiss Photomicroscope Axiophot (Zeiss, Oberkochen,
Germany), Leitz Laborlux (Leitz, Bad Bensheim, Germany), Confocal Leica TCS NT laser
scanning microscope.  PCR thermocycler devices PTC-100 from MJ Research Inc. (MA,
USA), and RoboCycler gradient 40 from Stratagene (Heidelberg, Germany).  Radiography
developing machine Gevamatik 60 from AGFA Gevaert (Hannover, Germany).  DNA
Sequencer 373A  from Applied Biosystems (Weiterstadt, Germany).  Transilluminators
302 and 366nm  from Bachofer (Reutlingen, Germany).  Sonicator: sonifier-B15 and 250
from Branson ultrasonics (Schwäbisch Gmünd, Germany)
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3  METHODS
Molecular biological and biochemical methods used in this work are in more
detail described in standard manuals like: “ Molecular Cloning” (Sambrook et al.,
1989), “Current Protocols in Molecular Biology” (Ausubel et al., 1997),“Current
Protocols in Protein Science (Coligan et al., 1997), Current protocols in cell biology
(Bonifacino et al., 1999).
3.1  Bacteria and yeast culture techniques
Bacterial strains were grown in the described media (see 2.1.2) at 37°C or at lower
temperatures.  For short-time storage, bacteria plates were sealed with Parafilm and
stored at 4°C. For long time storage, 0.9 ml of overnight cultures were mixed with an
equal volume of 50% sterile glycerol (50% glycerol / 50% LB medium), rapidly frozen
in liquid nitrogen and then kept at –80°C.
Yeast strains were grown in the described media (see 2.1.3), usually at 30°C, or,
when required, at different  temperatures ranging from 15°C to 37°C.  For short time
storage, streaked yeast plates were sealed with Parafilm and stored at 4°C.  For long
time storage, 0.9 ml of overnight cultures were mixed with equal volume of 60%
sterile glycerol (60% glycerol 50% SD medium), rapidly frozen in liquid nitrogen and
then stored at –80 °C.
3.2  DNA preparation, manipulation, amplification and analysis
3.2.1  Bacterial plasmid DNA preparation
Small-, medium- and large-scale plasmid extractions were performed using
Plasmid mini-, midi- and maxi-prep from QIAGEN according to the manufacturer's
recommendations.
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3.2.2  Yeast genomic and plasmid DNA preparation
10 ml of overnight cultures were centrifuged to collect the cells. The cell pellets
were washed with distilled water and resuspended in 200 µl of “braking buffer”.  To
this mixture 200 µl of phenol/chloroform/isoamyl alcohol (25:24:1) and 0.3 g of acid-
washed glass beads were added.  Cells were broken by vortexing for 5 min.  After
vortexing, 200 µl of TE buffer were added to each tube and subsequently the tubes
were centrifuged for 10 min at 14.000 rpm.  The aqueous phase was collected in new
test tubes and 2-5 µl used directly for transformation of E. coli when plasmid DNA
was isolated.  In the case of genomic DNA isolation, the DNA and the RNA present in
the aqueous  phase was precipitated with 1 ml 96% ethanol.  The DNA/RNA pellet,
obtained after 5 min centrifugation at 14.000 rpm, was dissolved in 400 µl of TE
buffer containing 0.1 mg/ml RNase A and incubated for 5 min at 37 °C.  Finally, the
genomic DNA was precipitated adding 10 µl of 4 M Ammonium acetate and 1 ml of
96% Ethanol. The DNA pellet was dissolved in 50-70 µl 10 mM Tris-HCl pH 8.0.
Breaking buffer 2% Triton X-100
1% SDS
100 mM NaCl
 10 mM Tris-HCl pH 8.0
1 mM EDTA pH 8.0
3.2.3  Spectrophotometric estimation of DNA purity and quantitation
As described in “Molecular Cloning” (Sambrook et al., 1989), it is possible to
quantify nucleic acids and to evaluate their purity by spectrophotometric analysis.
DNA and RNA absorb light of 260 nm wavelength, proteins (aromatic amino acids)
absorb light of 260 nm wavelength too, but absorption is much stronger at 280 nm.
The ratio A260/A280 gives an estimation of DNA purity.  For pure DNA, A260/A280
ratio is about 1.8.
Spectrophotometric conversion:1A260 of double-stranded DNA = 50 µg/ml
1A260 of single-stranded DNA = 33 µg/ml
1A260 of single-stranded RNA = 40 µg/ml
3.2.4  Enzymatic treatment of DNA
Restriction enzyme digestion was carried out according to standard procedures
(Sambrook et al., 1989).  Depending on the  enzymes used and their cutting sites,
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sticky-ended (5’- or 3’-protruding single strand DNA) or blunt-ended DNA fragments
can be generated.  Restricted DNA fragments were purified either by gel
electrophoresis and extraction using a QIAGEN gel extraction kit, or by using a
QIAGEN PCR and nucleotides purification kit.
DNA fragments with compatible cohesive ends can be ligated using T4 DNA
ligase which catalyses the ATP-dependent ligation of blunt or complementary sticky
ends of DNA.  Sticky-end ligations were carried out at room temperature for 2-4 h
using a 1:1 - 1:5 vector:insert molar ratio.  Blunt-ended ligations were carried out at
14°C overnight, with a 1:5 molar ratio of vector:insert.  A typical 20 µl reaction mixture
contain: 50-100 ng insert DNA, 10-50 ng vector DNA, 1x ligase buffer, 0.5-1 mM
ATP, 1U T4 DNA ligase, water.
3.2.5  E. coli transformation
E. coli cells were transformed either by heat shock or by electroporation.  The
two methods differ in the efficiency, in the first the efficiency can be 106-108
transformants per µg of DNA, in the second 107-109 transformants per µg of DNA.
a) Preparation of competent cells and transformation by heat shock
To render the cells competent, the method of Hanahan (Hanahan et al., 1991)
was employed.  Upon reaching an OD600 of 0.5-0.9, a 50 ml culture was harvested by
centrifugation (10 min at 4.000g, 4°C) .  Cells were resuspended in 20 ml of cold RF1
buffer and left on ice for 15 min, then the cells were centrifuged again and
resuspended in 4 ml RF2 buffer.  70 µl aliquots were taken, rapidly frozen in liquid
nitrogen and stored at –80°C.
RF1 100 mM RbCl
50 mM MnCl2
30 mM KOAc
10 mM CaCl2
15% (v/v) Glycerol
(pH adjusted to 5.8 with 0.2 M acetic acid; sterilized by filtration through 0.2µm filters)
RF2 10 mM MOPS
10 mM RbCl
75 mM CaCl2
15% (v/v) Glycerol
(pH adjusted to 6.8 with NaOH; sterilized by filtration through 0.2µm filters)
Methods32
Transformation: 1-10 ng of plasmid DNA or 10 µl ligation mixture were added to 70 µl
competent cells (thawed on ice).  Cells were incubated for 40 min on ice, then heat-
shocked for 90 sec at 42°C.  Thereafter, 1 ml SOC medium was added and the samples
were incubated with agitation at 37°C for 45 min.  Finally, cells were plated onto LB-agar
plates containing the appropriate antibiotic and incubated overnight at 37°C.
b) Preparation of competent cells and transformation by electroporation
10 ml of overnight culture of E. coli were used to inoculate 1l of fresh LB medium.
The culture was grown at 37 with agitation until an OD600 of 0.5-0.9 was achieved.  Cells
were harvested by centrifugation (10 min at 4.000g, 4°C) .  The cell pellet was washed 2
times with 1 volume sterile cold water and 1 time with 20 ml sterile cold 10% glycerol.
Finally, cells were resuspended in 2 ml sterile cold 10% glycerol, dispensed in 40 µl
aliquots and frozen in liquid nitrogen.  The frozen cells were stored at –80°C.
Transformation: 40 µl electro-competent cells were thawed on ice and
transferred to a chilled 0.2 cm electroporation cuvette. 1-2 µl of ligation mixture was
added and the sample was kept on ice for 1 min.  Thereafter, the cuvette was
transferred to a Gene Pulser electroporation chamber and pulsed once with 25 µF,
2500 V, 200 Ohms.  1 ml SOC medium was added immediately after the pulse and
the sample transferred to a 2 ml Eppendorf tube and incubated with agitation at 37°C
for 45 min.  Cells were then plated onto LB-agar plates containing the appropriate
antibiotic and incubated overnight at 37°C.
3.2.6  PCR amplification of DNA
The polymerase chain reaction (PCR) is a very useful technique that allows to
produce high yields of specific DNA target sequences (Saiki et al., 1988).  PCR was
used in this work:
- to isolate specific genes from yeast genomic DNA.
- to create appropriate restriction sites at the termini of DNA fragments to be cloned
into different vectors.
- to check whether a specific DNA fragment was correctly cloned into a vector or
correctly inserted into the genome.
- to check whether a gene was correctly deleted.
- to amplify  specific “cassettes” for gene disruption or gene tagging (see 3.3.2 and 3.3.3).
- for in vitro mutagenesis (see 3.2.7)
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Most PCR protocols are performed at the 25 µl -100 µl scale, larger volumes
are not recommended.
A typical 50 µl reaction mixture consist of:
1-10 ng plasmid DNA or 50-100 ng genomic DNA
20 pmol forward primer
20 pmol reverse primer
1x nucleotide mix (200 µM of each dNTP)
1x PCR buffer with MgCl2 (10 mM Tris-HCl pH8.3, 50 mM KCl, 1.5 mM MgCl2)
1 U DNA polymerase (Taq or a mixture Taq/Deep-Vent 5/1)
dH2O
The reaction is incubated in a thermocycler device where the temperature can
be  changed rapidly.  Usually there is a preheating step of 3 min at 93°C during which
the template DNA is denatured.  This is followed by  30-32 cycles of:
denaturing 30-60 sec at 92°C
annealing 30-60 sec at 45-60°C
elongation 30-120 sec at 72°C
the last cycle is followed by an extra elongation step of 5-10 min at 72°C.
The annealing temperature is dependent on the primers composition, on their
Tm (melting temperature) and on their homology with the template.  The primers may
have modifications such as extensions at their 5’ ends or point mutations.
PCR can be done directly from bacteria colonies.  Bacteria were taken with a
toothpick from agar plates, dissolved in 60 µl  PCR buffer 1x and boiled at 95°C for 5
min, after that 5 µl of the mixture were used as template for the PCR reaction.
PCR products were purified by using a QIAGEN PCR purification kit according
to the manufacturer's instructions.
3.2.7  In vitro mutagenesis
The Quick Change site-directed mutagenesis kit from STRATAGENE was used
to create point mutations in plasmid DNA containing cloned genes.  The basic
procedure starts with a supercoiled, dsDNA vector, with an insert of interest and two
long oligonucleotide primers (30-45 bases) containing the desired mutation.  The
oligonucleotide primers, each complementary to opposite strands of the vector, are
extended during temperature cycling by Pfu-Turbo DNA polymerase.  Incorporation of
the oligonucleotide primers generates a mutated plasmid.  After temperature cycling, the
product is treated with DpnI.  The DpnI is used to digest the methylated non mutated
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parental DNA template since DpnI is specific for methylated and hemimethylated DNA.  The
nicked vector DNA incorporating the desired mutations is then transformed into E. coli.
3.2.8  DNA-Sequencing
DNA fragments were sequenced using the thermo Sequenase dye terminator cycle
sequencing kit from Amersham on an ABI373A sequencing device according to the
manufacturer’s instructions.  Automated sequencing was performed by H. P. Geithe in this
department.
3.2.9  DNA-DNA hybridization (Southern blotting)
2-4 µg of genomic DNA (see 3.2.2) were digested overnight with the appropriate
restriction enzyme, run on an agarose gel, and then transferred to a nitrocellulose
membrane as described in (Sambrook et al., 1989, Southern, 1992 #26; Southern,
1975).  Specific DNA fragments obtained by PCR or by  plasmid digestion or synthetic
oligonucleotides, were used as probe. The probes were labeled with horseradish
peroxidase (HRP) using the ECL direct nucleic acid labeling system or the 3’-oligo-
labeling and detection system (Amersham) according to the manufacturer's instructions.
3.3  Yeast genetics and yeast cell biology methods
3.3.1  S. cerevisiae transformation
Transformation of yeast was carried out using a modified lithium acetate
method (Schiestl and Gietz, 1989). A 50 ml yeast culture was harvested by
centrifugation (4 min at 500g, RT)  upon reaching an OD600 of 0.8-1.0.  The cells
were washed once with 20 ml sterile distilled water and once with 2 ml filter-sterilized
LiOAc/TE/Sorbitol (100 mM LiOAc, 10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 7.5, 1M
Sorbitol), transferred to 2 ml tubes, harvested by centrifugation, resuspended in 0.5
ml LiOAc/TE/Sorbitol, and incubated at 30°C for 10 min.  50 µl cells mixture were
transferred to a new tube and to them were added: 300 µl of filter-sterilized 40%
PEG-3350 (40% w/v PEG-3350, 100 mM LiOAc, 10 mM Tris-HCl , 1 mM EDTA),
25µl 2 mg/ml denatured salmon sperm DNA (this can be omitted, but the efficiency of
transformation will be lower) and 1-5 µg PCR product or 0.1-1 µg plasmid DNA.  The
samples were mixed by vortexing and incubated at 30°C for 30 min, then heat-
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shocked at 42°C for 20 min.  Finally, cells were collected by centrifugation, washed
with 1 ml YEPG medium, resuspended in 2-3 ml YEPG medium (no vortexing) and
incubated for 2-3 h at 30°C (this incubation time can be avoid when cells are not
selected on geneticin).  After that cells were plated onto YEPG plates or SD plates
containing the appropriate selecting additives and incubated at 30 °C (or at the
required temperature) until colonies appeared.
3.3.2  Yeast PCR-mediated gene knock-out
A PCR-based gene deletion method as described in (Güldener et al., 1996) was
used.  The method relies on the amplification by PCR (see also 3.3.3) of the selectable
module loxP-kanMX-loxP from the pUG6 vector, using two primers with tail sequences
homologous to the yeast genomic sequences flanking the ORF to be deleted (the PCR
product is ~1600 bp long), followed by transformation and homologous recombination
into the yeast genome (see Fig. 3.1).  The minimum amount of homology sequence
required for homologous integration in S. cerevisiae's genome is 30 bp on each side of
a genomic locus (Manivasakam et al., 1995).  Transformants were selected on YEPG
plates containing 200 µg/ml G418).  The loxP sites flanking kanMX allow the excision
of the cassette (1507 bp) upon the expression of the Cre-recombinase (Güldener et
al., 1996; Sauer, 1987) (see Fig. 3.1.B).  In this way it is possible to delete different
genes using the same system repeatedly.  For Cre-mediated marker rescue the cells
were  transformed with the pSH47 plasmid containing the cre gene under the control of
the yeast GAL1 promoter.  Expression of the Cre-recombinase was induced by
incubating the transformants for 2-4 hours at 30°C in YEPGal medium (1 colony in 2 ml
medium).  The loss of the kanr marker was verified by replica plating onto YEPG/G418
selective medium.  pSH47 plasmid can be removed by streaking the cells on plates
containing 5-fluoroorotic acid.
With this method the strains ADY20-ADY28 and ADY40-ADY48 were created,
in which the genes GYP1, GYP5, GYP7 and GYP8 were deleted either alone or in
combinations (see Appendix, Table 7.2).  The primers used are listed in Table 7.7.
The correct deletion of these genes was verified by PCR (using primers that anneal
with sequences outside the deleted genes in combination with primers that anneal
with sequences inside the kanMX cassette) and by Southern blotting.
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3.3.3  Yeast PCR mediated epitope tagging
An epitope (also called antigenic determinant) is any structure or sequence that
is recognized by an antibody.  Epitope tagging is the addition of a short peptide to a
Fig. 3.1  Scheme of PCR-based gene deletion.  (A) PCR amplification of the loxP-kanMX-loxP
cassette from pUG6 using primers with tail sequences homologous to yeast genomic
sequences flanking the ORF to be deleted, and successive integration into that locus.  (B)
Excision of the kanr selection marker (1507bp DNA fragment) induced by the Cre recombinase;
one loxP sequence remains in the genome.
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target protein.  This technique has provided the means for the characterization and
purification of proteins without the need of specific antibodies.
A new method for PCR-mediated C-terminal epitope tagging, that allows the
tagging of chromosomal genes with sequences expressing the MYC, HA or VSV
epitopes, was created during this work (De Antoni and Gallwitz, 2000).  Three new
plasmids named pU6H2MYC, pU6H3HA and pU6H3VSV (pU-tag vectors) were
created (see Results, Section 4.3).  These plasmids contain the new modules 6His-
2MYC-loxP-kanMX-loxP, 6His-3HA-loxP-kanMX-loxP or 6His-3VSV-loxP-kanMX-loxP
that allow tagging of different genes by using the kanr marker repeatedly (see Fig. 3.2).
The method relays on the amplification by PCR of the tag-loxP-kanMX-loxP cassettes
using the  tag-forward and tag-reverse primers.  tag-forward = 5’-… … TCC CAC CAC
CAT CAT CAT CAC-3’, is a chimeric primer composed of 42-45 nucleotides derived
from the 3’-end of the gene of interest (excluding the stop codon, and in frame with the
epitope-encoding sequence), plus the 21 nucleotides shown, annealing to the 5’-end of
the cassette; tag-reverse = 5’-… … ACT ATA GGG AGA CCG GCA GAT C-3’, is
composed of 42-45 nucleotides derived from the sequence downstream of the gene of
interest (starting at either the stop codon or 50-100 nucleotides after the stop codon)
plus the 22 nucleotides shown, annealing to a sequence downstream of the cassette
(see Fig. 3.2).  The length of the amplified cassettes is 1711 bp from pU6H2MYC,
1735 bp from pU6H3HA, and 1753 bp from pU6H3VSV.  The primers used in this
study are listed in Table 7.7.  A 100 µl preparative PCR contains: 5-10 ng template
(pU6H2MYC, pU6H3HA or pU6H3VSV), 30 pmol of each primer (tag-forward and tag-
reverse), 200 µM of each dNTP, 1.5 U AmpliTaq (Perkin Elmer), 0.4U Deep Vent DNA
polymerase (NEB) and 10 µl 10X PCR buffer  (Perkin Elmer, containing 15 mM
MgCl2).  PCR conditions were: denaturation at 93°C for 3 min, followed by 32 cycles
(93°C for 1 min, 55°C for 1 min, 72 °C for 1.5 min) and a final elongation step at 72 °C
for 10 min.  The PCR products were purified with QIAquick PCR columns and 1-5 µg
used to transform yeast cells.  Transformants were plated onto YEPG plates
containing 200 µg/ml G418.  Plates were incubated at 30°C until colonies appeared.
Well grown colonies were re-streaked onto YEPG/G418 plates.
It is possible to excise the Kanr marker, by inducing the Cre-recombinase (see
3.3.2) and subsequently to tag other genes.
With this method the strains ADY1-ADY16 were created, that express different
tagged proteins such as Sec24p-MYC, Sec24p-HA, Sec24p-VSV, Sec23p-MYC,
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Sfb2p-MYC, Sfb2p-HA, Sfb2p-VSV, Sfb3p-MYC, Sfb3p-HA, Sfb3p-VSV, Gyp5p-
MYC, Gyp5p-HA and Gyp5p-VSV.
Fig. 3.2  Schematic representation of PCR-mediated epitope tagging.  The tag-loxP-kanMX-
loxP cassettes are amplified by PCR using pU6H2MYC, pU6H3HA and pU6H3VSV as
templates and chimeric primers (for more details see in the text).  The PCR products are then
used to transform yeast cells and the tag-cassette will be integrated in frame with the desired
ORF.  Finally, the kanr selection marker (1507 bp DNA fragment) is excised from the genome
by action of the Cre-recombinase so that another protein can be tagged.
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3.3.4  Growth analysis
To analyze growth defects of different mutant strains at different temperatures,
overnight cultures were diluted in fresh medium to reach an optical density OD600 ~
0.01, subsequently serial 10-fold dilutions were done.  5 µl cells from each dilution
were spotted onto a plate and put to grow at the appropriate temperature.
3.3.5  Invertase assay
Invertase catalyze the hydrolysis of sucrose in glucose and fructose.  Invertase
secretion is induced by low glucose concentration in the medium.  Secreted invertase
migrates in non-denaturing polyacrylamide gels as heterogeneous species with an
apparent molecular mass of 100-140 kDa.  The glycosylated ER-form has an apparent
molecular mass of 80-86 kDa.
Cells of different strains were grown in YEPG medium at 30°C to mid–log phase
and 10 OD units of cells were collected by centrifugation at 4.000g for 5 min at room
temperature.  Cells were washed with YEPG 0.1% (YEPG medium containing 0.1%
glucose) resuspended in 10 ml of YEPG 0.1% and incubated at the desired
temperature for 1-6 hours (1h at 37°C or 30°C, 2h at 25 °C, 4h at 20 °C, 6h at 15 °C)
(Esmon et al., 1981).  After induction, cells were collected, washed in 10 mM NaN3
and resuspended in 100 µl lyticase buffer.  Spheroplasts were formed by incubating
the cells at 30 °C for 1 hour with 200 units Lyticase (Sigma).  Subsequently, to isolate
periplasmic and intracellular invertase, the spheroplasts were fractionated as
described by (Schauer et al., 1985).  Spheroplasts were gently centrifuged at 1.000g
for 5 min at RT and the supernatant containing the periplasmic invertase was
transferred to a new tube.  The pellet, containing the intracellular invertase, was gently
washed with 1M sorbitol, resuspended in 100 µl lysis buffer and vortexed for 5 min at
4°C, finally the samples were centrifuged to eliminate cell debris, and the supernatant
(containing the intracellular invertase) was transferred to a new tube.  20 µl of each
sample were loaded onto a non denaturing 7% polyacrylamide gel.  Staining of active
invertase was performed as described by (Grossmann and Zimmermann, 1979).  The
gel was soaked in 200 ml sucrose buffer for one hour at 37°C, washed with water
and soaked in 150 ml staining buffer over a boiling bath till a red staining appeared.
The reaction was blocked washing the gel with cold water and 10% acetic acid.
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Lyticase buffer 1.4 M Sorbitol
50 mM K2HPO4/KH2PO4, pH 7.5
10 mM NaN3
80 mM β-mercaptoethanol
Lysis buffer 50 mM K2HPO4/KH2PO4, pH 7.5
10 mM NaN3
0.1% Triton X-100
Sucrose buffer 0.1 M Sucrose
0.1 M NaOAc
(pH 4.5-5.0)
Staining buffer (150 ml) 300 mg Triphenyltetrazoliumchloride
4 g NaOH
(dissolve separately then mix)
7% Polyacrylamide gel 5 ml 0.6M Tris-HCl pH 8.4
   (non denaturing) 8.7 ml 30% Acrylamide stock solution
26 ml H2O
0.3 ml 10% APS
17 µl TEMED
Running buffer (1l) 5.19 g Tris-HCl
2.5 g Glycine
(pH 9.5)
3.3.6  Pulse-chase
Overnight cultures of the appropriate strains were used to inoculate fresh SMM
medium and grown at the required temperature to reach an OD600 of 0.6-1.2.  Six OD
units of cells were harvested, resuspended in 500 µl SMM medium containing 1 mg/ml
ovalbumin and incubated at the appropriate temperature for 30-60 min.  After that cells
were pulsed for 10 min with 250 µCi Trans[35S]-label mix (a mix of [35S]-cysteine and
[35S]-methionine) followed by a chase of 30 minutes with methionine and cysteine (1.5
mg/ml each).  The incubation time for both pulse and chase was longer if the
temperature was lower than 30 °C.  To stop the reaction the samples were placed on ice
and NaN3, PMSF and Pefablock were added (final concentration was: 10 mM NaN3, 1
mM PMSF, 2 mM Pefablock).  The labeled samples were fractionated into intracellular
and extracellular fractions by centrifugation (1.000g for 5 min).  250 µl medium (the
extracellular fraction) was collected in new tubes and 10 µl 10% SDS were added, the
pellet (intracellular fraction) was washed once with PBS containing 10 mM NaN3 and
resuspended in 100 µl 1% SDS, both fractions were frozen in liquid nitrogen (they can
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be stored several days at -80°C).  The pellet samples were subsequently lysed by
vortexing for 5 min in the presence of 0.1 g glass beads, boiled for 5 min and centrifuged
at 14.000 rpm for 5 min.  The supernatant (~100 µl) containing the intracellular fraction
was transferred to new tubes and 500 µl 2x IP buffer plus 400 µl water were added .
The 250 µl extracellular fractions were treated in a similar way.  They were boiled for 5
min, centrifuged at maximum speed for 5 min and the supernatants transferred to new
tubes containing 500 µl 2x IP buffer plus 250 µl water.  The samples so treated were
ready for the immunoprecipitation with anti-carboxypeptidase Y (CPY), anti-Gas1p, or
anti alkaline phosphatase (ALP).  5-10 µl antiserum and 5 mg protein-A sepharose CL-
4B were added to each sample.  The samples were incubated overnight at 4°C (end-
over-end rotation).  After that the sepharose "beads" were sequentially washed with 1 ml
ice-cold washing buffer-1, washing buffer-2, and washing buffer-3.  The "beads" were
resuspended in 50 µl Laemmli buffer and boiled for 5 min at 95°C.  The
immunoprecipitated proteins were separated by SDS-PAGE on 10% Acrylamide gels
(see3.4.1.a).  After electrophoresis the gels were fixated for 20 min in a [10% acetic
acid / 25% methanol] solution, treated with Amplify (Amersham) according to the
manufacturer's instruction, dried and exposed to Kodak X-Omat AR films at -80°C for
2-10 days.
CPY is a soluble vacuolar hydrolase.  It leaves the ER as a core-glycosylated
precursor protein of 67 kDa, is further glycosylated in the Golgi apparatus (69 kDa),
and finally reaches the vacuole, where after a short proteolytic truncation, it becomes
active.  This mature form has a molecular mass of 61 kDa.  Gas1p is a 125 kDa
glycolipid-anchored plasma membrane protein.  The ER glycosylphosphatidylinositol-
containing precursor has a molecular mass of 105 kDa and, upon arrival in the Golgi,
is further glycosylated, reaching a molecular mass of 125 kDa.  ALP is a vacuolar
type II transmembrane enzyme.  The ER/Golgi glycosylated 76 kDa precursor protein
become active by proteolytic truncation after arrival to the vacuole.  The mature form
of ALP has a molecular mass of 72 kDa.
SMM 0.1% KH2PO4
0.1% NH4Cl
0.02% CaCl2
0.06% MgCl2
0.05% NaCl
0.3% Yeast extract
2% Glucose
Amino acids (according to the auxotrophy requirement)
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2x IP buffer 100 mM Tris-HCl, pH 7.5
2% Triton X-100
0.2% SDS
300 mM NaCl
2 mg/ml Ovalbumin
10 mM EDTA
4 mM Pefabloc
1 tablet/5ml protease inhibitors
Washing buff.-1 1x IP buffer
2M Urea
Washing buff.-2 : 1x IP buffer
500 mM NaCl
Washing buff.-3 150 mM NaCl
5 mM EDTA
50 mM Tris -HCl, pH 7.5
3.4  Biochemical methods
3.4.1  Polyacrylamide gel electrophoresis (PAGE)
The principle of polyacrylamide gel electrophoresis is the separation of a large
range of proteins of varying molecular masses under the influence of an electrical field
by means of a continuous, cross-linked polymer matrix.  Here, the polymer is
polyacrylamide and the cross-linking agent bis-acrylamide.  Cross-linking is effected
trough a radical-induced pathway by the addition of APS and TEMED (Ogden and
Adams, 1987).  In polyacrylamide gel electrophoresis, proteins migrate in response to an
electric field through pores in the gel matrix.  The pore size decreases with higher
acrylamide concentration.  The combination of gel pore size and protein charge, size
and shape determines the migration rate of the proteins (Coligan et al., 1997; Sambrook
et al., 1989).
a) Denaturing polyacrylamide gel electrophoresis (SDS-PAGE)
One dimensional gel electrophoresis under denaturing conditions (in presence
of 0.1% SDS) separates proteins on the base of their molecular size.  The mobility of
the proteins is inversely proportional to the logarithm of their molecular mass.  SDS is
employed to effect denaturation of the proteins, to dissociate protein complexes and
to impart upon the polypeptide chains net negative charge densities proportional to
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the length of the molecule.  A reducing agent such as DTT or 2-ME is used to reduce
any existing disulphide bond.  The method used is that described by Laemmli
(Laemmli, 1970).  Two gels are employed: a "stacking gel" with a low level of cross-
linkage and low pH, allowing proteins to enter the gel and collect without smearing,
and a "resolving gel" with a higher pH, in which the proteins are separated.  For an
8x10x0.1 cm gel the following volumes were used:
5% Stacking gel (5 ml) 3.4 ml H2O
0.83 ml 30% Acrylamide stock solution (see 2.2)
0.63 ml 1M Tris-HCl, pH 6.8
50 µl 10% SDS
50 µl 10% APS
5 µl TEMED
Resolving gel (10 ml) 10% 12% 15%
4 ml 3.3 ml 2.3 ml H2O
3.3 ml 4 ml 5 ml 30% Acrylamide stock sol
2.5 ml 2.5 ml 2.5 ml 1.5 M Tris-HCl, pH 8.8
100 µl 100 µl 100 µl 10% SDS
100 µl 100 µl 100 µl 10% APS
4 µl 4 µl 4 µl TEMED
For Laemmli loading buffer and electrophoresis buffer, see Materials 2.2.
b) Non-denaturing PAGE
The basis of separation in this case is as described above, with the exception
that proteins now separate with an apparent molecular mass based on the overall
size and shape of the molecule.  SDS is not added to such gels.  Electrophoresis is
performed at lower voltages and temperatures to reduce the risk of heat-denaturation
of the proteins.  In this study non-denaturing gel PAGE was used for analyzing
samples after invertase assay (see 3.3.5).
3.4.2  Preparative gel electrophoresis and electro-elution
To obtain up to milligrams amounts of proteins from an impure mixture, preparative
gel electrophoresis was employed.  The principle is the same as above (3.4.1), here
however, a gel of larger dimensions is poured , and a comb with a single slot is used that
allows the application of larger amounts of sample.  The band of interest is excised from
the gel after standard Coomassie staining (3.4.3.a) and eluted using an electro-elution
chamber.
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3.4.3  Staining of proteins in polyacrylamide gels
a) Coomassie brilliant blue staining
Gels were soaked in fixating solution with gentle shaking for 10 min, stained in
staining solution for 1 hour or for longer time at room temperature.  The background
was subsequently reduced by soaking the gel in 10% acetic acid solution in which
the gels can be kept for several days.  After that gels can be dried.
Fixating solution 25% (v/v) Isopropanol
10% (v/v) Glacial acetic acid
Staining  solution 10% (v/v) Glacial acetic acid
60 mg/l Coomassie brilliant blue R250
b) Silver staining
Gels were first fixated in fixating solution for 1 hour at room temperature, then
soaked for 30 min in incubation solution and washed 3x10 min in distilled water.
After that the gels were placed in binding solution for 20 min.  Finally the gels were
washed with water and put into developing solution till brown band appeared.  The
staining reaction was stopped by washing with 50 mM EDTA and subsequently the
gels were soaked in 10% acetic acid.  All the solutions should be freshly prepared.
Fixating solution 50% Ethanol
10% Acetic acid
Incubation solution 30% Ethanol
0.83 M NaOAc
13 mM Na2S2O3 (sodium thiosulfate)
0.25% Glutaraldehyde (to be added just before use)
Binding solution 6 mM AgNO3 (silver nitrate)
0.02% Formaldehyde
Developing solution 0.25 M Na2CO3
0.01% Formaldehyde
3.4.4  Western blotting and immunological detection of proteins on nitrocellulose filters
Proteins were separated by SDS-PAGE and electrophoretically transferred from
the polyacrylamide gels to nitrocellulose membranes as described by (Burnette, 1981).
The transfer was carried out at 100 mA constant current for 1 hour or at 30 mA
overnight.
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Transfer buffer 20 mM Tris-base
150 mM Glycine
20% (v/v) Methanol
After the transfer onto nitrocellulose the proteins were stained with Ponceau S
solution.  Then the membranes were washed briefly with washing buffer-A, treated with
blocking solution for 1 h at RT and incubated with the primary antibody in blocking
solution for 1 h at RT.  After 2x 5 min washes in buffer-A, 2x 5 min in buffer-B and once
again for 5 min in buffer-A, the membrane was incubated for 1 h at RT with the
horseradish peroxidase-coupled secondary antibody (1:10.000 dilution).  Finally, the
membranes were washed as described above.  Detection by chemiluminescence was
performed using the ECL detection system as recommended by the manufacturer.
Ponceau S solution 2.5 g/l Ponceau S
15% (v/v) Glacial acetic acid
40% (v/v) Methanol
Blocking solution 5% (w/v) low fat milk powder in washing buffer A
Washing buffer-A 10 mM Tris-HCl, pH 7.4
0.9% (w/v) NaCl
0.05% (v/v) Tween 20
Washing buffer-B 0.2% (w/v) SDS
0.9% (w/v) NaCl
0.5% (v/v) Triton X-100
0.5% (w/v) BSA
3.4.5  Protein quantitation
Protein concentrations were estimated according to the method of Bradford
(Bradford, 1976).  The method is based on the observation that the absorbance for the
protein-specific dye, Coomassie brilliant blue G-250 shift from 465 nm to 595 when
binding to protein occurs.  Therefore, the A595 yields  a good linear concentration
dependence for most soluble proteins.  800 µl of a proteins solution of unknown
concentration was mixed with 200 µl of the dye solution (BioRad) and the measured
A595 was plotted against a reference curve obtained with known concentrations of BSA.
3.4.6 Concentrating proteins
Protein solutions were concentrated using Centricon spin columns (Amicon), or
membra-spin PES columns (membraPure) as recommended by the manufacturer.
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3.4.7 Protein extraction
For a more detailed description about extraction conditions, see (Janson and
Ryden, 1989).
a) Proteins extraction from bacteria
Bacteria were harvested by centrifugation, suspended in cold lysis buffer (2-5
volumes per gram of wet weight) and sonicated 3 times on ice (1 min bursts/1 min
cooling/200-300 Watt).  The lysis buffer composition depended on the subsequent
use of the protein extracts (see 3.4.9).  After sonication the cell debris was separated
from the solubilized proteins by centrifugation (2x10 min at 5.000g).
Alternatively, total protein extracts for SDS-PAGE and western blotting were
obtained easily by resuspending the pellet from 1 OD600  cells with 100 µl Mg2+/SDS
buffer (Tris-HCl, pH 6.8 / 0.1 M MgCl2 / 4% SDS / 10% glycerol/ 5% 2-ME / 0.01%
bromophenol blue) and subsequently centrifuging for 2 min at 14000 rpm to remove
the precipitate (Chen and Christen, 1997).
b) Protein extraction from yeast
Total protein extracts from yeast can be obtained using several methods that
differ mainly in the way the cells are broken.  Those used during this work are
described below.
• Cell disruption by alkaline lysis
It is a fast method suitable to obtain denatured proteins for SDS-PAGE and
western-blotting analysis.
One OD600  unit of cells (~107 cells) was centrifuged (2 min at 10.000 rpm), and the
cell pellet washed with cold water, resuspended in 180 µl lysis buffer (2 M NaOH /
0.5% ß-mercaptoethanol) and incubated on ice for 5 min.  Proteins were precipitated
adding 20 µl 100% TCA.  After incubation on ice for 5 min, proteins were pelleted by
centrifugation (10 min at 14.000 rpm).  The pellet was then washed with acetone, left to
air dry thoroughly and resuspended in 100 µl  Laemmli loading buffer.  After being
boiled for 5 min proteins were separated by SDS-PAGE.
• Cell disruption by sonication
It is another fast method to obtain protein extracts for western blot analysis.  Five  OD600
units of
 
cells were centrifuged, washed with cold water, resuspended in 100 µl of lysis buffer
(20 mM HEPES⋅KOH, pH 7.2 / 150 mM KOAc / 1 mM MgOAc / 0.9% CHAPS / 2 mM
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Pefabloc) and sonicated for 5 sec.  To each sample were added 100 µl of 2X Laemmli
loading buffer.  After being boiled for 5 min proteins were separated by SDS/PAGE.
• Cell disruption by glass beads
This procedure is suitable for small-scale protein preparation.  It is very flexible
because it can be carried out easily on multiple small cell cultures, but the proteins
can be subjected to proteolysis due to the harsh treatment and heat developed
during the mechanical breakage.  These protein extracts are suitable for different
applications such as cell fractionation (see 3.4.10), immunoprecipitation (see 3.4.13)
and gel filtration (see 3.4.11).
Five ml of a mid-log phase culture was centrifuged, the cell pellet washed with cold
water was and resuspended with 200 µl cold lysis buffer.  The lysis buffer composition
was different depending on the subsequent use of the protein extract.  A typical glass
beads lysis buffer is composed of: 10 mM Tris-HCl, pH 8 / 2 mM MgCl2 / 1 mM DTT / 1
mM EGTA / 2 mM Pefabloc / protease inhibitors.  To each sample was added the same
volume of chilled acid-washed glass beads (0.45-0.55 mm) and the tubes were vortexed
3 times for 30-60 sec (maximum speed, at 4°C), with a pause on ice of 2 min each time.
Finally the tubes were centrifuged for 10 min at 500g.  The supernatant containing the
total protein extract was ready to be further processed.
• Cell disruption by liquid nitrogen
This method is designed for the processing of 50-500 ml of liquid culture  The
proteins obtained in this way are suitable for many applications.  This method was
mainly used in this work for cell fractionation (3.4.10).
The pellet from a 50-500 ml-culture was transferred to a mortar containing liquid
nitrogen and smashed until a fine powder was obtained.  The powder was dissolved
in the desired buffer and centrifuged 2 times at 500g for 5 min.  The supernatant
containing the total protein extract was ready to be further processed.
• Cell disruption by high-pressure homogenization (by french-press)
This is a method designed for processing big amounts of cells (> 1l liquid culture).
It was mainly used in this work to get big amounts of proteins to be purified by affinity
chromatography (3.4.9).
A 5 ml cell pellet was dissolved in 40 ml ice cold lysis buffer and the cell solution
was subjected for 3 times (with a pause on ice of 5 min each time) to 1380 bars
pressure produced by the "French press".  After centrifuging twice at 500g for 5 min,
the total protein extract was ready to be further processed.
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• Cell disruption by spheroplast formation and lysis
This is the most gentle way to break yeast cells, but also the most time
consuming.  Cells are converted to spheroplasts by zymolyase treatment, and then
lysed by osmotic shock.  This method was used in this work to obtain cell extracts
suitable for sucrose gradients (see 3.4.10.b).
c) Protein extraction from mammalian cells
During this work protein extracts from CV1 and Hela cells were used for
western-blotting analysis.  Cells were first washed twice with cold PBS, scraped off
the Petri dishes in PBS buffer with the aid of a rubber "policeman", then briefly
sonicated on ice and resuspended in Laemmli loading buffer.
3.4.8  Expression of proteins and recombinant proteins
Genes can be cloned into expression vectors, and expressed in the appropriate
cell systems.  An expression vector is a vector that contains the necessary regulatory
sequences for gene expression.  Both prokaryotic and eukaryotic expression vectors
exist, many of them are shuttle vectors (cloning vectors that can replicate in two or
more dissimilar hosts).  Many factors (number of copies of the gene per cell,
promoter strength and regulation, translation initiation, codon usage and protein
stability) can influence the level of expression of a gene.  In addition a suitable host
must be used in which the expression vector is most effective.  Often it is
advantageous to express proteins as a fusion product with a protein or an epitope.
Some of the sequence "tags" can facilitate detection and purification of the target
proteins, other increase the probability of biological activity by affecting the solubility
in the cytoplasm or the export into the periplasm.
a) Fusion tags
Here is a list of the fusion sequence tags (proteins or epitopes) used during this work.
c-myc (MYC) is a 10 aa peptide from the human c-myc protein (sequence:
EQKLISEEDL, aa 410-419).  It is recognized by the rabbit polyclonal or by the mouse
monoclonal anti-c-myc antibody (clone 9E10 (Evan et al., 1985).  PCR-mediated epitope
tagging (see 3.3.3) is one of the methods used for tagging yeast proteins with this epitope.
HA is a 9 aa peptide from the human influenza virus hemagglutinin protein
(sequence: YPYDVPDYA, aa 98-106).  It is recognized by the mouse monoclonal
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anti-HA antibody (clone 12CA5 (Wilson et al., 1984).  PCR-mediated epitope tagging
(3.3.3) is one of the methods used for tagging yeast proteins with this epitope.
VSV-G (VSV) is a 11 aa peptide from the vesicular stomatitis virus glycoprotein
(sequence: YTDIEMNRLGK, aa 501-511).  It is recognized by the mouse monoclonal
anti-VSV-G antibody (clone P5D4 (Kreis, 1986).  PCR-mediated epitope tagging
(3.3.3) is one of the methods used for tagging yeast proteins with this epitope.
6xHis and polyhistidine tags bind metal ligands.  Proteins containing this tag can
be purify by affinity chromatography on Ni-NTA matrices (see 3.4.9.a).  This tag is
present in the expression vectors pQE30, pQE50, pET30 and pET32.  It can be also
produced by PCR using primers containing the 6xhistidine coding sequence, or by
PCR-mediated epitope tagging (3.3.3).
S-tag is a 15 aa peptide that binds with high affinity to the 104 aa S-protein (derived
from pancreatic ribonuclease A).  It is recommended for detection, quantitation and
purification of target proteins.  S-tag is present in the expression vectors pET30 and
pET32.
Trx: thioredoxin (109 aa).  It increases protein solubility.  This tag is present in the
expression vector pET32.
GST: glutathione S-transferase (220 aa).  It is useful to purify proteins by affinity
chromatography on glutathione sepharose matrix (see 3.4.9.b).  This tag is present in
the expression vectors pGEX-TT (for expression in bacteria) and pEG(KT) (for
expression in yeast).
MBP: maltose binding protein (483 aa).  It is useful to purify protein by affinity
chromatography on amylose resin (see 3.4.9.c). This tag is present in the expression
vectors pMAL-c2 and pMAL-p2.
b) Expression of proteins in bacteria
To be expressed in bacteria, genes were cloned into expression vector containing
inducible promoters: pQE50, pQE30, pET12c, pET30a, pET32a, pGEX-TT, and pMAL-
c2 (see Appendix Tables 7.4 and 7.6).  After being established in a non-expression host,
the plasmids were transferred into hosts more suitable for protein expression such as
M15(pREP), Bl21, Bl21(DE3) or origami(DE3) (see Appendix Table. 7.1).  The last two
strains contain the T7 RNA polymerase gene (λDE3 lysogens) and have to be used
when the target genes are under T7 promoter control since it is not recognized by E. coli
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RNA polymerase.  Protein expression was induced with 1 mM IPTG (IPTG was added
when an OD600 of 0.5-0.8 was reached) at 25-30°C for 4-6 hours.
c) Expression of proteins in Yeast
Yeast expression vectors used in this work are pEG(KT), pYX112, pYX143,
pYX212, pYX243 (see Appendix Tables 7.5 and 7.6).  They are shuttle vectors
containing either the 2µ or CEN/ARS sequences and the strong TPI promoter or the
inducible GAL1 promoter.  Moreover, proteins can be expressed by genes carrying
their natural yeast promoter cloned into multi-copy vectors such as pRS315, pRS316,
pRS325, pRS326.  To induce protein expression of genes under GAL promoter,
yeast strains were first grown overnight in raffinose selection medium and then
transferred to fresh pre-warmed YEPGal medium and induced for at least 8 hours.
3.4.9  Protein purification
Different chromatography techniques were used to purify the target proteins from
total bacterial or yeast protein extracts (for more details see Janson and Ryden, 1989).
a) 6xHis-fusion protein purification
6xHis-fusion proteins can be purified on Ni-NTA metal affinity chromatography
matrices (Janknecht et al., 1991).  Purification can be performed under native or
denaturing conditions.
Purification under native conditions:  A 5 ml cell pellet from 1 l IPTG-induced
bacteria were dissolved in 20 ml lysis buffer and sonicated 3x1 min.  Cell debris was
eliminated by centrifugation for 10 min at 2.000g (4°C), then the supernatant was
further centrifuged at 10.000g for 30 min (4°C).  The 10.000g supernatant was
transferred to a new tube containing 0.5-1 ml of a 50% slurry of Ni-NTA resin (pre-
washed with lysis buffer), and incubated at 4°C for 1-2 h with end-over-end rotation.
After that  the resin was loaded onto a column and washed with 200 ml buffer-1, 200
ml buffer-2, and 200 ml buffer-3. Finally, the protein was eluted with elution buffer.
When the 6xHis-fusion proteins were produced in yeast, the same procedure
was used with the only difference that cells were lysed by French press (see 3.4.7.b).
Lysis buffer 20 mM Tris-HCl pH 7.5-8.00
500 mM NaCl
10 mM CHAPS
Proteinase inhibitors EDTA free (cocktail tablets, Roche)
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Buffer-1 20 mM Tris-HCl
500 mM NaCl
20 mM Imidazole
(pH 7.5)
Buffer-2 20 mM Tris-HCl pH 7.5
300 mM NaCl
20 mM Imidazole
(pH 7.5)
Buffer-3 50 mM NaH2PO4
300 mM NaCl
10 mM Imidazole
(pH 7.5)
Elution buffer 50 mM NaH2PO4
300 mM NaCl
250 mM Imidazole
(pH 7.5)
Purification under denaturing conditions:  The cell pellet from 100 ml culture was
dissolved in 10 ml buffer-B and sonicated.  The lysate was centrifuged for 30 min at
10.000g.  The supernatant was transferred to a new tube containing 250-500 µl of a
50% slurry of Ni-NTA resin and incubated at 4°C for 1-2 h with end-over-end rotation.
After that the resin was loaded onto a column and washed twice with 10 ml buffer-C.
Finally the protein was eluted with Laemmli buffer and analyzed by SDS-PAGE.
Buffer-B 100 mM NaH2PO4
10 mM Tris-HCl
8M urea
(pH 8.0)
Buffer-C 100 mM NaH2PO4
10 mM Tris-HCl
8M urea
(pH 6.3)
b) GST-fusion protein purification
GST-fusion proteins bind to a glutathione sepharose matrix with high affinity in
almost any biological buffer.  The solubility of fusion proteins is increased by the
presence of detergents (1% Triton X100 or 0.5% CHAPS).  GST-fusion proteins were
purified according to standard protocols as described by (Smith and Johnson, 1988)
(see also 3.4.12).
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c) MBP-fusion protein purification
The vectors containing the maltose binding proteins were developed by the
New England Biolabs company, the MBP-fusion proteins were purified as described
in the manufacturer’s  protocols manual.  A complete description can be downloaded
from http://www.neb.com/neb/tech/tech_resource/fusion/fusion_frame.html.
d) Anion exchange chromatography
By anion exchange chromatography biomolecules are separated on the basis of
differences in charge characteristics.  MonoQ (Pharmacia) is a strong anion exchanger
with trimethyl-aminomethyl (-CH2N+(CH3)3) moieties as functional groups.  Proteins were
diluted with 3 volumes MonoQ buffer and loaded onto FPLC monoQ HR (high resolution)
10/10 columns or onto HiLoad 16/10 Q sepharose HP (high performance), at a flow rate of
1 ml/min.  The columns were washed extensively with monoQ buffer until the baseline
was reached.  Proteins bound to the column were eluted with a linear gradient of 0-0.4 or
0-0.6 M NaCl solution in MonoQ buffer and 1 ml fractions were collected.
MonoQ buffer 20 mM Tris-HCl, pH 8.0
2 mM MgCl2
1 mM EGTA
1 mM DTT
10 % glycerol
e) Superdex 200 HR and Sephacryl S-200 HR size exclusion gel filtration chromatography
In Superdex 200 (Pharmacia) the gel material is composed of covalently bound
dextran to highly cross-linked porous agarose beads.  Sephacryl S-200 (Pharmacia)
is composed of allyl dextran and N,N’-methylenebisacrylamide.  Large proteins are
excluded from the porous cavity within the gel material and flow around the beads.
Therefore, having a shorter distance to travel, they migrate faster trough the column
and elute before smaller proteins.
Protein samples were loaded onto Superdex 200 HR 16/60 or onto Sephacryl
S-200 HR 16/60 columns, equilibrated with the desired buffer, at a flow rate of 0.5
ml/min.  2 ml fractions were collected.  This was the last purification step to obtain
pure Gyp5p constructs and Ypt1p.  As determined by SDS-PAGE the purity, typically
achieved at this stage, was above 95%.
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f) Ypt1p purification
The Ypt1p purification protocol is based on the method described in (Wagner et al.,
1992).  Two liters of liquid culture of Bl21(DE3) containing pET12c-YPT1 were induced by
1 mM IPTG at 30 °C for 6 hours.  After induction the cells were harvested by
centrifugation, suspended in 40 ml (20 mM Tris-HCl, pH 8.0, 10 mM MgCl2 1 mM DTT, 1%
Triton X100, 1 mM Pefabloc) and sonicated twice for 2 min on ice.  The cell lysate was
centrifuged for 10 min at 10.000g, and the supernatant was loaded onto a HiLoad 16/10 Q
Sepharose HP column and subjected to anion exchange chromatography as described
before with a 0-0.4 M NaCl linear gradient.  Ypt1p eluted with 0.19 M NaCl and the purity
was higher than 75%.  The fractions containing Ypt1p were further purified by Superdex
200 HR gel filtration chromatography in the reaction buffer (200 mM Tris-HCl, pH 8.0 / 10
mM MgCl2 / 1 mM DTT / 0.2 mM GDP).  Fractions containing Ypt1p were identified by
spectrophotometric analysis at 280 nm and by SDS-PAGE and collected. These fractions
were pooled, quantified by Bio-Rad protein assay (3.4.5), frozen in liquid nitrogen and
stored at -80 °C.  About 8 mg of protein with >95% purity could be obtained.
g) Gyp5(400-892)-6His protein purification
One liter liquid culture of Bl21(DE3) containing pET30-GYP5(400-892)A was induced
with 1 mM IPTG at 25 °C for 5 hours.  The 6xHis fusion protein was first purified as
described in 3.4.9.a (yielding ~6 mg protein with a purity of 75-80%), then subjected to
anion exchange chromatography (MonoQ HR 10/10 column, 1ml/min flow rate, 0-0.6
M NaCl linear gradient; see 3.4.9.d) and finally to gel filtration chromatography (see
3.4.9.e) using a Sephacryl S-200 HR 16/60 column equilibrated with reaction buffer
(0.1 M NaCl, 50 mM Tris-HCl, pH 8.0, 5 mM MgCl2 1 mM DTT).  The fractions
containing the purified proteins were pooled, quantified by Bio-Rad protein assay
(3.4.5), frozen in liquid nitrogen and stored at -80 °C.  From a monoQ column ~3 mg of
Gyp5(400-892)-6His protein eluted with 0.45 M NaCl with a purity higher than 85%; after
gel filtration, ~2 mg of protein with >95% purity could be obtained.
3.4.10  Subcellular fractionation
a) Subcellular fractionation by differential centrifugation
The pellet from 250 ml culture was transferred to a mortar containing liquid nitrogen
and smashed until a fine powder was obtained.  The powder was dissolved in 5 ml of
buffer-A and centrifuged for 15 min at 500g. The supernatant was divided into 4 tubes
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(500 µl each), and to each tube were added 500 µl of buffers A, B, C, D, respectively.
After incubation on ice for 15 min, the samples were centrifuged at 4°C for 15 min at
10.000g, the pellet (p10) was resuspended in 2 ml 1xLaemmli buffer.  950 µl of the
supernatant were transferred to new tubes and subjected to further centrifugation for 1 h
at 100.000g at 4°C, the pellet (p100) was resuspended in 1.9 ml of 1xLaemmli buffer
and to 900 µl of the supernatant (S100) were added 900 µl 2xLaemmli buffer.  All
samples were subjected to SDS-PAGE, followed by immunoblotting.
Buffer-A 20 mM HEPES⋅KOH pH 7.2
100 mM KCl
4 mM MgCl2
2 mM Pefabloc
protease inhibitors EDTA free (cocktail tablets, Roche)
Buffer-B  Buffer A containing 2% Triton X-100
Buffer-C  Buffer A containing 3M KCl
Buffer-D  Buffer A containing 8 M urea
b) Subcellular fractionation by velocity sedimentation on sucrose gradient
200 ml cells grown to mid-log phase were harvested and resuspended in 5 ml
buffer-1 and incubated for 10 min at RT.  Cells were collected by centrifugation (5 min at
2.000g), washed once with 10 ml buffer-2 (same composition as buffer-1 without 2-ME)
and resuspended in 2 ml buffer-2.  2.000 units of lyticase (Sigma) were added and the
mixture was incubated for 30min-1h at 30°C (spheroplast formation was checked under
the microscope).  When spheroplasting was completed, cells were centrifuged for 5 min
at 2.500 rpm (Eppendorf bench centrifuge) and the cell pellet was resuspended in 2 ml
water containing protease inhibitors EDTA free (1 tablet in 6 ml).  At this step
spheroplasts are osmotically lysed.  Unbroken cells were removed by centrifuging at
3.500 rpm for 2 min, the centrifugation should be repeated as many times as necessary
to remove all unbroken cells (this was checked under the microscope).  1.5 ml cleared
lysate was loaded carefully onto sucrose-gradient tubes (thawed at 4°C).  The samples
were centrifuged for 2.5 hours at 37.000 rpm at 4 °C in an ultracentrifuge using a SW40
rotor.  12 fractions of 1 ml each, plus a fraction of 500 µl containing the pellet, were
carefully collected.  To each fraction was added an equal volume of 2x Laemmli buffer
containing 8M urea, the fractions were then analyzed by SDS-PAGE and by
immunoblotting.  The chemiluminescence signals were quantified with a Lumi-Imager.
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Fractions 1 and 2 contain the cytosolic and vacuolar proteins, Golgi proteins are in
fractions 4-9 and ER proteins are in the last four fractions of the gradient.
Buffer-1 10 mM HEPES, pH 7
1 mM MgCl2
1.2 M Sorbitol
100 mM β−mercaptoethanol
10 mM NaN3
Preparation of frozen step-gradient tubes: eleven sucrose solutions were
prepared containing respectively, 18%, 22%, 26%, 30%, 34%, 38%, 42%, 46%, 50%,
54% and 60% (w/v) sucrose / 10 mM HEPES, pH 7.5 / 1 mM MgCl2.  Starting with
the 60% sucrose solution, 1 ml aliquot was loaded onto the bottom of a 13 ml
centrifuge tube, the tube was put into liquid nitrogen until the solution was frozen,
then 1 ml of the next solution was added.  The freezing procedure was repeated for
all the solutions.  The gradients were stored at –80 °C.  4-5 hours prior to use, the
gradients were put at 4°C for slow thawing.
3.4.11  Analytical separation of protein complexes by gel filtration
The pellet from a 500 ml culture grown to mid-log phase was suspended in 6 ml
of lysis buffer.  Cells were lysed by vortexing with glass beads at 4°C.  The
supernatant was centrifuged for 1 h at 100.000g.  5 ml of the supernatant were
loaded onto a Sephacryl S-400 or a Sephacryl S-300 column (Pharmacia).  The
column was eluted at 0.5 ml/min and 2 ml fractions were collected. Proteins from
each fraction were separated by SDS-PAGE, transferred to nitrocellulose filters and
probed with different antibodies.  The chemiluminescence signals were quantified
with a Lumi-Imager.
lysis buffer 20 mM HEPES, pH 7.0
150 mM KOAc
5 mM MgOAc
250 mM Sorbitol
0.5% CHAPS
 2 mM Pefabloc
protease inhibitors EDTA free (cocktail tablets, Roche)
3.4.12  Affinity binding assay with GST-fusion proteins
E. coli or S. cerevisiae strains expressing the desired GST-fusion protein were
lysed as described before (3.4.7).  The proteins were solubilized in lysis buffer and
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immobilized on glutathione sepharose 4B beads.  200 µl yeast protein extracts (500-
1000 µg) were added to 1-2 µg recombinant protein bound to 30 µl glutathione
sepharose beads, and incubated at 4 °C for 1-2 h with end-over-end rotation.  The
beads were washed 4 times with 1 ml lysis buffer and subsequently resuspended in
Laemmli buffer, boiled and analyzed by SDS-PAGE and immunoblotting.
Lysis buffer 25 mM HEPES, pH 7.0
150 mM KOAc
5 mM MgCl2
1 mM DTT
1 mM EDTA
1% Triton X-100
protease inhibitors (cocktail tablets, Roche)
3.4.13  Immunoprecipitation
The cell pellets from 50 ml cultures grown to mid-log phase were resuspended in
1.5 ml of lysis buffer.  The cells were lysed by vortexing with glass beads at 4°C
(3.4.7.b). The lysates were centrifuged for 30 min at 16.000g at 4°C.  The supernatants
were incubated for 30 min at 4°C with 100 µl of Protein A/G Sepharose-4B fast flow
(Pharmacia) with end-over-end rotation.  After centrifugation (in a table centrifuge for 1
min at top speed) 600 µl of the supernatant were transferred to a new tube, and 100 µl
of Protein A/G Sepharose-4B, previously coupled with anti-MYC, or anti-HA antibodies,
and 10 µl of 10% BSA were added.  The samples were then incubated for 1.5 h at 4°C
with end-over-end rotation.  After centrifugation at 5.000g for 1 min, the supernatant (S)
was transferred to a new tube and an equal volume of 2x Laemmli sample buffer was
added.  The beads with the immunoprecipitated bound proteins (IP) were washed three
times (for 5 min each) with 1 ml lysis buffer and twice with PBS, resuspended in 60 µl 1x
Laemmli buffer and boiled for 3 min.  20 µl from the IP sample (corresponding to 1/3 of
the total IP) and 20 µl from the supernatant sample (S) (corresponding to 1/70 of the
total supernatant) were separated by SDS/PAGE, followed by immunoblotting with the
desired antibodies.  For more details see also (Harlow and Lane, 1999).
lysis buffer 20 mM HEPES, pH 7.5
150 mM KOAc
5 mM MgOAc
 1% Triton X-100
2 mM Pefabloc
protease inhibitors (cocktail tablets, Roche)
Methods 57
Antibody coupling: 200 µg of antibody were added to 200 µl protein A/G
sepharose and incubated at RT for 1 h with gentle rocking (protein A is recommended
for rabbit polyclonal antibodies and for mouse monoclonal antibodies from IgG2a, IgG2b,
IgG3; protein G is recommended for mouse IgG1 and rat monoclonal antibodies).  The
beads were washed twice with 2 ml of 0.2 M Sodium borate (pH 9.0) and resuspended
in 2 ml of 0.2 M Sodium borate (pH 9.0).  Dimethylpimelimidate (solid) was added to
reach a final concentration of 20 mM (5.2 mg/ml) and the samples were incubated for
30 min at RT with gentle rocking.  The reaction was stopped by washing the beads
once with 0.2 M ethanolamine (pH 8.0) and incubating for 2 h at RT in 0.2 M
ethanolamine (pH 8.0) with gentle mixing.  Finally the beads were washed with PBS
and resuspended in 1 ml PBS with 0.01% merthiolate.  For more details see also
(Harlow and Lane, 1999).
3.4.14  GAP assay
The small GTPases of the Ypt/Rab family have a low intrinsic GTPase activity which
can be significantly accelerated by GTPase-activating proteins (GAPs).  The GTP-
bound form of the GTPase is the substrate for the GAP, the GDP-bound form of the
GTPase is the product of the GAP-mediated hydrolysis reaction.  The activity of a
GTPase activating protein can be detected in vitro by one of the methods described
in the sections below.
a) Quantitative HPLC-based GAP assay
The protocol is based on the method described by (Will et al., 2001).  The starting
material for the assay are GTPases loaded with GTP and purified Gyp proteins.
GTP loading:  After purification, the GTPases are bound to GDP, a condition
which is stabilized by Mg2+ ions present in the buffer.  The underlying principle of the
method, which is being applied here, relies on the fact that the exchange activity of the
substrate can be raised temporarily by a decrease in the concentration of free Mg2+
ions (for example by complexing them with EDTA).  During this time, GTP offered in
excess, will be exchanged for the (lost) GDP at the protein’s binding site.
To 200 µl of purified Ypt/Rab protein solution (at least 80 µM) in GAP reaction
buffer, a 50-fold molar excess of GTP (4 mM final concentration) and 4 µl of 0.5 M
EDTA (10 mM final concentration) were added.  The mixture was incubated at RT for
20 min and in the meantime two NAP5 columns (Pharmacia) were equilibrated with
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ice-cold GAP reaction buffer (the next steps must be done in the cold room as fast as
possible, because Ypt/Rab proteins intrinsically hydrolyze bound GTP).  The mixture
was passed over one of the columns at 4°C to separate the protein and free
nucleotides.  Drop-fractions were collected and protein-containing fractions (identified
by Bio-Rad protein assay) were pooled and passed over the second column.  The
protein-bound GTP was assessed by HPLC analysis on a calibrated reversed phase
5 µm ODS Hypersil column (250x4.6 mm, Bischoff, Germany) run under isocratic
conditions (Tucker et al., 1986).  Calibration of the column was done with GDP
solutions (more stable than GTP) of known concentration.  Guanine nucleotides were
detected by their absorbance at 254 nm (see Fig. 4.5).  Aliquots of the GTP-loaded
GTPase were shock-frozen in liquid nitrogen and stored at -80°C.
GAP reaction and HPLC analysis: 2 nmols of GTP-loaded protein were incubated
at 30°C together with 1-50 pmols (depending on their specific activity) of purified GAPs
in 200 µl GAP reaction buffer (pre-warmed).  To measure the intrinsic activity, the
same reaction is done without GAP.  Aliquots of 12 µl are taken at different intervals,
pipetted into cooled tubes that are immediately transferred to liquid nitrogen.  To
determine the GTP/GDP ratio, the frozen aliquots are thawed in a boiling water bath for
30 seconds and immediately subjected to HPLC (see above).  HPLC was performed at
1.5 ml/min with HPLC buffer on the HPLC system Gold (Beckman) with the pump
module 126 and the detector module 166.  From the GTP and GDP peak areas at
each time point (see Fig. 4.5), the relative amount of GTP is calculated according to:
and plotted as a function of time that can be fitted with the simple exponential decay
function:
where Y0 is the GTP/(GTP+GDP) ratio at the start of the reaction and t is the interval
time.
GAP reaction buffer 50 mM Tris-HCl, pH 8.0
5 mM MgCl2
1 mM DTT
HPLC buffer 10 mM Tetrabutylammonium bromide
100 mM K2HPO4/KH2PO4, pH 6.5
0.2 mM NaN3
2-4%(v/v) Acetonitrile
y= Y0 + e-kt
GTPGDP
GTP
+
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b) Kinetic analysis of GTPase-GAP interaction
As described in the Results Section 4.1.2, Gyp5p is a GAP for Ypt1p.  Under single
turnover conditions Ypt1p-GTP can be considered the substrate and Ypt1p-GDP the
product of the reaction.  As the intrinsic rate of GTP hydrolysis is negligible compared to
the GAP-activated rate, Gyp5p is regarded as an enzyme despite the fact that the catalytic
center of the reaction is present on Ypt1p.  To calculate Km and kcat of the reaction an
alternative method to that described by the classical Michaelis-Menten equation was used.
With this method, as has been described for the interaction of Ras and Ras-Gap
(Schweins et al., 1996), Km and kcat can be calculated from a single reaction.  The single
reaction was started at a high substrate concentration (100 µM Ypt-GTP or more).  The
concentration of Ypt-GTP after GAP addition, was determined by HPLC at different time
points (at least 15).  The fitting procedure involves numerical integration and simulation,
and leads to a representation of the concentration of Ypt-GTP as a function of time (see
Fig. 4.7).  For this procedure the reasonable assumption was done that the reaction
product (Ypt-GDP) does not interact with GAP.  Data fitting was performed using a model
file (kindly provided by Prof. R. Goody, MPI for Molecular Physiology, Dortmund,
Germany) and the software "SCIENTIST" (Micromath, Salt Lake City, Utah, USA).  The
model file, below shown, defines the concentration of the GAP-Ypt-GTP complex (EC1) at
a given time as a function of the Km, of the concentration of GAP (E1) and of the
concentration of Ypt-GTP (C1) at that time, and the rate (C1’) at a given time as the
product of the kcat for the concentration of the ternary complex (EC1).  The rate is entered
as a differential equation into the model file.  T= time, E1o= starting concentration of the
enzyme (GAP), Co= starting concentration of the substrate (Ypt-GTP).
//MM model file according to R. Goody
IndVars: T
DepVars:C1, E1, EC1
Params:kcat, KM, E1o, C1o
EC1=E1*C1/KM
C1’=-kcat*EC1
E1o=E1+EC1
C1o=C1+EC1
0<E1<E1o
//Parameter values
kcat= 100
KM=100
E1o=0.01
C1o=200
//initial conditions
T=0
C1=C1o-(E1o/(1+KM/C1o))
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c) Filter GAP assay
The assay is performed with a [γ32]GTP loaded GTPase (Ypt1p in this work).  100
pmols of Ypt1p (pre-run over a NAP5 column to eliminate GDP present in the buffer)
were incubated for 10 min with 200 µl of exchange buffer (put on ice thereafter).  To
the mixture, MgCl2 to a final concentration of 5 mM (so that the protein-GTP complex
was stabilized) and GTP to a final concentration of 0.1 mM, were added.
exchange buffer 50 mM Tris-HCl, pH 8.0
2 mM EDTA
0.5 mg/ml BSA
1 mM DTT
0.5 µM GTP
0.025 µM [γ32]GTP (6000 Ci/mmol, NEN, DuPont)
Two OD600 units of bacteria strains expressing different fragments of Gyp5p
were sonicated in 100 µl GAP reaction buffer (see 3.4.14.a).  10 µl of the bacterial
lysate were added to 10 µl of the exchange mixture (described above) to which were
added further 30 µl of GAP reaction buffer.  The reaction was allowed to proceed at
30°C for 30 min. 10 µl (taken at time points 0 and 30 min) were vacuum-filtered through
nitrocellulose filters (45 µm BA-Filter, Schleicher and Schüll) with the help of a vacuum
pump (Schleicher and Schüll).  Free nucleotides and γ−phosphate pass trough the filter
while proteins together with the bound-nucleotides stay on the filters.  The filters were
washed 3 times with 3 ml washing buffer.  Dried filters were overlaid with scintillation
liquid (Quicksafe A, Zinsser, Germany) and subjected to scintillation counting.  The
hydrolysis of GTP was measured as decrease of the radioactivity trapped on the filters
(due to the release of γ−phosphate).
Washing buffer 20 mM Tris-HCl, pH 8.0
5 mM MgCl2
10 mM NH4Cl
1 mM 2-ME
3.5  Antibody production
Antibodies against two fragments of human Sec24C protein were produced in
rabbit according to standard procedures.  Human 6His-Sec24C(363-522), Sec24C(363-522)-
6His and 6His-Sec24C(747-992) peptides were expressed in E. coli by using the plasmids
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pQE30-KIAA0079(363-522), pQE50-KIAA0079(363-522), pQE30-KIAA0079(747-992) (see Table 7.6).
The 6xHis-fusion protein fragments were purified under denaturing conditions as described
before (3.4.9a), electroeluted from a gel (3.4.2) and used to immunize four rabbits.  Two
rabbits, no 166 and no 167, were immunized with a mix of 6His-hSec24C(363-522) and
hSec24C(363-522)-6His proteins; two rabbits, no 168 and no 169, were immunized with
6His-hSec24C(635-827) protein.  Antibodies were first purified from serum over a protein-A
sepharose column, then over Amino-Links plus coupling gel columns (PIERCE) coupled
with purified MBP-hSec24C(363-522) or MBP-hSec24C(747-992) proteins (produced in bacteria
using the plasmids pMAL-KIAA0079(363-522) and pMAL-KIAA0079(635-827)) according to the
manufacturer’s recommendations.  For more details about antibody production and
purification see (Harlow and Lane, 1999).
3.6  Microscopic analysis
3.6.1  Indirect immunofluorescence of yeast cells
Indirect immunofluorescence of yeast cells was performed with a modified method
after (Pringle et al., 1991).  Yeast cultures were grown to an OD600 of 0.7-1.2.  10 ml cells
were harvested by centrifugation for 3 minutes at 1.000g, resuspended in 1 ml fixative
buffer and left at RT for 1-2 hours.  Cells were then centrifuged for 1 min at 5.000 rpm
(Eppendorf centrifuge), washed once with PBS/10%sorbitol, resuspended in 1 ml
PBS/10%sorbitol to which were added 5 µl 2-ME and 20 µl 10 mg/ml zymolyase T-100.
The cell mixture was incubated at 30°C for an appropriate period of time(~1h).  After
spheroplasting cells were collected by centrifugation at 2.000 rpm for 1 min, washed once
with 1 ml of PBS/10%sorbitol and resuspended in 0.5-1 ml PBS/10%sorbitol.  15-20 µl of
the cell suspension were put on a polylysine-coated multi-well slide and allowed to attach
for 10-15 minutes.  The supernatant was removed by suction and blocking solution added
to block unspecific binding sites.  After 15-20 minutes the liquid was removed again and
15 µl of the first antibody (adequately diluted in blocking solution) were added.  Incubation
was allowed to proceed at room temperature in a moist chamber for an appropriate period
of time. Hereafter the supernatants were removed and the slides washed 10 times with
PBS/10%sorbitol.  20 µl of the fluorochrome-conjugated secondary antibody (Cy3-
conjugated) were added (1:400 dilution).  After incubation in a dark moist chamber for 2-3
hours at RT, the supernatant was removed and the slides washed 10 times with
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PBS/10%sorbitol.  20 µl of DAPI solution were added (1:1000 dilution in PBS/10%sorbitol,
from a 1mg/ml stock solution) and incubated in the dark for 5 minutes.  After washing
twice again with PBS, a sufficient amount of mounting medium was pipetted onto the
slides (along the middle ridge) and a 60 mm cover slip carefully put on top.  After removing
(squeezing out) excess of mounting medium, the edges were sealed with nail-polish.
Finally, the sealed slides were rinsed with tap water before microscopic inspection.
fixative buffer 3.5% (v/v) Paraformaldehyde
10% (w/v) Sorbitol
1x PBS
blocking solution 1% (w/v) BSA
1% (w/v) Triton X-100
10% (w/v) Sorbitol
1x PBS
mounting medium 1mg/ml p-Phenylenediamine
90% Glycerol
1X PBS
(pH 8.5-9.0 adjusted with 0.5M Na2CO3)
3.6.2  Vacuole detection by FM 4-64 staining
The lipophilic styryl dye N-(3-triethylammmoniumpropyl)-4-(p-diethylaminophenyl-
hexatrienyl) pyridinium dibromide (FM 4-64) is a vital stain that can be used to follow
membrane internalization and transport to the vacuole in yeast.  The method used is
basically that described in (Vida and Emr, 1995).  10 OD600 cells from a logarithmic
growing culture were harvested and resuspended in 250 µl YEPG medium.  0.5 µl of
16 mM FM 4-64 (stock solution of 16 mM FM 4-64 in DMSO) were added.  Cells
were then incubated at 30°C for 15 min with shaking.  Subsequently cells were
harvested, washed one time with YEPG, resuspended in 1 ml YEPG medium and
incubated at 30°C for 1 h.  After this chase period, cells were harvested at 700g for 3 min,
resuspended in 250 µl water placed on standard slides and viewed.  To immobilize the
cells, the coverslips were treated with 1 mg/ml solution of concavalin A and air dried
before use.  A 564 nm filter was used to detect FM 4-64 florescence under a
florescence microscope.
3.6.3  Indirect immunofluorescence of mammalian cells
CV1 and Hela cells were grown on round (1 cm Ø) sterilized coverslips to about
15% confluence.  The coverslips were transferred to a ceramics mini racket (Coors,
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USA), washed 3 times with cold PBS then fixated putting the racket for 4 min in cold
methanol followed by 4 min in cold acetone.  Subsequently they were washed once
with PBS and put for 5 min in 0.1% saponin solution that permeabilize cell
membranes.  Coverslips were transferred to a moist chamber (put on wet filter paper
with the side containing the cells up) and 20 µl of the first antibody (adequately
diluted in TBS containing 0.5 mg/ml BSA) were added.  Incubation was allowed to
proceed at 37°C for 1h.  After washing the coverslips 3 times with PBS, 20 µl of the
fluorochrome-conjugated second antibody, adequately diluted in TBS/0.05% BSA,
were added (Oregon Green 488 conjugated antibody, 1:500 dilution, or Rhodamine
Red-X conjugated antibody, 1:100 dilution).  Incubation was allowed to proceed at
37°C for 1 h.  After that the coverslips were washed 3 times with PBS.  One drop of
embedding medium was added to each of them and subsequently they were
mounted on a microscope slide and sealed with nail-polish.
Embedding medium preparation: 6g Glycerol
     + 2,4 g MOWIOL, stirr 1 h at RT
     + 6 ml sterile distilled water, stirr 2 h at RT
     + 12 ml 0.2 M Tris-HCl, pH 8.5
-Heat up to 50°C for 10-15 min stirring.
-Centrifuge at 5.000g for 15 min.
-Store at -20°C.
3.7 Electron microscopic analysis of yeast cells
Electron microscopy analysis has be done by Dr. H. H. Trepte (this department).
Cells were fixated either with potassium permanganate and processed as described
previously (Benli et al., 1996) or by freeze-fixation/freeze-substitution as follows.
Yeast cultures were grown to an OD600 of 0.7-1.2.  5 µl of cell pellet were freeze fixated
on a copper mirror chilled to -190°C in liquid nitrogen.  For freeze-substitution, the
samples were soaked in 0.2% uranyl-acetate/acetone solution and maintained at -85°C
for three days.  The samples were then allowed to warm slowly (in 10 hours) to -35°C.
After that the substitution medium was replaced with cold acetone.  During the next two
days the samples were infiltrated with increasing concentration of HM20 resin.  The resin
was polymerized for two days at -35°C and for one day at +15°C.
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3.8  DNA and protein sequence computer analysis
Here are listed some of the programs used.  DNA sequences analysis and
alignment in contigs were done with "SEQUENCHER" (Gene Code, Michigan, USA).
Primer analysis with "OLIGO" (Med Probe, Sweden).  For molecular and atomic
visualization WebLab Viewer was used.
For multiple sequence alignments "clustal-w" was used (available at
http://www2.ebi.ac.uk/clustalw/help.html or at http://dot.imgen.bcm.tmc.edu:9331/multi-
align/multi-align.html).  Other sequence analysis tools are available at the ExPASy site:
http://www.expasy.ch/; or at the NPSA (network protein sequence analysis) site:
http://pbil.ibcp.fr/.  It is possible to retrieve sequences from different databases (such as
GENEBANK, EMBL, TREMBL, SWISSPROT etc.) at the SRS (Sequence Retrieval
System) site: http://www.embl-heidelberg.de/srs5/.  For sequences database search,
"WU-Blast2" or "Fasta3" were used, both available at the EBI (European Bioinformatics
Institute) site: http://www2.ebi.ac.uk/.  Other important database sites are: MIPS (Munich
Information Centre for Protein Sequences) http://www.mips.biochem.mpg.de/;  SGD
(Saccharomyces Genome Database) http://genome-www.stanford.edu/Saccharomyces/;
and the proteome database http://www.proteome.com/databases/index.html.
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  4  RESULTS
In this work, two different topics on ER-to-Golgi transport were treated, one
regarding the characterization of the Ypt1p-GAP Gyp5p, the second one regarding
the characterization of Sec24p family proteins.  Therefore, the results will be divided
into two sections in which the two topics will be considered separately.  In addition,
there will be a short third section regarding a new tagging technique that has been
invented during my work.
4.1  SECTION I (Gyp5p)
4.1.1  Cloning and expression of different fragments of GYP5
By a sophisticated computer search (Neuwald, 1997), many proteins sharing
a common domain with Ypt/Rab-specific GTPase-activators, were found.  We
named this domain the "GYP domain".  The protein product of the ORF YPL249c
was in this group, and we called it Gyp5p since other Ypt-GAP proteins had
already been characterized and named "Gyp" (the acronym "Gyp" stands for "GAP
for Ypt"); see Introduction 1.4.4.  The eight Gyp proteins characterized to date are
quite different in size and amino acid composition (see Table 1.3, and Fig. 4.1).
0      100    200     300    400    500    600    700     800    900   1000 aa
Gyp1 (630 aa)
Gyp2 (950 aa)
Gyp3 (633 aa)
Gyp4 (492 aa)
Gyp5 (894 aa)
Gyp6 (458 aa)
Gyp7 (746 aa)
Gyp8 (497 aa)
Fig. 4.1  Schematic representation of the eight Ypt/Rab-GAP proteins showing the "GYP
domain" as gray rectangles.
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They share sequence homologies only in the "GYP domain" in which it is possible to
distinguish six conserved motifs (A-F) harboring the highly conserved "fingerprint
sequences" (RxxW, IxxDxxR, YxQ) (see Figs. 4.2 and 5.2).
In Fig. 4.2, the alignment of Gyp5p and Gyp1p sequences is shown.  The
crystal structure of the Gyp1 catalytic domain (Fig. 1.9) (Rak et al., 2000) confirmed
that the conserved amino acids are located in critical positions for either the active
site or for the conservation of the structure of the protein (see Fig. 5.2).
Different fragments of the Gyp5 protein were expressed as 6xHis fusion
proteins.  The different peptides obtained are shown in Fig. 4.3.  The different DNA
fragments were obtained by PCR amplification using the primers schematically
shown by arrows in Figs. 4.2 and 4.3 (for the primer sequences, see Appendix Table
7.7).  The PCR fragments were cloned into pET30 or pET32 vectors (see Table 7.6).
For simplicity, I called the different fragments pep0-pep14.  Except for Gyp5(8-448)
(pep0B) and Gyp5(8-892) (pep1B) which were cloned as NcoI-NotI restriction fragments
into pET32, and which were expressed in bacteria as fusion proteins with N-terminal
Trx-6xHis-S-tags (see 3.4.8.a), all others were cloned into pET30 as NdeI-SalI
restricted fragments, and were expressed in bacteria as fusion proteins with C-
terminal 6xHis-tags.  The "GYP domain" of Gyp5p is contained between amino acids
451-624 (highlighted in Fig. 4.3, by a red frame).
The GAP activity on Ypt1p was assayed for all the different constructs by the filter
assay (see Methods 3.4.14.c), pep2 and pep5 were also tested by the HPLC-GAP-
assay (3.4.14.a).  The fragments, which have retained or which have lost the GAP
activity for Ypt1p, are indicated in Fig 4.3 by "+" or "-".  The data clearly show that
there is a region downstream of the "GYP domain" (up to the amino acid 759) that is
required for the catalytic activity.  Instead, the N-terminal part (up to amino acid 429,
and probably up to amino acid 451) is not important for its catalytic activity.
Computer analysis with the program COILS (Lupas et al., 1991) revealed also a
potential coiled-coil region at C-terminus of Gyp5p (between amino acids 730-870).
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Gyp5p        1 MSSDKSIEKNTDTIASEVHEGDNHSNNLGSMEEEIKSTPSDQYEEIAIIPTEPLHSDKEL
Gyp1p        1 --------MGVRSAAKEMHERDHNS-----------------------------------
Gyp5p       61 NDKQQSLGHEAPTNVSREEPIGISGDEDTQITEQNVNEQRQETREPSSEIDLNEPLDVEK
Gyp1p       18 -------------------------DSSSLVTSLMKS-WR-----ISSASSSKKPSLYKM
Gyp5p      121 DVTTDVQAPNGLNIEKEYDAVKENEKVYADTKEVVSSPENREVTGKNSGGEKSSSSKFLD
Gyp1p       47 NTTESTSLPSGYASSADRDRRTSDGNFEAMAKQQASTRRTSN-----------SYSPLRY
Gyp5p      181 DESGTTTAANANDISISSEVTPERSSENDNNQIHITNEVAAGINLNENKEQKAAIEDGPV
Gyp1p       96 VNPTLSTASNESPRPALLLRQHHQRHHHHQQPRHSSSGSVGNNCSNSTEPNKKGDRYFKD
Gyp5p      241 TAENLSSETARKVPPIPTQIINEKGDNSSENEVSAIPTTSSPPLPPRQNVATSTSPKLPP
Gyp1p      156 LDEDWSAVIDDYNMPIPILTNGGFG----------------------------T-PVAPT
Gyp5p      301 RGKQREQPPKTKNAVPPPLEEEMKSEKFRKNFEETKRNSYHHVPLTGSKTAQLESTAEIN
Gyp1p      187 RTLSRKSTSSSINSIS-------------------------------------------N
Gyp5p      361 LIASRYRKTSHHLNKEGEETRESLQEGQSFLKSTFTSFLENLSEYNEVENVNEEDREMFK
Gyp1p      204 MGTSAVRNSSSSFTYP-----QLPQLQKEK---------TNDSKKTQLEIENERDVQELN
Gyp5p      421 IDWSFWTQVVNDYATVASNEPENLEAHVTNGIPPQIRGIIWQLMANS-------------
Gyp1p      250 SIIQRISKFDNILKDKTIINQQDLRQISWNGIPKIHRPVVWKLLIGYLPVNTKRQEGFLQ
Gyp5p      468 -----KSREMEDIYETLLDTECLHEATIRRDLRRTKFVAEDKM-----ESLYKVIKVYSV
Gyp1p      310 RKRKEYRDSLKHTFSDQHSRDIPTWHQIEIDIPRTNPHIPLYQFKSVQNSLQRILYLWAI
Gyp5p      518 YDPDVGYTQGMGFIAAPLLINC----------------------------ENEAESFGLL
Gyp1p      370 RHPASGYVQGINDLVTPFFETFLTEYLPPSQIDDVEIKDPSTYMVDEQITDLEADTFWCL
Gyp5p      550 VGLMKNYGLRELFLPGMPGLMLMLYQFDRLLEEHSPSLYNRLIREGISSTMYATQWFLTF
Gyp1p      430 TKLLEQ--ITDNYIHGQPGILRQVKNLSQLVKRIDADLYNHFQNEHVEFIQFAFRWMNCL
Gyp5p      610 FAYKFPLEFVLRIFDIVFVEGI-EVLLKFAVNLMLKNEETLVKLRFDELLDFL---KDEL
Gyp1p      488 LMREFQMGTVIRMWDTYLSETSQEVTSSYSM--SSNDIKPPVTPTEPRVASFVTPTKD--
Gyp5p      666 FNYYLMGNQDDASVVQMGLSNGNSFKGNDDGTFSYNVDLFVHDAMTGVYITPLTLRRYRG
Gyp1p      544 FQ----------SPTT-ALSNMTPNNAVEDSGKMRQSSLNEFHVFVCAAFLIKWSDQLME
Gyp5p      726 EYVEIHEKEQKKEDHYESLRIQNHQLQREAQKLEHDYSILNKENISAANELIQNRLNMEM
Gyp1p      593 MDFQETITFLQNPPTKDWTETDIEMLLSEAFIWQSLYKDATSHWL---------------
Gyp5p      786 LLDEKNDLINTITDIKSQIEEEIRKQNLPNPDASLPKADLREDLERTISRNNEVMRENGQ
Gyp1p          ------------------------------------------------------------
Gyp5p      846 LEERITELQAEIDELININKEQVSTASLLERDSKAKGRKGWTGFKKVFK
Gyp1p          -------------------------------------------------
r2
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C D
E F
f1
f2
f3 f4
r4
r5
r3
r1
C
D
F
*
Fig. 4.2  Alignment of Gyp5p and Gyp1p sequences.  Identical or similar amino acids are shown
on black or shaded background, respectively.  The six conserved motifs (A, B, C, D, E, F) are
indicated by green bars  [Neuwald A. F., 1997 ; Raket al., 2000].  The conserved amino acids of
the "fingerprint sequences" RxxxW, IxxDxxR and YxQ and the conserved aspartic acid (D502 in
Gyp1p and D624 in Gyp5p) are highlighted in red.  The critical catalytic arginine (R343 in Gyp1p
and R496 in Gyp5p) is indicated by an asterisk.  Blue and red arrows represent the forward (f)
and the reverse (r) primers used to amplify different fragments of GYP5.
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Fig. 4.3  Schematic representation of Gyp5p and its different fragments expressed as 6xHis
fusion proteins in bacteria (see Table 7.6).  Arrows represent the forward (f) and reverse (r)
primers used to amplify the fragments from genomic DNA for subsequently cloning into
pET30 or pET32 vectors (see also Fig. 4.2).  Fragments showing GAP activity on Ypt1p
(determined by a filter test) are indicated by "+"; when the catalytic activity is lost, they are
indicated by "-".  The critical catalytic arginine-496 is highlighted in yellow.  The "GYP"
domain" is contained inside the red frame (between amino acids 451-624).  A putative
coiled-coil region is contained between amino acids 730-870.
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4.1.2  Ypt1p is the preferred substrate for Gyp5p
Gyp5p(400-892)-6His (pep2A) was expressed in E. coli, purified as described in
Methods 3.4.9.g on Ni-NTA resin, and subsequently by anion exchange and gel
filtration chromatography, see Fig. 4.4.  The purified protein was stored frozen or
used in GAP assays.
The GAP activity of Gyp5p(400-892)-6His (for simplicity, named Gyp5p(400-892) in
the following sections) was tested with different GTPases in a standard HPLC-based
GAP assay (3.4.14.a).  20 µM GTP-loaded GTPases were incubated with 0.1 µM
Gyp5p(400-892) at 30°C, and aliquots were taken at different time points.  Each sample
was subjected to HPLC that allows to separate GDP from GTP (see Fig. 4.5).  With
the help of the "Gold-System-software", the peak areas were evaluated and the
relative GTP amount GTP/(GDP+GTP), at each time point, was calculated.  These
values were plotted as a function of time that can be fitted with the simple
exponential decay function: y= Y0 + e-kt.  Y0 is the GTP/(GTP+GDP) ratio at the start
of the reaction, t is the incubation time and k represents the rate constant of the
reaction.  The different GTPases have different intrinsic GTP hydrolysis rates (see
Table 4.1) that can be accelerated several-fold by GAP proteins.  The acceleration
Fig. 4.4  Gyp5p(400-892)-6His was produced in E. coli and purified on Ni-NTA resin.  (A) The
eluted protein (TI is the protein sample after Ni-NTA purification) was further purified by
anion exchange chromatography and subsequently (B) by gel filtration chromatography.
Fractions 35-37 (TII) from MonoQ columns were loaded on Sephacryl-200 column.
Fractions 19-21 and 22-25 were pooled separately.  (C) 5 µl of the pooled fractions 19-21.
The purity achieved at this stage was greater than 95%.  M= Molecular mass marker.
M   TI    32   33  34   35  36   37  38  39  40
MonoQ 16/10
M TII  18   19   20   21  22   23   24   25  26  27
Sephacryl S200 16/60A B C
M (20-21)
58.8 kDa
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rate of the reaction in the presence of its GAP is given by the ratio between the GAP-
catalyzed GTP hydrolysis rate and the intrinsic hydrolysis rate.
Table 4.1  Intrinsic GTP hydrolysis rates of Ypt GTPases measured at 30°C
GTPase GTP hydrolysis rate(min-1)
Ypt1p 0.0035
Sec4p 0.0013
Ypt31p 0.0072
Ypt32p 0.0062
Ypt6p 0.0004
Ypt7p 0.0027
Ypt51p 0.0059
Ypt52p 0.0989
Ypt53p 0.0065
Fig. 4.5  Analysis of GTP hydrolysis through separation of the guanosine nucleotides by HPLC.
GDP is detected after ~ 4.2 min, GTP after ~ 7.5 min.  20 µM Ypt1p-GTP was incubated with
0.1 µM Gyp5p(400-892) at 30°C for 0 min, 1 min and 4 min (standard HPLC-based GAP assay).
Samples were shock-frozen in liquid nitrogen and boiled for 30 sec before being injected into the
HPLC apparatus (see Methods 3.4.14.a-b).  With the "Gold-System-Software", the peak areas
are calculated and the ratio GTP/(GDP+GTP) can be calculated.
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The acceleration of intrinsic GTPase activity of different Ypt-GTPases induced
by Gyp5p(400-892) is documented in Fig. 4.6.  Ypt1p is by far the best substrate for
Gyp5p.  Also the Sec4p GTPase activity is accelerated but, in comparison with
Ypt1p, much less efficiently .
4.1.3  Kinetic investigation of the Gyp5p/Ypt1p interaction
To characterize the efficiency of the catalysis, the kinetic constants of the
Gyp5p/Ypt1p interaction were determined.  Ypt1p-GTP can be considered the
substrate, Ypt1p-GDP the product of the reaction, and Gyp5p is regarded as the
enzyme.  The Michaelis-Menten model says that the velocity of the reaction will
increase with increasing substrate concentrations and asymptotically reach a
saturation value (Vmax.).  By dividing Vmax. by the enzyme concentration, one gets
the maximal number of substrate molecules which an enzyme molecule can
chemically transform within a given period of time (kcat).  The substrate concentration
at the half-maximal reaction velocity (Km) can be regarded as a measure for the
affinity of an enzyme for its corresponding substrate.  Km is the Michaelis constant.
To calculate Km and kcat of the Gyp5p/Ypt1p reaction, an alternative method to
the classical Michaelis-Menten equation was used.  An integrated Michaelis-Menten
Fig. 4.6  Specificity of the Gyp5(400-892)  protein for different GTPases, as determined by standard
HPLC-based GAP assay.  20 µM GTP-loaded GTPases were incubated at 30°C with or without
0.1 µM Gyp5p(400-892).  The ratio of the GTP hydrolysis velocity with and without GAP (intrinsic
GTPase activity), gives the acceleration rate.  The best, if not the only, substrate for Gyp5p is
Ypt1p.  The data are the average of two independent experiments.
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equation (Duggleby and Clarke, 1991) was used, that allows to calculate kcat and Km
from a single time curve.  The time curve is derived from a reaction with highly
concentrated substrate.  The absolute substrate concentration will decrease while the
reaction proceeds (see Fig. 4.7).  This method is generally applicable for stable
enzymes which catalyze irreversible reactions with none of the reaction products
having inhibitory effects.
The fitting procedure involves numerical integration and simulation, and leads to
a representation of the concentration of Ypt-GTP as a function of time.  This was
performed using a model file (kindly provided by Prof. R. Goody, MPI for Molecular
Physiology, Dortmund, Germany) and the software "SCIENTIST" (Micromath, Salt
Lake City, Utah, USA) (see Methods, 3.4.14.b).
In Fig. 4.7, a time curve obtained from a reaction with 118 µM Ypt1p-GTP and
0.134 µM Gyp5p(400-892) is shown.  The reaction was carried out at 30°C.
Yp
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Fig. 4.7  Kinetic analysis of Ypt1p-bound GTP hydrolysis accelerated by Gyp5p(400-892).  118 µM
Ypt1p-GTP was incubated with 0.134 µM Gyp5p(400-892) at 30°C.  Km and kcat values were
calculated according to the integrated Michaelis-Menten equation using the program
Scientist (as described in Methods 3.4.14.b).
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From the integration of this curve and from two other curves, a Km of 400 (µM)
and a kcat of 9 (s-1) were calculated.  This means that Gyp5p does not have a high
affinity for its substrate GTPase, but the turnover rate is quite high.  With an intrinsic
GTP hydrolysis rate of 0.0035 per minute, the GTPase activity is maximally
accelerated 1.6x105-fold by the action of Gyp5p(400-892). These values are comparable
with values obtained for other  GAPs (See Discussion, Table 5.1)
4.1.4  Arginine 496 is important for the catalytic activity of Gyp5p
It was shown previously, that Gyp1p and Gyp7p have a conserved arginine
residue (in motif B) which is critical for the catalytic activity (Albert et al., 1999).  The
"arginine finger" mechanism of the GTPase accelerating activity has been described
for other GAP proteins, Ras-GAP and Cdc42p-GAP (Scheffzek et al., 1998), (see
Fig. 1.8).  To verify whether this is also true for Gyp5p, the arginine-496 coding triplet
was mutated to one for either alanine or lysine.  The mutations were introduced into
pET30-GYP5(400-892)A by PCR (using the primers GYP5-R/A_f, GYP5-R/A_r, GYP5-R/K_f
and GYP5-R/K_r; see Methods, 3.2.7 and Tables 7.6 and 7.7).  The proteins
Gyp5R496A(400-892)  and Gyp5R496K(400-892)  were produced and purified as described
above (see 3.4.9.g and 4.1.2) and their GAP activity for Ypt1p was tested (for
simplicity, I will call them Gyp5pR496A, or Gyp5pR496K).  20 µM GTP-loaded Ypt1p was
incubated at 30°C with 0.2 µM Gyp5pR496A
 
 or with 0.2 µM Gyp5pR496K and the GTP
hydrolysis was evaluated by HPLC.  As shown in Fig. 4.8.A, both mutations have a
dramatic effect on the catalytic activity.  Both mutant proteins are unable (at the
concentration used) to stimulate the GTPase activity while the wild type protein (0.1 µM
Gyp5p(400-892)) can accelerate the same reaction 200 fold.  By strongly increasing the
concentration of Gyp5pR496K it is possible to see a weak enzymatic activity (see Fig.
4.8.B).  55 µM GTP-loaded Ypt1p was incubated at 30°C with 11 µM Gyp5pR496K
 
 or
with 0.13 µM Gyp5p(400-892).  While the wild type protein can accelerate the GTPase
activity 61-fold, the mutant protein can accelerate it only 4-fold.
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4.1.5  Gyp5p can accelerate the GTPase activity of the Ypt1pQ67L mutant
The Q67L mutation in Ypt1p is homologous to the well known oncogenic Q61L
mutation of Ras that impairs its GTPase activity (Der et al., 1986; Frech et al., 1994).
This glutamine residue in Ras is thought to form a hydrogen bond with an H2O
molecule which is positioned to attack the phosphoryl bond of GTP (Krengel et al.,
1990); see also Fig. 1.8.  Importantly, Ras-GAP cannot accelerate the intrinsic GTPase
activity of this mutant (Bollag and McCormick, 1991; Scheffzek et al., 1997; Vogel et
al., 1988).  The homologous mutation in many members of the Ras superfamily was
shown to impair their GTPase activity, among them also a number of Ypt/Rab
proteins: Rab2pQ65L (Tisdale, 1999), Rab3ApQ81L (Brondyk et al., 1993), Rab5pQ79L
(Stenmark et al., 1994), Rab6pQ72L (Martinez et al., 1997), Sec4pQ79L (Walworth et
al., 1992) and Ypt51pQ66L (Singer-Kruger et al., 1995).
Fig. 4.8  Kinetic analysis of the Ypt1p-bound GTP hydrolysis acceleration induced by
Gyp5(400-892) mutant proteins (Gyp5pR496A  and Gyp5pR496K).  (A) 20 µM Ypt1p was incubated
at 30°C together with 0.2 µM Gyp5pR496A or with 0.2 µM Gyp5pR496K or with 0.1 µM
Gyp5p(400-892).  The mutant proteins are not able to accelerate the GTP hydrolysis at this
concentration while the wild type can accelerate it 200-fold.  (B) 55 µM Ypt1p-GTP was
incubated at 30°C together with 11 µM Gyp5pR496K, or with 0.13 µM Gyp5p;  GTPase
hydrolysis is accelerated 61-fold by the wild type and 4-fold by the mutant protein.
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To test whether Gyp5p could stimulate the GTPase activity of Ypt1pQ67L, I introduced
by PCR (using the primers YPT1-Q/L_f and YPT1-Q/L_r; see Methods, 3.2.7) this mutation
in pET12c-YPT1.  The protein was produced in E. coli and purified as described in 3.4.9.f
(for GTP loading, see 3.4.14.a).  20 µM GTP-loaded Ypt1pQ67L was incubated at 30°C with
1 µM and 2 µM Gyp5p(400-892) and a kinetic analysis was done (Fig. 4.9).  The intrinsic
GTPase activity of Ypt1pQ67L (0.00017 min-1) is reduced ~20-fold in comparison to that of
the wild type protein (0.003 min-1).  Nevertheless, Gyp5p is able to accelerate it several-
fold: 269-fold when [Ypt1pQ67L]:[Gyp5p] is 20:1, 382-fold when the ratio is 10:1.
4.1.6  Mutant strains with different GYP genes deleted in combination with ypt1Q67L
In order to understand the biological meaning of the GTPase-accelerating
activity observed in vitro, the genes GYP5, GYP1 and GYP8  (Gyp1p and Gyp8p are
Fig. 4.9  Gyp5p(400-892) can accelerate the intrinsic GTP hydrolysis of the GTPase-activity-
deficient Ypt1pQ67L.  The reaction was done at 30 °C. "[S]:[E]" is [Substrate]:[Enzyme].
GTPase Gyp5p(400-892) Acceleration GTPase activity(-fold)
Ypt1p (20 µM) 0.1 µM 196
Ypt1pQ67L (20 µM) 1 µM 269
Ypt1pQ67L (20 µM) 2 µM 382
min
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also GAPs for Ypt1p, see Table 1.3) were deleted in two different haploid yeast
strains (MSUC-3D and the protease-deficient strain cI3-ABYS-86).  The genes were
deleted using loxP-kanMX-loxP cassettes and the PCR-based method described in
the Section 3.3.2.  The correct gene deletion was checked by both PCR and
Southern blotting.  Strains with one, two or the three GYP genes deleted didn’t have
any particular phenotype.  Only a weak growth retardation at 15°C was observed in
cI3-ABYS-86 ∆gyp5/∆gyp1/∆gyp8 strains (ADY27 and ADY28) (data not shown).
Since there was no evident mutant phenotype, it was decided to combine the
deletions with ypt1Q67L.  To introduce the Q67L mutation into the yeast YPT1 locus,
the plasmid pRE-YPT1Q67L was used (from U. Vespermann, this department); pRE-
YPT1 is described by (Schmitt et al., 1988).  This plasmid contains ypt1Q67L in addition
to the genomic flanking regions (where there are TUB2 and ACT1; see Fig 4.10).
Haploid strains with the different GYP genes deleted were transformed with
linearized pRE-YPT1Q67L and selected on LEU- media.  To check for the presence of
the Q67L mutation, the YPT1 gene was amplified by PCR (using the primers
YPT1_f0 and YPT1_r0b) and subsequently digested with XhoI (see Fig. 4.11).  As
shown in Fig. 4.11,  when more than one GYP gene was deleted the probability of
getting ypt1Q67L was lower.  This could be an indication of functional interplay of
YPT1, GYP5, GYP1 and GYP8.
Fig. 4.10  Schematic representation of pRE-YPT1Q67L linearized by HindIII digestion.  An XhoI
site is present in ypt1Q67L.  This "cassette" is used to transform yeast cells and in order to
replace the  wild type YPT1 gene with the ypt1Q67L allele.
LEU2TUB2 ACT1YPT1
Q
        CAA GAA
          CTC GAG
           L
ampR
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Fig. 4.11  Schematic view of the method to obtain ypt1Q67L mutants, and their verification.  It is
evident that it is more difficult to obtain ypt1Q67L mutants when more than one GYP gene is deleted.
Transformation with pRE-YPT1Q67L containing ypt1Q67L
(ypt1Q67L mutants contain an XhoI site)
Genomic DNA extraction from the LEU+ colonies
Amplification by PCR of the ypt1 gene and subsequent digestion with XhoI
[Undigested (WT) PCR product =829 bp, digested (mutant) PCR products =556 bp + 273 bp]
cI3-ABYS-86
Haploid strains transformed
with pRE-YPT1Q67L
Leu+ colonies
checked
strains containing
ypt1Q67L
WT 10 9
∆gyp1 10 5
∆gyp5 10 6
∆gyp8 10 8
∆gyp5/∆gyp1 10 0
∆gyp5/∆gyp8 10 0
∆gyp1/∆gyp8 10 0
∆gyp5/∆gyp1/∆gyp8 20 0
MSUC-3D
Haploid strains transformed
with pRE-YPT1Q67L
Leu+ colonies
checked
strains containing
ypt1Q67L
WT 10 10
∆gyp1 10 10
∆gyp5 10 9
∆gyp8 10 10
∆gyp5/∆gyp1 10 1
∆gyp5/∆gyp8 10 5
∆Gyp1/∆Gyp8 10 7
∆gyp5/∆gyp1/∆gyp8 20 0
829 bp
556 bp
273 bp
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4.1.7  Growth analysis of different strains carrying ypt1Q67L
To assess the effect on cell growth of ypt1Q67L alone or in combination with
GYP5, GYP1 or GYP8 deletions, serial 10-fold dilutions of cells (see Methods 3.3.4)
were spotted onto YEPG plates and grown at temperatures ranging from 15°C to
37°C (see Fig. 4.12 and Fig. 4.13).  In the protease deficient strain cI3-ABYS-86, it
was not possible to introduce the ypt1Q67L mutation when more than one GYP gene
was deleted, while in MSUC-3D ypt1Q67L was obtained also in strains where two GYP
genes were disrupted (see Fig. 4.11).  ypt1Q67L/∆gyp7 (ADY32 and ADY52) strains
were used as negative controls since Ypt1p is not a substrate for Gyp7p.  A first
observation was that mutants based on cI3-ABYS-86 strain background showed
stronger growth defects than mutants based on MSUC-3D.  The ypt1Q67L mutant in the
cI3-ABYS-86 genetic background (ADY29) was not able to grow at 15°C (see Fig.
4.12, lane 2, last panel) while ypt1Q67L mutants in a MSUC-3D genetic background
(ADY49) could grow at 15°C (see Fig. 4.13 lane 2, last panel).  Interestingly, cell
growth of MSUC-3D based mutants at 15°C was dramatically slowed down when, in
combination with ypt1Q67L, GYP5 was deleted  (see Fig. 4.13, last panel, lane 5, 7
and 8).  The cI3-ABYS-86 ypt1Q67L/∆gyp5 strain (ADY31) showed a defect in growth
already at 20°C (see Fig. 4.12, lane 4, fourth  panel).  The  strains ypt1Q67L/∆gyp1 or
ypt1Q67L/∆gyp8 (in both cI3-ABYS-86 and MSUC-3D genetic background) did not show a
growth defect at low temperatures.  The cI3-ABYS-86 based ypt1Q67L/∆gyp8 (ADY33)
showed a growth retardation at 37°C.  The MSUC-3D based strains with ypt1Q67L
combined with double GYP deletions (ypt1Q67L/∆gyp5/∆gyp1, ADY54;
ypt1Q67L/∆gyp5/∆gyp8, ADY55; ypt1Q67L/∆gyp1/∆gyp8, ADY56) showed slower growth at
all temperatures, but the strongest effect was in the strains lacking GYP5.  The growth of
these strains at 15°C was almost completely blocked (see Fig. 4.12, last panel).
From these data it became evident that ypt1Q67L mutants show a stronger
growth defect at low temperature when GYP5 is missing.  This was the first indication
supporting the importance of GTP hydrolysis for the function of Ypt1p, and for a role
in vivo of Gyp5p as Ypt1p-GAP.
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Fig. 4.12  Synthetic growth defect analysis
of the strains
1) wt (cI3-ABYS-86)
2) ypt1Q67L (ADY29)
3) ypt1Q67L/∆gyp1 (ADY30)
4) ypt1Q67L/∆gyp5 (ADY31)
5) ypt1Q67L/∆gyp8 (ADY33)
6) ypt1Q67L/∆gyp7 (ADY32)
(for genotype description, see Appendix
Table 7.2).
10-fold serial dilutions of cells (starting at
0.01 OD) were spotted on YEPG plates
and grown at different temperatures for 3
days, (7 days at 15° C).
37 °C
30 °C
15 °C
20 °C
25 °C
1    2      3      4      5      6
cI3-ABYS-86
1    2      3      4      5      6
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Fig. 4.13  Synthetic growth defect analysis
of the strains
1) wt (MSUC-3D)
2) ypt1Q67L (ADY49)
3) ypt1Q67L/∆gyp7 (ADY52)
4) ypt1Q67L/ ∆gyp1 (ADY50)
5) ypt1Q67L/∆gyp5 (ADY51/K-)
6) ypt1Q67L/∆gyp8 (ADY53)
7) ypt1Q67L/∆gyp5/∆gyp1 (ADY54)
8) ypt1Q67L/∆gyp5/∆gyp8 (ADY55)
9) ypt1Q67L/∆gyp1/∆gyp8 (ADY56)
(for genotype description, see Appendix
Table 7.2).
10-fold serial dilutions of cells (starting at
0.01 OD) were spotted on YEPG plates
and grown at different temperatures for 3
days, (7 days at 15° C).
MSUC-3D
37 °C
30 °C
15 °C
20 °C
25 °C
1   2   3   4    5   6    7   8   9
1  2    3   4    5   6   7    8   9
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4.1.8  Partial rescue of the growth defect of the ypt1Q67L mutant by high expression
of Gyp5p
As shown in Fig. 4.14.A, the cold sensitivity of cI3-ABYS-86 ypt1Q67L (ADY29) could
be partially rescued by overexpression of Gyp5p(8-892) but not by the catalytically active
fragment Gyp5p(400-892) lacking the N-terminus.  The two gene fragments were cloned into
the pYX212 shuttle vector (see Appendix, Table 7.6), a 2µ vector containing the strong
constitutive TPI-promoter.  The two proteins with a 6xHis-tag at their C-terminus could be
detected by immunoblot analysis using anti-6xHis antibody (Fig. 4.14.B).  The near full-
length Gyp5p was prone to degradation even in the protease -deficient strain.
4.1.9  Analysis of possible transport defects in the different mutants
To verify whether the reduction of Ypt1p GTPase activity could affect vesicular
ER-to-Golgi transport, the transport of different proteins (secreted invertase, vacuolar
carboxypeptidase Y and plasma membrane-localized Gas1p), that pass through the
ER and the Golgi compartments on the way to their final destinations, was tested in
different mutants.  Carboxypeptidase Y (CPY) is a soluble vacuolar hydrolase.  It
Fig. 4.14  (A) Partial rescue of the growth defect at 15°C of cI3-ABYS-86 ypt1Q67L (ADY29) by
high expression of Gyp5p (aa 8-892).  The catalytically active fragment Gyp5p(400-892) cannot
rescue the same mutant.  The strains were grown on uracil-free plates, at 15 °C for 2 weeks.
(B) Western blot showing Gyp5p expression in the strains containing pY212-GYP5-6H(8-892) and
pY212-GYP5-6H(400-892).  For the immunoblot, anti-6xHis antibody was used.
ypt1Q67L
pYX212
WT
pYX212
ypt1Q67L
pYX212-GYP5(8-892)
ypt1Q67L
pYX212-GYP5(400-892)
- 102 kDa
- 58.8 kDa
BA
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leaves the ER as a core-glycosylated precursor protein of 67 kDa (p1), it is further
glycosylated in the Golgi apparatus (p2, 69 kDa), and finally reaches the vacuole,
where after a short proteolytic truncation, it becomes active.  This mature form (m)
has a molecular mass of 61 kDa.  Gas1p is a 125 kDa glycolipid-anchored plasma
membrane protein.  The ER glycosylphosphatidylinositol-containing precursor has a
molecular mass of 105 kDa and, upon arrival in the Golgi, is further glycosylated,
reaching a molecular mass of 125 kDa.  Invertase is a secreted protein (induced by
low glucose concentration in the medium) that is modified by 14 core oligosaccharides
in the ER, and by outer chain glycosylation in the Golgi apparatus.  Secreted
invertase migrates on non-denaturing polyacrylamide gels as heterogeneous species
with an apparent molecular mass of 100-140 kDa, the glycosylated ER-form has an
apparent molecular mass of 80-86 kDa.
MSUC-3D based strains (∆gyp5, ypt1Q67L, and ypt1Q67L/∆gyp5) were tested for
invertase secretion at 30°C and 15°C (see Methods 3.3.5).  As can be seen in Fig.
4.15, no significant differences were found between the mutant and the wild type
strains.  Similar results were also observed with cl3-ABYS-86 based strains.  In the
ypt1Q67L containing mutants the secreted invertase seems to be under-glycosylated to
some extent, and there is probably a slight accumulation of the ER core-glycosylated
invertase form; this is more visible in cells induced at 15°C.  sec18-1, a mutant with a
block at multiple steps in the secretory and endocytic pathways at non permissive
temperature of 37°C,  was used here as positive control.
Fig. 4.15  Staining of active invertase in
non-denaturing gels.  MSUC-3D based
strains ∆gyp5 (ADY41/K-), ypt1Q67L
(ADY49), ypt1Q67L/∆gyp5 (ADY51/K-),
induced for invertase synthesis at 15°C
for 2 h; sec18-1 induced at 37°C for 1h.
For genotype description, see Appendix
Table 7.2.  "I"= intracellular fraction,
"E"= periplasmic fraction, "S"= secreted
form, "ER" = ER form.
sec18-1WT ypt1Q67L∆gyp5
    ypt1Q67L
∆gyp5
S
E      I     E      I     E     I     E      I     E      I
ER-
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Transport of CPY and Gas1p was tested in MSUC-3D based strains (for
genotype description, see Appendix, Table 7.2).  Cells were grown at 30°C until
reaching an optical density of 0.5.  The cells were then incubated for 1 h at 20°C,
pulse-labeled for 10 min at 20°C with Trans 35S-label mix and chased for 45 min at
20°C with methionine and cysteine (see Methods, 3.3.6).  The cytosolic proteins were
precipitated with anti-CPY or anti-Gas1p antibodies (see Figs 4.16 and 4.17).  No
effect on CPY maturation was observed, but a slight delay of Gas1p maturation was
seen with the ypt1Q67L/∆gyp5 mutant (Fig. 4.17).  This is probably due to the growth
defect of these cells.  In fact, a similar delay of Gas1p secretion was observed also in
the cell cycle mutant cdc28 at non permissive condition (data not shown).
Fig. 4.16  CPY transport in MSUC-3D based
strains: ypt1Q67L (ADY49), ∆gyp5 (ADY41/K-),
ypt1Q67L/∆gyp5 (ADY51/K-), ypt1Q67L/∆gyp1
(ADY50), ypt1Q67L/∆gyp8 (ADY53),
∆gyp5/∆gyp1/∆gyp8 (ADY47),
ypt1Q67L/∆gyp5/∆gyp1 (ADY54),
ypt1Q67L/∆gyp5/∆gyp8 (ADY55) and
ypt1Q67L/∆gyp1/∆gyp8 (ADY56).
All the strains were grown to an OD600 of 0.5,
incubated for 1 h at 20°C, pulsed for 10 min
and chased for 45 min at 20 °C.  p1= ER core-
glycosylated CPY, p2= Golgi-modified CPY,
m= mature CPY.  There is no evident
difference in terms of secretion in the mutant
strains as compared to the wild type.
WT
   ypt1Q67L
∆gyp5
∆gyp1
   ypt1Q67L
∆gyp5
∆gyp8
    ypt1Q67L
∆gyp1
∆gyp8
p2-
p1-
m-
0         45       0       45       0       45        0       45
WT   ypt1Q67L ∆gyp5
    ypt1Q67L
∆gyp5
p2-
p1-
m-
0         45        0       45       0       45        0       45
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    ypt1Q67L
∆gyp1
    ypt1Q67L
∆gyp8
∆gyp5
∆gyp1
∆gyp8
p2-
p1-
m-
0         45        0       45       0       45        0       45
Fig. 4.17  Gas1p secretion in MSUC-3D
based strains: ypt1Q67L (ADY49), ∆gyp5
(ADY41/K-), and ypt1Q67L/∆gyp5 (ADY51/K-).
All the strains were grown to an OD600 of 0.5,
incubated for 1 h at 20°C, pulsed for 10 min
and chased for 45 min at 20 °C.  p= ER
proform, m= mature form. There is a slight
delay of Gas1p maturation in the double
mutant ypt1Q67L/∆gyp5.
WT    ypt1Q67L     ∆gyp5
   ypt1Q67L
∆gyp5
0         45        0       45       0       45        0       45
m-
p-
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4.1.10  Gyp5p is primarily a cytosolic protein
Genomic GYP5 was changed in such a way that Gyp5p became tagged at the C-
terminus with 2xMYC, or 3xHA or 3xVSV epitopes by PCR-mediated epitope tagging
(see Methods 3.3.3).  Yeast strains (ADY14, ADY15, ADY16) expressing tagged Gyp5
proteins were lysed and the lysates fractionated by differential centrifugation (see
Methods 3.4.10.a).  The different proteins were detected by immunoblotting.  As shown
in Fig. 4.18, Gyp5p is almost exclusively present in the supernatant (after a 100.000g
centrifugation).  To be sure that the fractionation was done correctly, soluble and
membrane proteins were detected as well.  Hxk2p (Hexokinase II), a cytosolic protein,
Bos1p, a SNARE protein that fractionates with Golgi and ER membranes and Wbp1p
(oligosaccharyltransferase β subunit), an ER integral membrane protein, fractionated
as predicted either as soluble proteins (fraction S) or as integral membrane proteins (in
the P10-P100 pellets).  Bos1p and Wbp1p became soluble only by treatment of cell
lysates with detergent.
P10  P100  S    P10  P100  S   P10  P100  S    P10  P100  S       T
BUFFER        1% TRITON      1.5 M KCl          4 M UREA
Gyp5p-MYC
Hxk2p
Bos1p
Wbp1p
Fig. 4.18  Cell fractionation by differential centrifugation.  The different fractions, "P10" (pellet
after 10.000g centrifugation), "P100" (pellet after 100.000g centrifugation), "S" (supernatant
after 100.000g centrifugation), "T" (total protein extract after 500g centrifugation), were
separated by SDS-PAGE (12% polyacrylamide gel).  Proteins were detected by
immunoblotting using anti-MYC, anti-Hxk2p, anti-Bos1p  and anti-Wbp1p antibodies.
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4.1.11  Electron microscopic inspection of ∆gyp5/ypt1Q67L mutant cells
To analyze the morphology of our mutant cells, an electron-microscopic
inspection of potassium permanganate-fixed or cryo-fixed/cryo-substituted cells was
performed (see Figs. 4.19 and 4.20).  Wild type (MSUC-3D), ypt1Q67L (ADY49),
∆gyp5 (ADY41/K-) and ypt1Q67L/∆gyp5 (ADY51/K-) strains were grown at 30°C.  The
liquid cultures were divided into two parts and before fixation one part was incubated
at 30°C and the second part at 15°C for 2 h.  The ypt1Q67L, but much more the
ypt1Q67L/∆gyp5 mutant cells exhibited a surprisingly altered morphology.  Cells of
these strains exhibited an accumulation of ER membranes and of various
membrane-bounded structures already at the permissive temperature.  These
included vesicles of different sizes, and structures resembling autophagosomes.  In
addition, the vacuoles were fragmented and often showed large invaginations
resembling autophagic tubes (Müller et al., 2000) and engulfed multivesicular bodies.
This was most clearly observed in cryo-fixed and cryo-substituted samples (see Figs.
4.20.C and 4.20.D).  Incubation at 15°C for 2 h before fixation did not show dramatic
differences in comparison with cells incubated at 30°C, probably because two hours
are two little to induce visible changes.
4.1.12  Visualization of vacuolar membranes in living cells by FM 4-64 vital staining
The peculiar behavior of vacuolar compartments could also be shown in living
cells by using the lipophilic styryl dye FM 4-64 (see Methods 3.6.2).  As can be seen
in Fig. 4.21, in ∆gyp5/ypt1Q67L mutants (ADY51/K-) the vacuolar membrane forms
invaginations and convoluted structures inside the vacuole itself.  This phenomenon
could be partially observed in ypt1Q67L (ADY49) mutants, too.  A similar phenomenon
was described by (Müller et al., 2000) studying the formation of autophagic tubes.
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Fig. 4.19  Thin-section electron micrographs of wild type (MSUC-3D; A) ypt1Q67L (ADY49;
B), ∆gyp5 (ADY41/k-; C) and ∆gyp5/ypt1Q67L (ADY51/k-; D) mutant cells.  Cells were grown
in YEPG medium at 30 °C and then subjected to potassium permanganate fixation.  In
ypt1Q67L, but more accentuated in the double ∆gyp5/ypt1Q67L mutant, the vacuoles are
fragmented in addition to ER proliferation and an accumulation of membrane-bounded
structures (indicated by white arrows).  In the ∆gyp5/ypt1Q67L double mutant the vacuoles
contain large membrane-bounded structures filled with cytosol which resemble autophagic
tubes (indicated by black arrowheads in panel D).  This is most clearly observed  in Fig.
4.20.  N= nucleus, V= vacuole, E= ER, M= mitochondria.  
1 µm
A B
C D
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Fig. 4.20  Thin-section electron micrographs of the ∆gyp5/ypt1Q67L double mutant (ADY51/k-)
grown at 30°C.  (A-B) Potassium permanganate-fixed cells.  (C-D) Cryo-fixed and cryo-
substituted cells.  Large invaginations of the vacuolar membrane can be observed (indicated
by arrows).  The lumen of  the vacuolar invaginations is continuous with the cytosol.  These
structures resemble the autophagic tubes described by (Müller et al, 2000).  In the vacuoles
putative autophagic bodies are also visible .   N= nucleus, V= vacuole, AB= autophagic
body, MB= multi-vesicular body.
250 nm 250 nm
500 nm 500 nm
A B
C D
AB
AB
V
AB
V
V
V
V
V
N
MB
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Fig. 4.21  Wild type (MSUC-3D), ypt1Q67L (ADY49), ∆gyp5/ypt1Q67L (ADY51/k-) and ∆gyp5
(ADY41/k-) mutants stained with FM-4-64.  Cells were incubated at 30°C for 15 min with 30 µM
FM-4-64 in YEPG medium, then "chased" for 1h at 30°C with fresh YEPG medium.  Finally,
the cells were resuspended in water and viewed under a fluorescence microscope with a
546 nm filter  (for FM 4-64), or by DIC (differential interference contrast).
WT
∆gyp5
ypt1Q67L
∆gyp5/ypt1Q67L
DIC FM 4-64 merge
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4.2  SECTION II (Sec24p family)
The Ypt1p-dependent transport vesicle docking/fusion with Golgi organelle(s) is
preceded of course by the budding of vesicles from the ER membrane.  Sec24p
complexed with Sec23p is an essential component of the COPII coat which itself is
involved in curving the ER membrane and, most likely, in integral membrane cargo
selection (see Introduction 1.3.1).  As already mentioned in the Introduction (1.3.2), in
S. cerevisiae there are two close orthologues to Sec24p, named Sfb2p and Sfb3 (the
acronym "Sfb" stands for Sed-five binding).  The name "Sfb" was given to them after it
was demonstrated that Sec24p is able to bind Sed5p in vitro (Peng et al., 1999).
Sfb2p/Iss1p (product of YNL049c; Iss1p stands for interacting with sec-sixteen) shares
56% sequence identity with Sec24p, Sfb3p/Lst1p (product of YHR098c; Lst1 stands for
lethal with sec-thirteen) shares 23% sequence identity with Sec24p.  The three
proteins contain a putative zinc-binding motif (CysX2CysX18CysX2Cys), the four
conserved cysteines are highlighted in red in Fig. 4.22.
The present study (in collaboration with Dr. R. Peng; Peng et al., 2000) was
undertaken to get further insight into the functional relationship between Sec24p,
Sfb2p and Sfb3p.  It was possible to demonstrate that Sfb2p and Sfb3p are functional
COPII components and that they could have a role in specific cargo selection as it
was also demonstrated by other research groups (Higashio et al., 2000; Kurihara et
al., 2000; Pagano et al., 1999; Roberg et al., 1999; Shimoni et al., 2000).
While SEC24 is an essential gene, both SFB2 and SFB3 are nonessential genes.
This was proven by experimental work performed in our laboratory and also in others
(Kurihara et al., 2000; Pagano et al., 1999; Peng et al., 2000; Roberg et al., 1999).
4.2.1  Sec24 family proteins are differently expressed in the cell
To study the behavior of Sec24 family proteins, the three different genes in
addition to SEC23 were elongated so that their protein products were tagged at their
C-termini with MYC epitopes by PCR-mediated epitope tagging as described in
Methods (Section 3.3.3).  Total protein extracts from the strains ADY1, ADY2, ADY3
and ADY4 (see Appendix Table 7.2), expressing respectively Sfb2p-MYC, Sfb3p-MYC,
Sec23p-MYC and Sec24p-MYC, were used to determine the relative abundance of
these proteins (see Fig 4.23).  The protein extracts were obtained by alkaline lysis or
by sonication as described in Methods (3.4.7.b).
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Sec24p     1 MSHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQ
Sfb2p      1 MSHHKKRVYPQAQVPY----------------------------I-----ASMPIVAEQ-
Sfb3p      1 MSQQNILAASVSALSLDESTVHTGGASS-KKSRRPHRAYHNFSSGTVPTLGNSPYTTPQL
Sec24p    61 FLTPAQEQLHQQIDQATTSMNDMHLHN-VPLVDPNAYMQP-QVPVQMGTPLQQQQQPMAA
Sfb2p     27 -----Q-QSQQQIDQTAYAMGNLQLN-----------NR---A--NSFTQLAQNQQ---F
Sfb3p     60 N---QQDGFQQPQAFTPKQFGGFNNGSGSVMSTPVMVSQERFGASEASSPYGQSMLDMTA
Sec24p   119 PAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNAS
Sfb2p     62 PGSG---------K-VVNQLYPVDLFTELPPPIRDLSLPPLPITISQDNIVTPSEYSNVP
Sfb3p    117 PQPTS-------HIVPTQRFEDQAQYLQRSFETCRDSVPPLPTTQ-----FYCVDQGSCD
Sec24p   179 PDYIRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPP---PLNEDGLIVRCRRCR
Sfb2p    112 YQYVRSTLKAVPKTNSLLKKTKLPFAIVIRPYLHLQDSDNQV---PLNTDGVIVRCRRCR
Sfb3p    165 PHLMSLSMYNIPESEHLRAATKLPLGLTIQPFSTLTPNDAEVPTIPLPMDGTPLRCRRCR
Sec24p   236 SYMNPFVTFIEQGRRWRCNFCRLANDVPMQMDQSD-PNDPKS-RYDRNEIKCAVMEYMAP
Sfb2p    169 SYMNPFVVFINQGRKWQCNICRFKNDVPFGFDQNL-QGAPIN-RYERNEIKNSVVDYLAP
Sfb3p    225 AYANPKFQFTYDS-SVICNICRVKMQVPGEHFAPMGPNGQRSDLNEKSELLHGTVDFLVP
Sec24p   294 KEYTLRQPP---PATYCFLIDVSQSSIKSGLLATTINTLLQNLDSIPNHDERTRISILCV
Sfb2p    227 VEYSVREPP---PSVYVFLLDVSQNAVKNGLLATSARTILENIEFLPNHDGRTRIAIICV
Sfb3p    284 SIYNAIQEKELLPLHYVFLIDVSLLANENGSSLAMVEGVRSCIEYISDFQPNCEVAIIVY
Sec24p   351 DNAIHYFKIPLDS------ENNEES----------------ADQINMMDIADLEEPFLPR
Sfb2p    284 DHSLHYFYVPLDDDYEVSDEDDEESDGEEEDEDEEEEDVDNSETIQMFDIGDLDEPFLPM
Sfb3p    344 DNKLRFFNLRPDL-----------------------------DNAQEYIVSELDDVFLPF
Sec24p   389 P-NSMVVSLKACRQNIETLLTKIPQIFQS--NLITNFALGPALKSAY----HLIGGVGGK
Sfb2p    344 PSDELVVPLKYCKNNLETLLKKIPEIFQD--THSSKFALGPALKAAS----NLIKSTGGK
Sfb3p    375 YNGLFVKPGNSMKIINDTLIKISGYISTDKYSHVPQVCYGSALQAAKLALDTVTGGQGGK
Sec24p   442 IIVVSGTLPNLGIGKLQRRNESGVVNTSKETAQLLSCQDSFYKNFTIDCSKVQITVDLFL
Sfb2p    398 VEVISSTLPNTGIGKLKKRSEQGILNTPKESSQLLSCKDSFYKTFTIECNKLQITVDMFL
Sfb3p    435 IICSLNSLPTIGNGNLSLKRDN-------AHIAHVKCDNGFYKKLASDFLKSYISLDLYV
Sec24p   502 ASEDYMDVASLSNLSRFTAGQTHFYPGFSGKNPNDIVKFSTEFAKHISMDFCMETVMRAR
Sfb2p    458 ASEDYMDVATLSHLGRFSGGQTHFYPGFNATSLNDVTKFTRELSRHLSMDISMEAVMRVR
Sfb3p    488 TNAGFIDMATVGHPVEMTSGILKYYPHFQQET--DAFTLVNDMVTNVSNIVGYQALLKVR
Sec24p   562 GSTGLRMSRFYGHFFNRSSDLCAFSTMPRDQSYLFEVNVDESIMA-DYCYVQVAVLLSLN
Sfb2p    518 CSTGLRATSFFGHFFNRSSDLCAFSTMPRDQSYLFGISIEDSLMA-EYCYLQVSTLLTLN
Sfb3p    546 CSTGLSVEQYYCDSSDNTDHDPIIPVLTRDTTLDVLLKYDSKIKTGTDVHFQTALLYTDI
Sec24p   621 NSQRRIRIITLAMPTTESLAEVYASADQLAIASFYNSKAVEKALNSSLDDARVLINKSVQ
Sfb2p    577 TGERRIRVMTLALPTSESAREVFASADQLAITDFMTQNAVTKALNSSMYSARDFITKSLE
Sfb3p    606 DGVRKVRSINTSGAVSNNIREIFKFINQNPVMRIMIKDVIKTLGDCDFVKIRRLIDDKMV
Sec24p   681 DILATYKKEIVVSNTAGGAPLRLCANLRMFPLLMHSLTKHMAFRSGIVPS--DHRASALN
Sfb2p    637 DILNAYKKEISMSNINSVTSLNLCANLRMLPLLMNGLSKHIALRPGVVPS--DYRASALN
Sfb3p    666 EILTQYRGLVSS---NSSTQLILPDSIKTLPAYMLAFEKSELMKPNAQSTRGNERIYDLL
Sec24p   739 NLESLPLKYLIKNIYPDVYSLHDMADEAGLPVQTE---DGEATGTIVLPQPINATSSLFE
Sfb2p    695 RLETEPLHYLIKSIYPTVYSLHDMPDEVGLP---------DFEGKTVLPEPINATISLFE
Sfb3p    723 KYDSLNSAQLCYKLYPQIVPFHVLLEETDLTFYDANDKLLQINSSSINNLSVRASHSNFI
Sec24p   796 RYGLYLIDNGNELFLWMGGDAVPALVFDVFGTQD---IFDIPIGKQEIPVVENSEFNQRV
Sfb2p    746 RYGLYLIDNSAELFLWVGGDAVPELLIDVFNTDT---ISQIPVGKSELPLLNDSPFNERL
Sfb3p    783 NGGCYLIFQGDTIYLWFNENTNRMLLQDLLSVDESLPVSQISLFSGTLPETGTS-INQKA
Sec24p   853 RNIIN---QLRNHD---------DVITYQSLYIVRGASLSEPVNHASARE--VATLRLWA
Sfb2p    803 RRIIG---RIRENN---------DTITFQSLYIIRGPSINEPANLNSEKD--MASLRLWV
Sfb3p    842 SNVIKNWQQVVNKSSLPLVLLRPNVDQYYSNVMSQLLCEDKTVNRIESYDNYLVIMHKKI
Sec24p   899 SSTLVEDKILNNESYREFLQIMKARISK
Sfb2p    849 LSTLVEDKVLNCASYREYLQSMKTSINR
Sfb3p    902 QEKLQKDDFIKVSTAATHENIHQKFVQF
Y (sec24-11)
Fig. 4.22  Multiple alignment of Sec24p, Sfb2p and Sfb3p.  Identical or similar amino acids
in two or all three proteins are shown on black or shaded background, respectively.  In red
are the cysteine residues of the putative zinc-finger domain.  The single amino acid change
(D351Y) in the sec24-11 allele in the temperature-sensitive strain is also indicated.
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Equal amount of protein extracts from these strains were separated by SDS-
PAGE and subjected to immunoblot analysis with monoclonal anti-MYC and polyclonal
anti-Sly1p antibodies, the latter serving as control.  The relative abundance of the
proteins was calculated by measuring the chemiluminescent intensities of the bands
using a Lumi-Imager.  The values obtained by Lumi-Imager for the MYC-tagged
proteins were normalized on the values obtained for Sly1p.  As shown in Fig. 4.23,
Sec23p was found to be the most abundant of the four proteins and Sfb2p the least
abundant.  Note that while the calculated molecular masses are 103.6 kDa for Sec24p,
98.9 kDa for Sfb2p and 103.9 kDa for Sfb3p, on SDS-PAGE the apparent molecular
mass of Sfb3p is smaller than the calculated.
Fig. 4.23  Relative abundance of Sec23p and Sec24p family members.  (A) Triplicate
samples of total protein after alkaline lysis of MYC-tagged Sec24p-, Sfb2p-, Sfb3p- or
Sec23p-producing cells were separated by SDS-PAGE, and subjected to immunoblotting
with anti-MYC or anti-Sly1p antibodies. The concentrations were calculated measuring the
chemiluminescent intensity of the protein bands with a Lumi-Imager. (B) Histograms
representing the relative concentrations of Sec23p, Sec24p and Sfb3p in proportion to
Sfb2p as determined by Lumi-Imager analysis. The values were normalized on Sly1p. The
data are the average of three measurements derived from two different protein extracts.
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4.2.2  Sec24p, Sfb2p and Sfb3p form complexes with Sec23p
It is known that Sec24p forms a stable complex with Sec23p (Hicke et al., 1992).
More precisely, it was determined that the binding site for Sec23p lies in between
amino acids 56-594 (Peng et al., 1999).  To test whether Sfb2p and Sfb3p could also
form stable complexes with Sec23p, these proteins were immuno-precipitated and the
co-precipitated protein-complexes analyzed.  The MYC-tagged proteins were expressed
in the previously described ADY1, ADY2, ADY3 and ADY4 strains (see 4.2.1), and
were precipitated from 16.000g supernatants (cells lysed in the presence of 1% Triton
X-100, see Methods 3.4.13) with polyclonal anti-MYC antibodies.  The target and co-
precipitated proteins in the "IP" (immunoprecipitation pellet) and the non-precipitated
protein in the "supernatant" were separated by SDS-PAGE and probed with polyclonal
anti-Sec23p and anti-Sec24p antibodies.  As shown in Fig. 4.24, immunoprecipitation
of Sfb2p-MYC and Sfb3p-MYC led to co-precipitation of Sec23p but not of Sec24p.
Immunoprecipitation of Sec23p-MYC led to the complete co-precipitation of Sec24p.
In contrast, complete immunoprecipitation of Sec24p-MYC left some of the Sec23p in
the supernatant.  This argues for Sec23p being in excess over Sec24p, and the
exceeding part should be in complex with Sfb2p or Sfb3p.
The complexes of Sfb2p and Sfb3p with Sec23p were also observed by other
researchers (Higashio et al., 2000; Kurihara et al., 2000; Roberg et al., 1999).
Similarly, in mammalian cells hSec23Ap could co-immunoprecipitate with hSec24Bp
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Fig. 4.24  Immunoprecipitation of MYC-tagged proteins with anti-MYC antibodies and analysis
of co-precipitated Sec24p and Sec23p.  The target and co-precipitated proteins in the "IP" and
the non-precipitated protein in the "supernatant" were separated by SDS-PAGE and probed
with polyclonal anti-Sec23p and anti-Sec24p antibodies.  The amount of supernatant loaded
on each lane of the gel corresponds to 1/20 of the total.
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and hSec24Cp (Pagano et al., 1999).  In the same study it was determined, by two-
hybrid assay, that the interacting domain of hSec24Cp is located in the region within
amino acids 485-807 (corresponding to amino acids 289-611 in Sec24p).
4.2.3  Sfb2p behaves differently from Sec24p and Sfb3p on gel filtration chromatography
For further analysis of Sec23p complexes with either Sec24p or its orthologues,
the 100.000g supernatant (obtained in the presence of 0.5% CHAPS) from ADY6
strain (expressing Sfb2p-HA and Sfb3-MYC proteins, see Table 7.2) was subjected
to Sephacryl S-400 gel filtration (see Methods 3.4.11).  As can be seen in Fig. 4.25,
all the proteins show an overlapping peak at ~ 250-300 kDa.  This is a further proof of
Sfb2p and Sfb3p forming complexes with Sec23p as was previously shown for
Sec24p (Hicke et al., 1992).  Interestingly, a significant portion of Sfb2p, in contrast to
the other proteins, eluted from the column at a higher molecular mass (~650 kDa).  It
is therefore possible that part of Sfb2p is in a large complex free of Sec23p.
4.2.4  Intracellular distribution of Sec24p and its orthologues
Previous studies had shown that the Sec23p/Sec24p subcomplex is recruited to
the ER membrane in the process of vesicle budding and that it dissociates from
vesicles before fusion (Barlowe et al., 1994) (see also Introduction 1.3.1).  It is
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Fig. 4.25  Gel filtration chromatography on S-400 columns (1.6 cm x 65 cm) of 100.000g
supernatants obtained in the presence of 0.5% CHAPS.  Proteins were separated by SDS-
PAGE and subjected to immunoblotting using antibodies specific for the different proteins.
The chemiluminescence intensities of the protein bands were evaluated with a Lumi-Imager.
The position of molecular size markers used to calibrate the column are indicated.
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therefore expected that there is a soluble and a membrane associated pool of the
different COPII components.
To see whether Sec23p and Sec24p orthologues form distinguishable complexes
and whether the individual proteins might behave differently with respect to membrane
association, we examined the distribution of the four COPII components by differential
centrifugation of cell lysates (see Methods 3.4.10a and Fig. 4.26), and by sucrose
gradients (see Methods 3.4.10b and Fig. 4.26).
By differential centrifugation it is possible to distinguish whether a protein is
cytosolic, membrane-associated or part of large protein complexes.  As can be seen
in Fig. 4.26, all four COPII components were distributed almost evenly between the
pellet and supernatant fractions obtained from successive centrifugation at 10.000g
and 100.000g.  In contrast to Sec24p, a larger fraction of Sfb2p appears to be
associated with membranes or in larger pelletable protein complexes.  Sfb2p and
Sfb3p were more resistant to solubilization with detergent than Sec24p under
conditions where the integral membrane protein Bos1p became completely soluble.
Treatment of the cell fractions with high salt or urea, conditions expected to
dissociate protein complexes, efficiently solubilized all four COPII proteins.
Sec24p
Sec23p
Sfb2p-HA
Sfb3p-MYC
Bos1p
P10  P100  S P10  P100  S P10  P100  S P10  P100  S
BUFFER         1% TRITON        1.5 M KCl           4 M UREA
Fig. 4.26  Cell fractionation by differential centrifugation.  Cleared cell lysates from the ADY6
strain (expressing Sfb2p-HA and Sfb3-MYC proteins, see Table 7.2) were treated on ice for
15 min with buffer alone, or buffer containing 1% Triton X-100, or 1.5 M KCl, or 4 M urea and
then subjected to consecutive centrifugation at 10.000g and 100.000g.  The different fractions,
"P10" (pellet after 10.000g centrifugation), "P100" (pellet after 100.000g centrifugation), "S"
(supernatant after 100.000g centrifugation), were separated by SDS-PAGE (12% polyacrylamide
gel).  Proteins were detected by immunoblotting using anti-MYC, anti-HA, anti-Sec23p, anti-
Sec24p and anti-Bos1p antibodies.
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In Fig. 4.27, the distribution of the proteins on a 18%-60% sucrose density
gradient is shown .  The distribution of the membrane proteins Emp47p, Bos1p and
Sec61p were determined as controls.  At steady, state Emp47p is mostly localized in
the Golgi (Schröder et al., 1995), the v-SNARE Bos1p cycles between ER and Golgi
(Ossipov et al., 1999) and Sec61p is an ER membrane protein (membrane
component of the ER protein translocation apparatus) (Deshaies et al., 1991).  Only
a minor part of the COPII components tested appeared to be cytosolic (fraction 1-3),
the majority fractionated with higher sucrose density of the gradient and partially
overlapped with Golgi fractions (fractions 6-10).  A very small part of the COPII
proteins was found in ER fractions (fractions 11-13).  This distribution could be due to
either membrane association or to complex formation.  There was no significant
difference in the distribution of the three different Sec24p family components.
Fig. 4.27  Cell fractionation by velocity sedimentation on 18-60% sucrose gradient of ADY6
cells.  Fractions 1 to 13 were collected (top to bottom).  Proteins from each fraction were
separated by SDS-PAGE (12% polyacrylamide gel) and detected by immunoblotting using anti-
MYC, anti-HA, anti-Sec23p, anti-Sec24p, anti-Emp47p anti-Bos1p and anti-Sec61p antibodies.
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4.2.5  Sfb2p, like Sec24p, binds Sed5p
Previously it was demonstrated by two-hybrid analysis and affinity chromatography
that Sec24p could specifically bind the t-SNARE Sed5p (Peng et al., 1999).  It was
therefore of interest to investigate whether the two Sec24p orthologues would have the
same capability.  For that reason an affinity chromatography experiment (see Methods
3.4.12) was performed using the GST fusions of all the known yeast syntaxins (lacking
their C-terminal transmembrane domains): the ER localized Ufe1p (Lewis and Pelham,
1996), the cis-Golgi Sed5p (Hardwick and Pelham, 1992), the prevacuolar Pep12p
(Becherer et al., 1996), the vacuolar Vam3p (Wada et al., 1997), the endosomal and/or
late Golgi Tlg1p and Tlg2p (Abeliovich et al., 1998; Holthuis et al., 1998), and the plasma
membrane Sso1p and Sso2p (Aalto et al., 1993).  The fusion proteins were obtained
using the plasmids pTT-VAM3(1-261), pTT-SSO1(2-264), pTT-SSO2(1-267), pTT-TLG1(1-204), pTT-
TLG2(1-317), pGEX-UFE1∆C,  pGEX-SED5∆C, pEG-PEP12∆C (see Tables 7.4, 7.5 and 7.6).
Except for GST-Pep12p, which was produced in yeast, all the other proteins were
produced in bacteria.  500 µg detergent solubilized proteins from ADY1 and ADY2 strains
expressing Sfb2p-MYC and Sfb3p-MYC, respectively, were incubated overnight at 4°C
with 1 µg GST or GST fusion SNAREs, previously coupled to glutathione-Sepharose
beads, in 200 µl lysis buffer (25 mM HEPES, 1% Triton, 150 mM KOAc, 5 mM MgCl2, 1
mM DTT, 1 mM EDTA).  After extensive washing with lysis buffer proteins were separated
by SDS-PAGE and analyzed by immunoblotting using anti-MYC antibodies.  As can be
seen in Fig. 4.28, Sfb2p bound Sed5p specifically while Sfb3p could not (under these
conditions).  In a similar experiment, using only cytosolic proteins and slightly different
buffer conditions, a weak interaction could also be detected for Sfb3p (Peng et al., 2000).
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Fig. 4.28  500 µg proteins from detergent-lysed yeast cells were incubated with 1 µg purified
GST or GST-fusion t-SNAREs which had previously been immobilized on glutathione-
Sepharose beads.  After intensive washing, the bound proteins were separated by SDS-PAGE
and detected by immunoblotting with polyclonal anti-MYC antibody.
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4.2.6 Sfb2p can rescue the growth defect of sec24-11
To check whether overexpression of Sfb2p or Sfb3p could compensate the loss
of Sec24p function, it was tested if these proteins could rescue the growth defect of
the temperature-sensitive sec24-11 mutant (RPY18).  As can be seen in Fig. 4.29,
expression of Sfb2p from a high-copy-number vector (2µ) allowed mutant cells to
grow whereas high expression of Sfb3p did not.  On the contrary, high expression of
Sfb3p alone was somehow toxic for the cells (data not shown).  Both these data were
subsequently confirmed by other researchers (Higashio et al., 2000; Kurihara et al.,
2000; Roberg et al., 1999)
4.2.7 Effects on protein transport of ∆sfb2 in combination with the sec24-11 allele
As already mentioned, SFB2 and SFB3 are nonessential genes.  Cells lacking
either SFB2, SFB3 or both genes, grew like wild type cells at temperatures between
15°C and 37°C.  Transport of the vacuolar hydrolases carboxypeptidase Y (CPY) and
alkaline phosphatase (ALP) and secretion of invertase (see Methods 3.3.5 and 3.3.6)
seemed to be unaffected.  Invertase was apparently not fully glycosylated in the
mutant cells (data not shown).
Fig. 4.29  Elevated levels of Sfb2p rescued the growth defect of a sec24-11 mutant (RPY18)
at the non-permissive temperature.  sec24-11 cells were transformed with the 2µ based
vectors pRS326-SFB2, pRS325-SFB3 and pRS326-SEC24 (see Tables 2.5 and 2.6) and
grown on selective agar plates for 3 days at 37°C or 25°C.  (WT) is MSUC-3D transformed
with pRS325 and pRS326.
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 SFB3, 2µSFB2, 2µ
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SEC24 is an essential gene and the sec24-11 mutant cannot grow at the non-
permissive temperature of 37°C (see Fig. 4.29).  Surprisingly only a mild effect on
transport of CPY, ALP and invertase was observed at 37°C (see Fig. 4.30).
We tried therefore to combine the cromosomally integrated sec24-11 allele with
the deletion of either SFB2 or SFB3.  Only the double mutant ∆sfb2/sec24-11 could be
obtained, the combination of ∆sfb3 with sec24-11 led to lethality.  In contrast to the
single mutants, transport of CPY and ALP was completely blocked in the double
mutant ∆sfb2/sec24-11 (see Fig. 4.30.A).  In this mutant, accumulation of the ER core-
glycosylated form of invertase was also observed, but most of the enzyme appeared to
reach the periplasmic space in a somewhat hypoglycosylated form (see Fig 4.30.B).
Fig 4.30  (A) Cells from sec24-11 (RPY18),
∆sfb2/sec24-11 (RPY72), sec23-1 (RH227-
3A) and wild type (MSUC-3D), were grown
at 25 °C, transferred to 37 °C for 30 min,
pulse-labeled for 10 min and chased  for 0,
15 and 30 min at 37 °C.  CPY and ALP were
immunoprecipitated and separated by SDS-
PAGE, followed by autoradiography.  "p1"= ER
core-glycosylated CPY, "p2"= Golgi-modified
CPY, "p"= ER- and Golgi-modified ALP
proform and "m"= mature form.
(B) Staining of active invertase in non-
denaturing gels.  Cells were grown at 25 °C
and induced for secreted invertase synthesis
at 37°C for 1h.  "I"= intracellular fraction, "E"=
periplasmic fraction, "S"= secreted form,
"ER" = ER form, "C"= cytosolic invertase.
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4.2.8 Electron microscopic inspection of the ∆sfb2/sec24-11 mutant
By electron microscopic inspection of potassium permanganate fixed cells we
tried to look whether there were morphological differences between wild type (MSUC-
3D), ∆sfb2 (RPY61), sec24-11 (RPY18) and ∆sfb2/sec24-11 (RPY72) mutants.  Cells
were grown at 25°C to mid-log phase, then incubated at 37°C for 1h before fixation.
Compared to wild type (Fig. 4.31.A), ∆sfb2 (Fig. 4.31.B) and sec24-11 (Fig. 4.31.C)
mutant cells had an about 2-fold increase in the number of 30-50 nm vesicles
(indicated by arrowheads).  Interestingly, the ∆sfb2/sec24-11 double mutant (Fig.
4.31.D) exhibited enhanced proliferation of ER membranes, and a further increase
(approximately 3-fold compared to wild type) of vesicular structures many of which
formed aggregates (Fig. 4.31.E); these aggregates were present in about 20 % of the
sections. The aggregated structures were of round and sometimes of short rod-like
appearance. In some cases it can be seen that they are surrounded by a membrane.
4.2.9 Immunofluorescence detection of one member of the mammalian Sec24p
family in monkey CV1 cells
When this work was started, the mammalian homologues of Sec24p were
unknown.  By database search, a full-length human cDNA clone named KIAA0079
was found sharing significant homology with Sec24p (GenBank accession number
D38555, kindly provided to us by Dr. Nomura from the Kazusa DNA research
institute, Japan; (Nomura et al., 1994).  The cDNA encodes a 1094 amino acid-long
protein with a calculated molecular mass of 118 kDa which is 27.2% identical to
Sec24p in 960 overlapping amino acids, 27.8% identical  to Sfb2p in 802 overlapping
amino acids and 26.4% identical to Sfb3p in 904 overlapping amino acids.  The
sequence present in the database contains a mistake (an extra base at position 3233
and consequently a frame-shift after amino acid 1040).  The sequence shown in Fig.
4.32 is the correct one.  This sequence mistake was found after multiple alignment
with different ESTs and subsequently confirmed by sequencing.
In order to produce antibodies against this protein, different fragments were
cloned and expressed as 6xHis fusion proteins.  The two protein fragments,
highlighted in Fig. 4.32, corresponding to the sequence regions 365-522 (for simplicity
named peptide 2) and 747-992 (peptide 5), respectively, were used as antigens.
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Fig. 4.31  Thin-section electron-micrographs
of wild type (MSUC-3D; A), ∆sfb2 (RPY61; B),
sec24-11 (RPY18; C) and ∆sfb2/sec24-11
(RPY72; D) mutants.  Cells were grown at
37°C for 1 h before potassium permanganate
fixation.  (E) enlarged view of ∆sfb2/sec24-11
double mutant cells showing clusters of
round and rod-like membrane-bounded
structures.  Vesicle aggregates are indicated
by an arrow in D, and 30-50 nm vesicles
by arrowheads.  N= nucleus, V= vacuole,
M= mitochondria.  
1 µm
0.1 µm
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The two 6xHis-tagged fragments were expressed in bacteria containing the
expression plasmids pQE30-KIAA0079(363-522), pQE50-KIAA0079(363-522) and pQE30-
KIAA0079(747-992) (see Table 7.6).  The methods used to produce and purify these
antibodies are described in Section 3.5.  In Fig. 4.33 an immunoblot of protein extracts
from Hela and CV1 cells using the antibodies anti-KIAA0079-2 (serum from rabbits 166
and 167) and anti-KIAA0079-5 (serum from rabbits 168 and 169) is shown.
1 MNVNQSVPPV PPFGQPQPIY PGYHQSSYGG QSGSTAPAIP YGAYNGPVPG
51 YQQTPPQGMS RAPPSSGAPP ASTAQAPCGQ AAYGQFGQGD VQNGPSSTVQ
101 MQRLPGSQPF GSPLAPVGNQ PPVLQPYGPP PTSAQVATQL SGMQISGAVA
151 PAPPSSGLGF GPPTSLASAS GSFPNSGLYG SYPQGQAPPL SQAQGHPGIQ
201 TPQRSAPSQA SSFTPPASGG PRLPSMTGPL LPGQSFGGPS VSQPNHVSSP
251 PQALPPGTQM TGPLGPLPPM HSPQQPGYQP QQNGSFGPAR GPQSNYGGPY
301 PAAPTFGSQP GPPQPLPPKR LDPDAIPSPI QVIEDDRNNR GTEPFVTGVR
351 GQVPPLVTTN FLVKDQGNAS PRYIRCTSYN IPCTSDMAKQ AQVPLAAVIK
401 PLARLPPEEA SPYVVDHGES GPLRCNRCKA YMCPFMQFIE GGRRFQCCFC
451 SCINDVPPQY FQHLDHTGKR VDAYDRPELS LGSYEFLATV DYCKNNKFPS
501 PPAFIFMIDV SYNAIRTGLV RLLCEELKSL LDFLPREGGA EESAIRVGFV
551 TYNKVLHFYN VKSSLAQPQM MVVSDVADMF VPLLDGFLVN VNESRAVITS
601 LLDQIPEMFA DTRETETVFV PVIQAGMEAL KAAECAGKLF LFHTSLPIAE
651 APGKLKNRDD RKLINTDKEK TLFQPQTGAY QTLAKECVAQ GCCVDLFLFP
701 NQYVDVATLS VVPQLTGGSV YKYASFQVEN DQERFLSDLR RDVQKVVGFD
751 AVMRVRTSTG IRAVDFFGAF YMSNTTDVEL AGLDGDKTVT VEFKHDDRLN
801 EESGALLQCA LLYTSCAGQR RLRIHNLALN CCTQLADLYR NCETDTLINY
851 MAKFAYRGVL NSPVKAVRDT LITQCAQILA CYRKNCASPS SAGQLILPEC
901 MKLLPVYLNC VLKSDVLQPG AEVTTDDRAY VRQLVTSMDV TETNVFFYPR
951 LLPLTKSPVE STTEPPAVRA SEERLSNGDI YLLENGLNLF LWVGASVQQG
1001VVQSLFSVSS FSQITSGLSV LPVLDNPLSK KVRGLIDSLR AQRSRYMKLT
1051VVKQEDKMEM LFKHFLVEDK SLSGGASYVD FLCHMHKEIR QLLS
Fig. 4.32  Protein encoded by the cDNA KIAA0079 (hSec24Cp).  The sequences highlighted
represent the two fragments (for simplicity named peptides 2 and 5) used to produce anti-KIAA0079-
2  and anti-KIAA0079-5 antibodies, respectively.  The putative zinc finger domain is underlined.
Fig. 4.33  Protein extracts from Hela (H) and
CV1 (C) cells were separated by SDS-PAGE and
immunoblotted with serum from two rabbits (166,
167) immunized with "peptide 2" and from two
rabbits (168, 169) immunized with "peptide 5".
The calculated molecular mass of the KIAA0079-
encoded protein is 118 kDa.
H       C       H       C        H      C       H      CkDa
120 -
87-
166 167 168 169
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By indirect immunofluorescence with anti-KIAA0079 antibodies it was possible to
judge the subcellular localization of KIAA0079-encoded protein in methanol-acetone
fixed CV1 cells (see Methods 3.6.3).  The following proteins were immuno-labeled
and used for reference: protein disulfide-isomerase (PDI), β1 and  β2 adaptins and
Golgi 58K.  PDI is a soluble ER resident protein containing at its C-terminus the highly
conserved KDEL sequence (Kaetzel et al., 1987); β1 and β2 adaptins are components of
the adaptor complexes AP-1 and AP-2, the antibodies against β1 and  β2 adaptins
anti-KIAA0079-2
(166)
anti-β1 and  β2
adaptins
Merge 10 µm
anti-KIAA0079-2
(166)
anti-Golgi K58 Merge 10 µm
anti-KIAA0079-2
(167)
anti-PDI Merge 10 µm
Fig. 4.34  Double immunofluorescence of methanol-acetone fixed CV1 cells using anti-
KIAA0079-2 antibody in combination with the antibodies indicated in the panels.  The
secondary antibodies were rhodamine red-X-conjugated and Oregon-Green-488-conjugated.
Confocal images were taken using a Leica TCS NT confocal laser scanning microscope.
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stain clathrin-coated domains at the plasma membrane and at the Golgi region (Ahle
et al., 1988);  Golgi 58K is a microtubule-binding peripheral Golgi membrane protein
(Bloom and Brashear, 1989).
As can be seen in Fig. 4.34, the anti-KIAA0079 antibodies revealed a punctate
pattern scattered throughout the cytoplasm along with some concentration at the
perinuclear region (overlapping with Golgi markers).  Some of the punctate structures
were overlapping with ER structures, as can be seen in the double staining with PDI.
This distribution pattern is similar to what was previously described for another COPII
component, the mammalian Sec13p (Tang et al., 1997).  The same was subsequently
observed by other research groups (Pagano et al., 1999; Tang et al., 1999; Tani et al.,
1999), who described the entire family of mammalian Sec24 proteins: hSec24Ap,
hSec24Bp, hSec24Cp, hSec24Dp.  The KIAA0079-encoded protein is hSec24C.
hSec24Ap and hSec24Bp seem to form one class sharing about 56% identity, while
hSec24Cp and hSec24Dp form another class with about 52% identity.  There is
about 20% identity between the two pairs (Tang et al., 1999), which is almost the
same degree of identity observed for Sec24p, Sfb2p (56% identity between them)
and Sfb3p (23% identity with Sec24p and 24% with Sfb2p).
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4.3 SECTION III (Epitope tagging vectors)
During my Ph.D. work, I created three plasmids containing a multi-purpose
cassette for repeated integrative PCR-mediated epitope tagging (see Methods 3.3.3;
De Antoni and Gallwitz, 2000).  These plasmids were named pU6H2MYC (GenBank
accession number AJ132965), pU6H3HA (AJ132966) and pU6H3VSV (AJ132967),
because they were created through modification of the plasmid pUG6 (Güldener et
al., 1996).  A DNA fragment expressing six histidines in combination with either two
MYC epitopes (9E10 epitope; Evan et al., 1985), three HA epitopes (12CA5 epitope;
Wilson et al., 1984) or three VSV epitopes (P5D4 epitope; Kreis, 1986) was inserted
into pUG6.  More precisely, three adaptors (see Fig. 4.35) obtained by annealing
three pairs of long primers (forward and reverse) were inserted into pUG6 digested
with BsiWI and SalI.  The resulting plasmids contain the "tag" epitopes fused to the
loxP-kanMX-loxP cassette (see Fig. 4.36).
6His-2MYC adaptor
 BsiWI    BamHI
GT ACG GGA TCC CAC CAC CAT CAT CAT CAC GGA GAG CAG AAA TTG ATC AGC GAG GAA GAC TTG GGC
     c cct agg gtg gtg gta gta gta gtg cct ctc gtc ttt aac tag tcg ctc ctt ctg aac ccg
        G   S   H   H   H   H   H   H   G   E   Q   K   L   I   S   E   E   D   L   G
GAA CAA AAG CTT ATT TCT GAA GAA GAC TTG TAA TGA G
ctt gtt ttc gaa taa aga ctt ctt ctg aac att act cag ct
 E   Q   K   L   I   S   E   E   D   L   -   -   SalI
6His-3HA adaptor
 BsiWI    BamHI
GT ACG GGA TCC CAC CAC CAT CAT CAT CAC GGA TAC CCG TAT GAT GTT CCG GAT TAC GCT GGC
     c cct agg gtg gtg gta gta gta gtg cct atg ggc ata cta caa ggc cta atg cga ccg
        G   S   H   H   H   H   H   H   G   Y   P   Y   D   V   P   D   Y   A   G
TAC CCA TAC GAC GTC CCA GAC TAC GCT GGC TAC CCA TAC GAC GTC CCA GAC TAC GCT TAA TGA G
atg ggt atg ctg cag ggt ctg atg cga ccg atg ggt atg ctg cag ggt ctg atg cga att act cag ct
 Y   P   Y   D   V   P   D   Y   A   G   Y   P   Y   D   V   P   D   Y   A   -   -   SalI
6His-3VSV  adaptor
 BsiWI   BamHI
GT ACG GGA TCC CAC CAC CAT CAT CAT CAC GGA TAC ACC GAT ATC GAG ATG AAC CGT TTG GGT AAG GGC
     c cct agg gtg gtg gta gta gta gtg cct atg tgg cta tag ctc tac ttg gca aac cca ttc ccg
        G   S   H   H   H   H   H   H   G   Y   T   D   I   E   M   N   R   L   G   K   G
TAC ACT GAC ATT GAA ATG AAT CGT TTG GGT AAG GGC TAC ACT GAC ATT GAA ATG AAT CGT TTG GGT AAG
atg tga ctg taa ctt tac tta gca aac cca ttc ccg atg tga ctg taa ctt tac tta gca aac cca ttc
 Y   T   D   I   E   M   N   R   L   G   K   G   Y   T   D   I   E   M   N   R   L   G   K
TAA TGA G
att act cag ct
    -   -   SalI
Fig. 4.35  Adaptors used to create pU6H2MYC, pU6H3HA and pU6H3VSV. The adaptors
contain the sequences encoding six histidines followed by the sequences encoding either two
MYC epitopes, three HA epitopes or three VSV epitopes.  The epitope-expressing sequences
are followed by two STOP codons.  Note that in each adaptor the first epitope (MYC, HA or
VSV) is different in nucleotide sequence from the following, so that it is possible to design
primers that anneal either in the region of the six histidines or in the region of the first epitope.
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The kanMX module (Wach et al., 1994) consists of the kanamycin resistance gene
(from the e. coli transposon TN903, coding for aminoglycoside phosphotranspherase;
Oka et al., 1981) fused to the Ashibya gossypii TEF (translation elongation factor)
promotor and terminator sequences. The aminoglycoside phosphotranspherase activity
renders E. coli kanamycin resistant and S. cerevisiae resistant to the aminoglycoside
G418.  The loxP flanking sequences allow for the excision of the marker by induction of
the Cre recombinase (Güldener et al., 1996), see also Methods 3.3.2.  An example of a
strain expressing two tagged  proteins is shown in Fig 4.37.
pU6H2MYC (4099bp)
pU6H3HA (4123bp)
pU6H3VSV (4141bp)
ampr
“tag” loxP
kanr
TEFt
loxP
TEFp
SacI
XhoI
EcoRV
SpeI
SfiI
NotI
SacII
ScaI
BamHI
PvuII
BsiWI
NotI
SalI
XbaI
BglII
BstXI
NcoI
ScaI
6xHis  2xMYC
or
6xHis  3xHA
or
6xHis  3xVSV
SacI
XhoI
EcoRV
SpeI
SfiI
NotI
SacIIScaI
NcoI
NotI
PvuII
BsiWI
BamHI
SalI
XbaI
BglII
BstXI
loxP TEFp kanr TEFt loxP
Fig 4.36  Schematic representation of the plasmids pU6H2MYC (4099 bp), pU6H3HA (4123 bp)
and pU6H3VSV (4141 bp).  The two restriction sites (BsiWI an SalI) into which the described
adaptors were inserted are underlined.
α MYC α HA α MYC/α HA
Sec24p-HA
Sfb3p-MYC
Fig. 4.37  Immunoblot analysis of total
cellular proteins from the yeast strain ADY13
expressing simultaneously two tagged
proteins, Sec24p-HA and Sfb3p-MYC.  The
tagged proteins were identified with anti-MYC
and anti-HA antibodies.  Duplicate samples
were analyzed.  To separate the proteins, a
7% SDS-polyacrylamide gel was used.
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5  DISCUSSION
To maintain their intricate, internal structure of specialized compartments as
well as meeting the necessity to react to changes of environmental conditions,
eukaryotic cells have evolved an elaborate transport machinery to selectively deliver
biochemical components to their various destinations.  Vesicular carrier units are
used as vehicles of targeted transport by all eukaryotic cell types.  Vesicles of various
types exist, each serving one or a small number of specialized functions.  Every
vesicle is generated by a multi-step process known as budding at a donor
compartment’s membrane.  After its formation, including specific cargo-selection,
vesicles travel within the cell in a directed manner to finally meet their target
membrane and fuse with it.  As already mentioned in the Introduction, the formation
of transport vesicles, their correct targeting and the specificity of membrane fusion
events depend on a considerable array of proteins, lipids and enzyme complexes,
some of which function as structural component while others regulate spatial and
temporal aspects of these processes.
COPII vesicles are involved in ER-to-Golgi transport.  The assembly of the
vesicle’s protein coat provides the necessary energy to deform the vesicle’s
membrane into a spherical shell and also serves as an affinity matrix for the selective
partitioning of cargo molecules into the vesicle.
Before the fusion process at the vesicle’s target membrane a proof-reading
process, involving the compartment-specific Ypt/Rab GTPases, plays an essential
role in guaranteeing correct delivery of vesicle contents to their respective target
location.  These GTPases are important regulators during the tethering/docking of
vesicles to their target membranes.  Ypt1p and Ypt1 GTPase-interacting proteins
belong to these regulators in ER-to-Golgi and intra-Golgi transport.
In this thesis, I described the main characteristics of two close orthologues of
the COPII component Sec24p.  I described how Sec24p orthologues are presumably
actively involved in COPII vesicle formation and I showed that they do possess
overlapping and distinct functions.  In addition to that I reported the characterization
of a new member of the Gyp family of GTPase activating proteins (GAPs), named
Gyp5p, which shows remarkable specificity for Ypt1p.
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5.1  Sec24p family
In addition to the essential Sec24p in S. cerevisiae, there are two non-essential
but related proteins named Sfb2p/Iss1p (product of the ORF YNL049c) and
Sfb3p/Lst1p (product of the ORF YHR098c), see also Table 1.2.  The acronym "SFB"
stands for "Sed-five binding".  In a previous study, Sec24p was isolated as a protein
that interacts with Sed5p (Peng et al., 1999) and therefore the protein was temporally
(before being recognized as Sec24p) named Sfb1p.  The two homologues were
consequently named Sfb2p and Sfb3p.  Sfb2p, as does Sec24p, binds Sed5p; Sfb3p
instead, binds this protein only weakly.  Sfb2p shares 56% sequence identity with
Sec24p, while Sfb3p shares only 23% sequence identity with Sec24p.  The N-terminal
regions of these proteins are the least conserved.
Similarly, in mammalian cells, four proteins were identified as components of a
Sec24p family and named hSec24A, hSec24B, hSec24C and hSec24D (Pagano et
al., 1999).  hSec24Ap shares 56% identity with hSec24Bp, and hSec24Cp shares
52% identity with hSec24Bp and there is about 20% identity between the two pairs.
The four cysteines of the putative Zn2+ binding motif are conserved in all the
Sec24p homologues from yeast to man (see Fig. 5.1).  In a previous study it was
demonstrated that a single cysteine change renders the yeast Sec24p nonfunctional,
but this does not interfere with Sec23p or Sed5p binding (Peng et al., 1999).
5.1.1  Sfb2p
Among the three homologues Sfb2p is the least abundant.  It was calculated
that the intracellular concentrations ratio [Sec24p]:[Sfb2p]:[Sfb3p] is about 3.4:1:2.8.
Sec24p   218 D--PPPLNEDGLIVRCRRCRSYMNPFVTFIEQGRRWRCNFCRLANDVP-MQMDQ
Sfb2p    151 N--QVPLNTDGVIVRCRRCRSYMNPFVVFINQGRKWQCNICRFKNDVP-FGFDQ
Sfb3p    205 EVPTIPLPMDGTPLRCRRCRAYANPKFQFTYD-SSVICNICRVKMQVPGEHFAP
hSec24Ap 404 ---QLPVVTSSTIVRCRSCRTYINPFVSFLDQ-RRWKCNLCYRVNDVP-EEFLY
hSec24Bp 593 ---QLPVITSNTIVRCRSCRTYINPFVSFIDQ-RRWKCNLCYRVNDVP-EEFMY
hSec24Cp 410 ASPYVVDHGESGPLRCNRCKAYMCPFMQFIEGGRRFQCCFCSCINDVPPQYFQH
hSec24Dp 348 SPLYLVNHGESGPVRCNRCKAYMCPFMQFIEGGRRYQCGFCNCVNDVPPFYFQH
Fig. 5.1  Multiple alignment of the putative Zn2+ binding region sequences from human and
yeast Sec24p related proteins, highlighted in red are the four cysteine residues of the motif.
Identical or similar amino acids in four or more sequences are shown on black or shaded
background, respectively.
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When overexpressed, Sfb2p can rescue the growth defect of the temperature-
sensitive sec24-11 mutant.  Like Sec24p (Hicke et al., 1992), Sfb2p, forms stable
complexes with Sec23p in vivo, Sec23p but not Sec24p could in fact be
immunoprecipitated together with Sfb2p .  According to the co-immunoprecipitation
analyses, Sec23p is in excess over Sec24p.  It is therefore easy to think that the
exceeding Sec23p can be in complex with Sfb2p or Sfb3p.  By gel filtration
chromatography it was found that a portion of Sfb2p was overlapping with the
Sec23p peak at about 250-300 kDa, but unlike Sec23p, Sec24p and Sfb3p, a
significant portion of Sfb2p eluted from the column with a molecular mass of around
650 kDa.  It is therefore possible that Sfb2p might form larger complexes without
Sec23p.  Cell fractionation experiments also documented that Sfb2p is a membrane-
associated protein and a component of complexes.  It was found in cellular fractions
sedimenting at 10.000g and 100.000g.
Secretion of CPY and ALP was completely blocked in a double ∆sfb2/sec24-11
mutant at the non permissive temperature, while in the single mutants these proteins
were normally processed.  Instead, invertase is secreted to a large extent, and only a
small portion of invertase is accumulated in its ER core-glycosylated form.  This
phenomenon is not easily explainable, unless one would hypothesize a more efficient
packaging of invertase with Sfb3p being the only functional protein.  This could be a
clue about a different role in cargo selection of the different Sec24p related proteins.
The electron microscopic inspection of the ∆sfb2/sec24-11 mutant revealed ER
proliferation and the accumulation (about three-fold compared to wild type) of
membrane-enclosed vesicular and rod-like structures, sometimes organized in
clusters.  The accumulated vesicles have an approximate size of 30-50 nm, a size
typical for ER-derived transport intermediates that occasionally were also found in
clusters in other sec mutants with defects in fusion (Kaiser and Schekman, 1990).  It is
quite difficult to give an explanation for the accumulation of these vesicles in a mutant
in which both Sec24p and Sfb2p function is impaired.  It might be that Sfb3p is enough
to permit vesicle budding, but the vesicles so produced cannot fuse efficiently with their
target membrane.  This inability to fuse efficiently could be due either to the incorrect
packaging into the vesicle of proteins required for docking and fusion or to a direct
involvement of Sec24p and Sfb2p in vesicle docking and fusion processes.
Most of the data presented here were confirmed by other researchers (Higashio et
al., 2000; Kurihara et al., 2000). In addition they reported that Sfb2p could physically
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interact with Sec16p (and for that reason they named this protein Iss1p = interacting with
sec-sixteen), and that there was a synthetic lethal interaction between ISS1 (SFB2) and
SEC22 and BET1 but not with SEC12, SEC13, SEC16, SEC23, SEC17, and SEC18, as
was the case for SEC24 (Kurihara et al., 2000).  They could also demonstrate that
purified Sfb2p/Sec23p complexes could drive vesicle formation from the ER in vitro and
that the vesicles were comparable to those produced with Sec24p/Sec23p complex, but
the packaging efficiency was lower in Sfb2p containing vesicles.
5.1.2  Sfb3p
SFB3 encodes a ~100 kDa membrane-associated protein that is expressed at
higher levels than Sfb2p but at slightly lower levels than Sec24p.  Co-immunoprecipitation
and chromatographic experiments revealed that Sfb3p, like Sec24p and Sfb2p, in vivo
forms complexes with Sec23p that can associate with membranes in cellular fractions
sedimenting at 10.000g and 100.000g.  Unlike Sfb2p, Sfb3p could not rescue the
growth defect of the temperature-sensitive sec24-11 mutant. On the contrary, its
overexpression was toxic for the cells.  The deletion of SFB3 did not induce any visible
phenotype but its combination with the sec24-11 allele resulted in lethality.  Since the
∆sfb2/sec24-11 combination was possible, one could speculate that Sfb3p might have
a more critical role in transport than Sfb2p.
Other researchers isolated SFB3 in a screen for mutants that are lethal in
combination with sec13-1 and named it LST1 (lethal with sec-thirteen) (Roberg et al.,
1999).  The same investigators found that ∆lst1 is lethal when combined with
mutations in genes required for COPII vesicle budding (SEC12, SEC13, SEC16,
SEC23, SEC24, SEC31), but it is not lethal when combined with mutations in genes
required for vesicle fusion (SEC17, SEC18).  It was furthermore demonstrated that
deletion of LST1 (SFB3) reduces the secretion of a subset of soluble proteins (Pagano
et al., 1999) and inhibits the transport of the plasma membrane proton-ATPase
(Pma1p) to the cell surface (Roberg et al., 1999).  Subsequently it was demonstrated
that Sec24p and Lst1p (Sfb3p) are present on the membrane of the same COPII
vesicles and cooperate in sorting Pma1p.  Vesicles formed with a mixture of
Sec23p/Lst1p and Sec23p/Sec24 complexes were morphologically similar and with a
similar buoyant density, but ~ 15% larger in diameter than normal COPII vesicles
(Shimoni et al., 2000).  However, Sec23p/Lst1p (Sfb3p), in contrast to Sec23p/Iss1p
(Sfb2p), could not drive vesicle formation efficiently (Shimoni et al., 2000).
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5.1.3  Why are there three Sec24 related proteins?
As mentioned above, a family of Sec24p-related proteins exists not only in
yeast.  As we and other researchers documented, all the members of the family are
expressed, even if at different levels, and all can form complexes with Sec23p.  This
would argue in favor of a direct involvement of all the different Sec24p members in
COPII-mediated transport.  However, there are differences among the members.  In
yeast we have seen that only Sec24p is essential for viability, the two others are not.
We observed that SFB3 deletion is lethal when combined with mutation in SEC24
gene.  Instead, in the ∆sfb2/sec24-11 mutant there was a block in transport of the
vacuolar enzymes CPY and ALP.  Only overexpression of Sfb2p, which is the most
similar to Sec24p, and which is the least expressed in the cell, can partially substitute
for Sec24p function.  Sfb3p on the contrary is somehow toxic when overexpressed, but
this effect is overcome when overexpression was performed in combination with Sfb2p
or with Sec24p.  Previously it was reported that also overproduction of Sec23p impairs
cell growth (Kurihara et al., 2000) and that excess of Sec23p inhibits the budding
reaction in vitro (Yoshihisa et al., 1993).  It is therefore probable that an appropriate
balance of Sec23p, Sec24p and its related proteins is important for efficient budding.  It
is also known that  during the process of vesicle formation, cargo proteins are
specifically packaged, whereas ER resident proteins are excluded (Kuehn et al., 1998;
Kuehn and Schekman, 1997; Matsuoka et al., 1998a).  A subset of COPII components,
Sar1p and Sec23p/Sec24p, is thought to be involved in cargo recognition and
recruitment (Aridor et al., 1998; Kuehn et al., 1998; Springer and Schekman, 1998).
We also found a direct interaction of Sec24p and Sfb2p with the t-SNARE Sed5p
(Peng et al., 2000; Peng et al., 1999).  Therefore it is not unreasonable to hypothesize
that Sec24p family members are involved in packaging and sorting of the cargo.  The
two non essential proteins Sfb2p and Sfb3p could be involved in sorting and
concentrating of some subtype of cargo into the nascent vesicle.  The specificity of
Sfb3p for particular proteins was actually demonstrated (Pagano et al., 1999; Roberg
et al., 1999; Shimoni et al., 2000).
We also found that Sfb2p could be part of a large (~650 kDa) protein complex.
There is therefore the possibility that this COPII component acts in processes other
than budding and cargo selection.  Finally, the interaction observed for both Sec24p
and Sfb2p with Sed5p could also be an indication for the involvement of these
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proteins in another step of transport, for example tethering/docking.  However, the
latter hypotheses are simple speculations and require further investigations.
5.2  Ypt /Rab proteins as regulators of protein transport
Once the cargo-containing vesicles have pinched off from the donor organelle
membrane, they must be targeted to and fuse with the correct target membrane.  As
was shown in the Introduction, many proteins are involved in tethering, docking and
fusion events.  Ypt/Rab proteins are important regulators of the tethering/docking
processes.  They might be involved in recruiting tethering and docking factors and/or
in the removal of inhibitors of SNARE complex assembly, as could be proteins of the
Sec1 family.  Ypt/Rab proteins are GTPases that cycle between a GDP-bound
(inactive) and a GTP-bound (active) form.  This functional cycle is tightly controlled
through the interaction with guanine nucleotide exchange factors (GEFs) which
stimulate the exchange of GDP for GTP, and GTPase activating proteins (GAPs)
which accelerate the slow intrinsic GTPase activity of Ypt/Rab proteins.  In yeast
these GTPase activating proteins were named Gyp (Gap for Ypt) (Strom et al., 1993).
The GTPase that regulates the transport between the endoplasmic reticulum
and the Golgi apparatus is Ypt1p.  Here, I report on a new Gyp protein the preferred
substrate of which turned out to be Ypt1p.
5.3  Gyp proteins and the "GYP domain"
Advanced homology search algorithms (Neuwald, 1997) identified sequence motifs
(termed motifs A, B, C, D, E, F, see Fig. 4.2) shared among three known Gyp proteins
(Gyp1p, Gyp6p, Gyp7p) and many other proteins from different species, among them
several yeast proteins with unknown function.  The six motifs are localized within the
catalytic domain of Gyp proteins (Albert et al., 1999), therefore we referred to this region
as the "GYP domain".  However, additional sequences C-terminal of the GYP domain
are required for GAP activity (see below).  The six motifs harbor three highly conserved
"fingerprint sequences" (RxxxW, in motif A; IxxDxxR, in motif B; and YxQ, in motif C)
and in addition a conserved aspartic acid residue in motif F (see Figs. 4.2 and 5.2).
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A detailed mutational analysis of the catalytically active regions of Gyp1p and Gyp7p
(Albert et al., 1999) revealed that the arginine residue in motif B (R343 in Gyp1p) is
critical for the catalytic activity.  This was an indication for a generalized "arginine
finger" mechanism of GTPase activation as described for Ras- and Rho-GAP
(Scheffzek et al., 1998).  After the crystal structure of Gyp1p GAP-domain had been
resolved (Rak et al., 2000), it was seen that the critical catalytic arginine is positioned
in the presumed GTPase binding cleft of the molecule (see Fig. 1.9) and forms a salt
bridge with the conserved aspartic acid in motif B (see Fig. 5.2).  The conserved
residues are clustered in two different areas of the Ypt1-GAP domain.
Fig. 5.2  Multiple alignment of the regions containing the "fingerprint sequences" IxxDxxR (in
motif B), YxQ (in motif C), RxxxW (in motif A) and the conserved aspartic acid (in motif F).
The numbers at the top indicate the residues’ positions relative to Gyp1p, the blue numbers at
the bottom indicate  the residues’ positions relative to Gyp5p.  Under each alignment group
the ball-and-stick representation (visualized with WebLab Viewer) of the conserved residues’
side chains in Gyp1p is given.  The residues can interact via hydrogen and ionic bonds (H-
bond are detected when the distance between donor and acceptor atom is from 2.35 up to 3.2
Angstroms).  The oxygen atoms are in red, the nitrogen atoms are in blue.  White numbers
and sticks indicate the distance between the atoms (in Angstroms).
         286  290      502
Gyp1p RPVVWK   IRMWD
Gyp2p RGEIWE   VRIMD
Gyp3p RGNAWW   LRIWD
Gyp4p RGNAWW   LRIWD
Gyp5p RGIIWQ   LRIFD
Gyp6p RGWLWK   LIVWD
Gyp7p RGKVWG   MHIWE
Gyp8p RKDCWY   GDNNL
         457  461      624
  ...A... ...F...
          337 340 343     376 378
Gyp1p QIEIDIPRTNP  SGYVQGIN
Gyp2p EIEKDLKRSLP  VGYCQAMN
Gyp3p IIERDLNRTFP  IGYCQSMN
Gyp4p AIERDLYRTFP  IGYCQSMN
Gyp5p TIRRDLRRTKF  VGYTQGMG
Gyp6p IIDLDLSRIML  LQYKQGFH
Gyp7p RISKDVRRCDR  LGYVQGMT
Gyp8p QVILDAERSFG  LNYYQGYH
490 493 496     525 527
...C... ...B...
2.36
2.75
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D340
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2.84
2.78
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The residues of the IxxDxxR and YxQ "fingerprint sequences" cluster at the surface
of the potential binding cleft of the molecule and can interact via hydrogen and ionic
bonds.  The conserved aspartic acid in motif F can interact with the conserved
residues of the RxxxW "fingerprint sequence".  These residues cluster in the central
core of the molecule and their interaction seems to be important for the stability of
Gyp1p (see Fig. 5.2).  To date there are eight yeast proteins proven to be Ypt-GAPs
(see Table 1.3) among them Gyp5p.
5.4  Gyp5p
One of the unknown yeast proteins containing the GYP domain was the product of
the ORF YPL249c, and we named it Gyp5p.  Gyp5p is a 101.8 kDa (894 amino acids)
cytosolic protein, as could be demonstrated by cell fractionation.  The GYP domain is
contained between the amino acids 451-624 (see Figs. 4.2 and 4.3), but for catalytic
activity additional C-terminal regions are required.  Expressing different fragments of
Gyp5p as 6xHis fusion proteins it was possible to determine that the catalytic region of
the protein was situated in the C-terminal half of the molecule.  The N-terminal 430
amino acids were dispensable for GAP activity, whereas the deletion of the C-terminal
261 amino acids rendered this GAP inactive.  The minimum active fragment obtained
was comprised of amino acids 400-759 (see Fig.  4.3).  We do not know the function of
the N-terminal half of the protein.  It might serve a role in regulating the activity through
the interaction with other proteins or it could be necessary for the recruitment of the
GAP to a specific cellular location where its activity is required.  Computer analysis
with the program COILS revealed also a potential coiled-coil region at the C-terminus
of Gyp5, between the amino acids 730-870.  This part of the molecule (at least after
amino acid 759) is dispensable for GAP activity but it could be involved in protein-
protein interactions.
5.4.1  Ypt1p is the preferred substrate of Gyp5p
The Gyp5(400-892) fragment was tested for its GAP activity on different GTPases
in a standard HPLC-based GAP assay (20 µM GTP-loaded GTPases and 0.1 µM
Gyp5p(400-892)).  Ypt1p turned out to be the best substrate by far.  At standard
conditions, the intrinsic GTPase activity of Ypt1p was accelerated 150-fold, that of
Sec4p 20-fold and those of other GTPases were not accelerated at all.
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For further characterization of the Gyp5p(400-892)/ Ypt1p interaction, the Km and kcat
values were calculated from single time curves using the integrated Michaelis-Menten
equation.  A Km of 400 µM and a kcat  of 9 s-1 were calculated.  Given an intrinsic GTP
hydrolysis rate of 0.0035 min-1, the GTPase activity of Ypt1p is maximally accelerated
1.6x105-fold by the action of Gyp5p(400-892).  Therefore, although Gyp5p(400-892)  has a
very low affinity
 
for its preferred substrate, Ypt1p, the activation rate of the GTPase is
comparable with the values obtained for other GAPs (see Table 5.1)
Table 5.1  Catalytic properties of different GTPase activating proteins
GAP GTPase Km (µM) kcat (s-1) Activation (-fold) References
Gyp5p(400-892) Ypt1p 400 9 1.6x105 This work
Gyp1-46p Ypt51p 143 3.9 4.5x104 (Albert et al., 1999)
Gyp3p/Msb3p Sec4p 154 13.3 5x105 (Albert and Gallwitz, 1999)
GST-Gyp6p Ypt6p 592 18.8 5.1 x106 (Will and Gallwitz, 2001)
Gyp7p Ypt7p 400 7.5 2x105 (Albert et al., 1999)
Gyp7-47p Ypt7p 42 30 7.8x105 (Albert et al., 1999)
p120-GAP H-Ras 9.7 19 1.6 x105 (Gideon et al., 1992)
GAP-334 H-Ras 19 4.2 3.5x x104 (Gideon et al., 1992)
NF1-230 H-Ras 0.65 7.3 6.1 x104 (Ahmadian et al., 1996)
P190 RhoA 1.79 1.61 4.4 x103 (Zhang and Zheng, 1998)
p50RhoGAP RhoA 2.83 0.99 2.7x103 (Zhang and Zheng, 1998)
Ran-GAP Ran/TC4 0.43 2.1 1.2x105 (Klebe et al., 1995)
5.4.2  Gyp5, like other Gyp proteins, contains a putative catalytic arginine finger
It was previously demonstrated that Gyp1p, Gyp7p (Albert et al., 1999) and
Gyp6p (Will and Gallwitz, 2001), contain an arginine residue in motif B (R343 in Gyp1p,
R458 in Gyp7p and R155 in Gyp6p) that is absolutely critical for GAP activity.  This led
to the hypothesis that an arginine finger mechanism similar to that described for Ras-
and Rho-GAPs (Scheffzek et al., 1997; Scheffzek et al., 1998; Wittinghofer et al., 1997)
could have been adopted by all Gyp proteins.  Here, I demonstrate that also Gyp5p
contains a critical catalytic arginine (R496) in motif B.  Arginine-496 of the active
fragment Gyp5p(400-892) was mutated to either alanine or lysine (conservative exchange)
and the accelerating activity of these mutant proteins on Ypt1p was evaluated.  By
kinetic analysis under standard conditions (0.2 µM Gyp5p and 20 µM Ypt1p) I observed
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that both the R496A and the R496K mutations resulted in an apparently complete
inactivation of Gyp5p(400-892).  Only by strongly increasing the concentration of the
R496K mutant (11 µM  Gyp5pR496K and 55 µM Ypt1p) a 4-fold acceleration of GTP
hydrolysis could be observed. This shows that even mutated Gyp5pR496K  is able to
interact with its substrate but its activity is severely compromised.
5.4.3  Gyp5p can accelerate the GTPase activity of the Ypt1pQ67L mutant
The Q67L mutation of Ypt1p is analogous to the oncogenic Q61L mutation of
p21ras.  This Ras mutant has an impaired intrinsic GTPase and is insensitive towards
GAP (Bollag and McCormick, 1991; Der et al., 1986).  It was proposed that during the
GTPase reaction, glutamine-61 would activate a water molecule for a nucleophilic
attack of the γ-phosphate (Krengel et al., 1990; Pai et al., 1990; Sprang, 1997).
Alternatively, it was proposed that the role of glutamine-61 is involved in the
transition-state stabilization of the hydrolysis reaction (Privé et al., 1992).
The Ypt1pQ67L mutant has a strongly decreased intrinsic GTPase activity
(<0.0002 min-1, wt = 0.0035 min-1).  Surprisingly, Gyp5p, in contrast to Ras-Gap, can
accelerate the GTPase activity of Ypt1pQ67L.  The GTPase activity of 20 µM Ypt1pQ67L
in the presence of 2 µM Gyp5p(400-892) can be accelerated ~400-fold.  Therefore,
against common belief, a mutant analogous to Q61L Ras was sensitive towards GAP
action.  We don't know the molecular mechanism that allows the hydrolysis of GTP
bound to Ypt1pQ67L.  Glutamine-67 of Ypt1p seems to be important for GTP
hydrolysis, in fact the intrinsic GTPase activity is drastically reduced.  A possible
hypothesis is that Gyp5p supplies amino acid residues for the glutamine of the
GTPase that can mimic its function in the activation of the water molecule for the
nucleophilic attack of the γ-phosphate or in the transition-state stabilization.  Gyp
proteins could therefore constitute a new class of GAPs able to activate GTPases
mutated in the critical conserved glutamine.
5.4.4  Is GTP hydrolysis important in vivo?
Deletion of GYP5 alone or in combination with GYP1 and GYP8 (the proteins
product of which are known to be GAPs for Ypt1p, too) did not induce any particular
mutant phenotype. Therefore, we thought to combine the GYP gene deletions with
ypt1Q67L.  Analyzing growth at different temperatures of the different mutant strains it
was observed that ypt1Q67L became cold-sensitive (at 15°C) when the GYP genes
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were missing.  The strongest growth defect was observed for strains lacking GYP5.
This was the first indication for an interaction of Gyp5p and Ypt1p in vivo, and also an
indication that Ypt1p is more conditioned by Gyp5p than by the other two Gyp
proteins (that in vitro were also active on Ypt1p).
When the ypt1Q67L allele replaced the wild type YPT1 gene in the protease
deficient strain cI3-ABYS-86, it was observed that the cells could not grow at 15°C.
This growth defect could be partially rescued by overexpression of Gyp5p(8-892) but not
by the catalytically active fragment Gyp5p(400-892).  Therefore, the N-terminal part of the
protein, that is not important in vitro for the catalytic activity, became important in vivo.
This region could be important to target and concentrate the enzyme to a specific
cellular location where GAP activity is required.
We tested whether the different  gyp null mutants in combination with ypt1Q67L had
secretion defects. Transport of CPY and invertase were not affected at the restrictive
temperature.  Only a slight retardation in Gas1p maturation was observed, but this was
probably due to the growth defects of these cells and not to a transport defect.
Surprisingly, the ypt1Q67L mutant, but much more the double mutant
∆gyp5/ypt1Q67L, exhibited an altered morphological phenotype, visible under the
electron microscope, and also under the fluorescence microscope by FM 4-64
staining (that visualizes vacuolar membranes).  The double mutant cells exhibited,
already at the permissive temperature, an accumulation of ER membranes and of
various membrane bounded structures.  These included vesicles of different size and
structures resembling autophagosomes.  In addition, vacuoles were fragmented and
often showed large invaginations resembling autophagic tubes (Müller et al., 2000)
and engulfed multivesicular bodies.
Therefore, despite a lack of transport defects, as expected for mutants of
proteins involved in docking/fusion processes, growth defects and morphological
changes were observed.  We should keep in mind that Ypt1p in the double mutant
∆gyp5/ypt1Q67L is probably kept in a "permanently" active state.  This could make
vesicle transport more active, up to the point that too much material is transported
and accumulated.  The different membraneous structures accumulated in the
cytoplasm and inside the vacuoles could be due to an overload of material that
cannot be used and needs to be eliminated, probably through autophagocytosis.
Autophagocytosis is a major protein degradation process that allows the transfer of
cytosolic proteins and organelles into lysosomes (for review see Klionsky and Emr,
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2000; Seglen and Bohley, 1992).  It operates at the constitutive level, but can be
induced under condition of stress such as starvation.  In our case, the stress condition
could be due to over-active transport with a subsequent overload of materials that have to
be eliminated.  Autophagocytosis is distinguished into macro- and microautophagocytosis.
Macroautophagocytosis occurs through the formation of autophagosomes which are
specialized vesicle bounded by double or multiple membranes (Scott and Klionsky, 1998).
The origin of these vesicles is unknown, both ER and Golgi have been proposed as
precursors.  Microautophagocytosis induces direct invagination of lysosomes (vacuoles in
yeast), leading to the formation of autophagic tubes and single membrane bounded
vesicles in the vacuolar lumen that are rapidly degraded.  Microautophagocytosis was
proposed to be directly connected to macroautophagocytosis (Müller et al., 2000).  In our
electron micrographs, membrane-bounded structures, resembling both autophagosomes
and autophagic tubes, could be detected.
It is interesting to note that autophagocytosis could be demonstrated in yeast
with proteinase-deficient mutants (Takeshige et al., 1992), because cellular
components sequestered in the vacuoles could not be degraded and accumulated.
We observed that ypt1Q67L mutants in the cI3-ABYS-86 strain background (a protease
deficient strain) showed more severe growth defects than mutants in the MSUC-3D
background.  In addition, it was impossible to replace the wild type YPT1 gene with the
ypt1Q67L allele in ∆gyp5/∆gyp1, ∆gyp5/∆gyp8 and ∆gyp1/∆gyp8 mutants in cI3-ABYS-86
strain background.  This could be due to the fact that mutant cells, where vesicular
transport is "over-active", accumulate material that needs to be eliminated, but in
proteinase deficient strains, cellular components sequestered in the vacuoles cannot
be degraded, and therefore, proteinase deficient strains suffer more than others from
the "permanently" activated state of Ypt1p.
The effects induced by the Q67L mutation in Ypt1p were studied also by other
researchers (Richardson et al., 1998).  These investigators could not observe any
particular altered phenotype in ypt1Q67L and concluded that GTP hydrolysis is not
important for Ypt1p GTPase function in vivo, but only for recycling of Ypt1p between
compartments.  Their conclusions, however, did not take into proper consideration
the action of GAP proteins.
Other investigators analyzed sec4Q79L, rab2Q65L,  rab5Q79L and rab6Q72L.  sec4Q79L
cells were cold sensitive at 14°C, and the investigators observed that a decrease in
GTPase activity led to a loss of Sec4p function (Walworth et al., 1992).  Rab2pQ65L
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was found to be an inhibitor of ER-to-Golgi transport when overexpressed (Tisdale et
al., 1992).  This was attributed to the fact that this mutant protein could stimulate
vesicle formation from pre-Golgi compartments altering the correct distribution of
VTCs (vesicular tubular clusters)  (Tisdale, 1999).  Rab5pQ79L stimulated membrane
fusion in endocytosis (Stenmark et al., 1994), and subsequently it was suggested
that GTP hydrolysis acts as a timer that determines the frequency of membrane
docking/fusion events (Rybin et al., 1996).  Rab6p is involved in intra-Golgi transport,
and overexpression of Rab6pQ72L induces a brefeldinA-like effect redistributing Golgi
resident proteins into the ER (Martinez et al., 1997).
Our data would support a role of the GTPase control as a timer, as it was
previously postulated (Rybin et al., 1996), regulating the velocity and efficiency of
transport depending on the needs of the cell.  When this timer is blocked, as it is the
case in our ∆gyp5/ypt1Q67L mutant, there is accumulation of materials that find a
different way to be eliminated, as for example by autophagocytosis .
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6  SUMMARY
In this thesis, I described the main characteristics of two close orthologues of
the COPII component Sec24p.  These proteins were named Sfb2p and Sfb3p.  I
described how Sec24p orthologues are most likely actively involved in COPII vesicle
formation and in cargo selection.  It was found that SFB2 and SFB3 are dispensable,
but combining ∆sfb2 null with the sec24-11 conditional allele led to serious secretion
defects.  The combination of ∆sfb3 with the sec24-11 allele resulted in lethality.  Both
Sfb2p and Sfb3p form stable complexes with Sec23p.  Sfb2p was also found in a
large complex without Sec23p.  It was also observed that Sfb2p, like Sec24p,
interacts with Sed5p, while the interaction of Sfb3p with Sed5p is very weak.
In addition to that, I characterized a new member of the Gyp family of Ypt/Rab-
specific GTPase activating proteins (GAPs), named Gyp5p, which shows remarkable
specificity for Ypt1p.  Furthermore, I investigated the biological function of Ypt1p GTP
hydrolysis in the cells.  I demonstrated that Gyp5p, like other GAP proteins, contains
a critical catalytic arginine and that it is able to accelerate the GTP hydrolysis not only
of Ypt1p but also that of the Ypt1pQ67L mutant.  The ∆gyp5/ypt1Q67L mutant is cold-
sensitive at 15°C and shows morphological alterations (also at 30°C) that are
reminiscent of autophagy.
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7  APPENDIX
7.1  Bacterial and yeast strains and mammalian cell lines
7.1.1  Bacterial E. coli strains
Table 7.1
Strain Genotype Source
DH5α F
-φ80 dlacZ∆M15 ∆(lacZYA-argF)U169 endA1 recA1
hsdR17(rk- mk+) deoR thi-1 supE44 λ-gyrA96 relA1
Gibco-BRL
(Karlsruhe, Germany)
DH5α F´IQ
F´pro AB+lacIq Z∆M15 zzf::Tn5[Kanr]/ φ80
dlacZ∆M15 ∆(lacZYA-argF)U169 endA1 recA1
hsdR17(rk- mk+) deoR thi-1 supE44 λ-gyrA96 relA1
Gibco-BRL
Xl1Blu endA1 recA1 gyrA96 thi
-
 hsd R17(rk- mk+) supE44
relA1 lac- [F´traD36 proAB lacIq Z∆M15 Tn10(Tcr)
Stratagene
(Heidelberg, Germany)
Origami
(DE3)
∆ara-leu7697 ∆lacX74 ∆phoAPvuII phoR araD139 galE
galK rspL F [´lac-(lacIq)pro] gor522::Tn10(Tcr) trxB::kan (DE3)
Novagen
(Darmstadt, Germany)
BL21 F- ompT hsdS (rB-mB-) gal dcm Novagen
BL21(DE3) F- ompT hsdS (rB-mB-) gal dcm (DE3) Novagen
M15[pREP4] F- NalS StrS RifS Thi- Lac- Ara- Gal- Mtl- recA+ Uvr+ Lon+ QIAGEN (Hilden)
For a description of gene nomenclature see (Bachmann, 1987).
7.1.2  Yeast strains
Table 7.2
Strain Genotype Source
cl3-ABYS-86 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR
D. H. Wolf,  Univ. of
Stuttgart, Germany
MSUC-3D MATα ura3 trp1 leu2  his3 lys2 This Department
MSUC-IA MATa ura3 trp1 leu2  his3 ade8 This Department
sec18-1 MATα leu2 Dr. H. D. Schmitt,this Department
BHY11 MATa ura3-52 his3∆200 trp1∆901 ade2-101 suc2-∆9leu2-3 112::pBHY11 (CPY-InvLEU2)
(Horazdovsky et al.,
1994)
RH227-3A MATa ura3  leu2 his3 sec23-1 Prof. H. Riezman, Univ.of Basel, Switzerland
RPY18 MATa ura3 trp1 leu2 his3 ade8 sec24-11 (Peng et al., 1999)
RPY61 MATa ura3 trp1 leu2 his3 ade8  sfb2::kanMX4 (Peng et al., 2000)
RPY63 MATα ura3 trp1 leu2 his3  lys2 sfb2::kanMX4 sfb2::LEU (Peng et al., 2000)
RPY72 MATα ura3 trp1 leu2 his3 ade8 sec24-11 sfb2::kanMX4 (Peng et al., 2000)
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ADY1 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SFB2-6His-2MYC-loxP-KanMX-loxP
(De Antoni and
Gallwitz, 2000; Peng
et al., 2000); This work
ADY1/K- MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SFB2-6His-2MYC-loxP
This work
ADY2 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SFB3-6His-2MYC-loxP-KanMX-loxP
(De Antoni and
Gallwitz, 2000; Peng
et al., 2000); This work
ADY2/K- MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SFB3-6His-2MYC-loxP
This work
ADY3 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SEC23-6His-2MYC-loxP-KanMX-loxP
(De Antoni and
Gallwitz, 2000; Peng
et al., 2000); This work
ADY4 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SEC24-6His-2MYC-loxP-KanMX-loxP
(De Antoni and
Gallwitz, 2000; Peng
et al., 2000); This work
ADY5 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1cps1-3 can
R
SFB2-6His-2MYC-loxP SFB3-6His-3HA-loxP-KanMX-loxP
(Peng et al., 2000);
This work
ADY6 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1cps1-3 can
R
SFB2-6His-3HA-loxP-KanMX-loxP SFB3-6His-2MYC-loxP
(Peng et al., 2000);
This work
ADY7 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SEC24-6His-3HA-loxP-KanMX-loxP
(De Antoni and Gallwitz,
2000);  This work
ADY8 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1 cps1-3 canR SFB2-6His-3HA-loxP-KanMX-loxP
(De Antoni and Gallwitz,
2000);  This work
ADY9 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1 cps1-3 canR SFB3-6His-3HA-loxP-KanMX-loxP
(De Antoni and Gallwitz,
2000);  This work.
ADY10 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR SEC24-6His-3VSV-loxP-KanMX-loxP
(De Antoni and Gallwitz,
2000);  This work
ADY11 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1 cps1-3 canR SFB2-6His-3VSV-loxP-KanMX-loxP
(De Antoni and Gallwitz,
2000);  This work
ADY12 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1 cps1-3 canR SFB3-6His-3VSV-loxP-KanMX-loxP
(De Antoni and Gallwitz,
2000);  This work
ADY13
MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-
1 cps1-3 canR SEC24-6His-3HA-loxP-KanMX-loxP
SFB3-6His-2MYC-loxP
(De Antoni and Gallwitz,
2000);  This work
ADY14 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR GYP5-6His-2MYC-loxP-KanMX-loxP
This work
ADY15 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR GYP5-6His-3HA-loxP-KanMX-loxP
This work
ADY16 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR GYP5-6His-3VSV-loxP-KanMX-loxP
This work.
ADY20 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp1::loxP-KanMX-loxP
This work
ADY20/K- MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp1::loxP
This work
ADY21 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP-KanMX-loxP
This work
ADY21/K- MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP
This work
ADY23 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp8::loxP-KanMX-loxP
This work
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ADY24 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP gyp1::loxP-KanMX-loxP
This work
ADY24/K- MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP gyp1::loxP
This work
ADY25 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP gyp8::loxP-KanMX-loxP
This work
ADY25/K- MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP gyp8::loxP
This work
ADY26 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp1::loxP gyp8::loxP-KanMX-loxP
This work
ADY27 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1 cps1-3
canR gyp5::loxP gyp1::loxP gyp8::loxP-KanMX-loxP
This work
ADY28 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1 cps1-3 canR gyp5::loxP gyp8::loxP gyp1::loxP-KanMX-loxP
This work
ADY29 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR ypt1Q67L-LEU2
This work
ADY30 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp1::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY31 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp5::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY32 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp7::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY33 MATα ura3-∆5 leu2-3 112 his3 pra1-1 prb1-1 prc1-1
cps1-3 canR gyp8::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY40 MATα ura3 trp1 leu2 his3 lys2 gyp1::loxP-KanMX-loxP This work
ADY40/K- MATα ura3 trp1 leu2 his3 lys2 gyp1::loxP This work
ADY41 MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP-KanMX-loxP This work
ADY41/K- MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP This work
ADY42 MATα ura3 trp1 leu2 his3 lys2 gyp7::loxP-KanMX-loxP This work
ADY43 MATα ura3 trp1 leu2 his3 lys2 gyp8::loxP-KanMX-loxP This work
ADY43/K- MATα ura3 trp1 leu2 his3 lys2 gyp8::loxP This work
ADY44- MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp1::loxP-KanMX-loxP
This work
ADY44/K MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp1::loxP This work
ADY45 MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp8::loxP-KanMX-loxP.
This work
ADY45/K MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp8::loxP This work
ADY46 MATα ura3 trp1 leu2 his3 lys2 gyp1::loxP gyp8::loxP-KanMX-loxP.
This work
ADY47 MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp1::loxPgyp8::loxP-KanMX-loxP.
This work
ADY48 MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp8::loxPgyp1::loxP-KanMX-loxP.
This work
ADY49 MATα ura3 trp1 leu2 his3 lys2   ypt1Q67L-LEU2. This work
ADY50 MATα ura3 trp1 leu2 his3 lys2 gyp1::loxP-KanMX-loxPypt1Q67L-LEU2.
This work
ADY51/K- MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP ypt1Q67L-LEU2 This work
ADY52 MATα ura3 trp1 leu2 his3 lys2 gyp7::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
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ADY53 MATα ura3 trp1 leu2 his3 lys2 gyp8::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY54 MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp1::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY55 MATα ura3 trp1 leu2 his3 lys2 gyp5::loxP gyp8::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
ADY56 MATα ura3 trp1 leu2 his3 lys2 gyp1::loxP gyp8::loxP-KanMX-loxP ypt1Q67L-LEU2
This work
For a description of gene nomenclature see (Rose et al., 1990; Sherman, 1991).
7.1.3  Mammalian tissue culture cell lines
The cell lines, the equipment, and materials for cell culture were gently provided
by Prof. Mary Osborn (department of biochemistry and cell biology, MPI for
Biophysical Chemistry).  Cells were cultivated on Petri dishes in DME 10% FCS
medium at 37 °C 95% humidity 7% CO2 (I was helped for cell culture by Heinz
Juergen Dehne and Susanne Brandfass)
Table 7.3
Strain Origin Cell type Source
HeLa Human cervix adenocarcinoma epithelioid ATCC
CV1 African green monkey kidney fibroblastic ATCC
7.2  Plasmids
7.2.1  E. coli cloning and expression vectors
Table 7.4
Vector Description Source
pBluescript SK+ General cloning vector.  Ampicillin resistance. Stratagene(Heidelberg, Germany)
pQE50 Expression vector.  T5 promoter, lac operator,
ampicillin resistance
QIAGEN
(Hilden, Germany)
pQE30 Expression vector for production of N-terminus 6xHis taggedproteins.  T5 promoter, lac operator, ampicillin resistance
QIAGEN
pET12c Expression vector.  T7 promoter, ampicillin resistance Novagen
pET30a
Expression vector for production of N- terminus 6xHis-tag
and S-tag proteins or C-terminus 6xHis fusion proteins.  T7
promoter, lac operator, lacI repressor, kanamycin resistance
Novagen.(Darmstadt,
Germany)
pET32a
Expression vector for production of N- terminus Trx-
tag, 6xHis-tag and S-tag proteins or C-terminus
6xHis fusion proteins.  T7 promoter, lac operator,
lacI repressor, ampicillin resistance
Novagen
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pGEX-TT
Expression vector for production of GST fusion
proteins.  Contains the polylinker from pEG-KT, tac
promoter, lacIq repressor, ampicillin resistance
Dr. S. Albert, this
Department
pMAL-c2 Expression vector for production of MBP fusion proteins,.Ptac promoter, lacIq repressor, ampicillin resistance
New England Biol.
(Frankfurt, Germany)
pET12c-YPT1 Plasmid for Ypt1p expression. S. Albert, this Dep.
KIAA0079 Plasmid containing hSEC24c cDNA (KIAA0079) (Nomura et al., 1994)
pGEX-SED5∆C for expression of GST-Sed5p (amino acids 1-319) Dr. R Grabowski,this Deptartment
pGEX-UFE1∆C for expression of GST-Ufe1p (amino acids 1-326) Dr. R. Peng, this Dept.
7.2.2  Yeast vectors
Table 7.5
Vector Description Source
pUG6 Plasmid containing the loxP-KanMX-loxPgene disruption cassette. (Güldener et al., 1996)
pSH47 Vector containing cre, GAL1 promoter, CEN, URA3 (Güldener et al., 1996)
pU6H2MYC Plasmid containing the 6His-2MYC-loxP-KanMX-loxP cassette for PCR mediated epitope tagging.
(De Antoni and Gallwitz,
2000); this work
pU6H3HA Plasmid containing the 6His-3HA-loxP-KanMX-loxP cassette for PCR mediated epitope tagging
(De Antoni and Gallwitz,
2000); this work
pU6H3VSV Plasmid containing the 6His-3VSV-loxP-KanMX-loxP cassette for PCR mediated epitope tagging
(De Antoni and Gallwitz,
2000); this work
pEG(KT) 2µ vector containing GST, galactose-inducibleCYC1 promoter, URA3 (Mitchell et al., 1993)
pRS315 CEN, LEU2 (Sikorski and Hieter, 1989)
pRS316 CEN, URA3 (Sikorski and Hieter, 1989)
pRS325 2µ, LEU2 (Tsukada and Gallwitz, 1996)
pRS326 2µ, URA3 (Vollmer and Gallwitz, 1995)
pYX112 CEN, URA3, TPI-promoter R&D-Systems(Wiesbaden, Germany)
pYX143 CEN, LEU2, GAL1-promoter R&D-Systems
pYX212 2µ, URA3, TPI-promoter R&D-Systems
pYX243 2µ, LEU2, GAL1-promoter R&D-Systems
pRE-YPT1Q67L Plasmid containing TUB2-YPT1
Q67L
-LEU2-ACT1,
to replace YPT1 gene with YPT1Q67L allele
Dr. U. Vespermann, this
Dept.; (Schmitt et al., 1988)
pRS326-SEC24 2µ vector containing SEC24 and its promoter (Peng et al., 1999)
pEG-SEC24(56-549)
(pEG-SEC24N) Galactose inducible GST-Sec24(56-549) (Peng et al., 1999)
pEG-SEC24NC231S Galactose inducible GST-Sec24NC231S (Peng et al., 1999)
pEG-
SEC24NC231S-C234S Galactose inducible GST-Sec24N
C231S-C234S (Peng et al., 1999)
pRS326-SFB2 2µ vector containing SFB2 and its promoter (Peng et al., 2000)
pMG28
(pEG-PEP12∆C) galactose inducible GST-Pep12(1-220) Dr. M. Götte this Dept.
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7.2.3  Recombinant plasmids created in this work
Table 7.6
GYP5 constructs
Construct Insertpreparation
Vector
preparation Features
Prot.
expression
pET30-GYP5(8-448)A
(or pET30-pep0A)
PCR fragment from
genomic DNA (primers:
GYP5_f1/GYP5_r1)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Poorly
expressed
pET30-GYP5(8-448)B
(or pET30-pep0B)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r1)
NcoI-NotI digested
pET30a
NcoI-NotI digested
N-terminus
6xHis-Tag,
S-Tag
Poorly
expressed
pET32-GYP5(8-448)
(or pET32-pep0)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r1)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pTT-GYP5(8-388)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r1)
NcoI-HindIII digested
pGEX-TT
NcoI-NotI digested
N-terminus
GST-Tag
Good
pY212-GYP5-6H(8-448)
(or pY212-pep0)
(yeast shuttle vector)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r16H)
NcoI-XmaI digested
pYX212
NcoI-XmaI
digested
C-terminus
6xHis-Tag.
2µ, URA3,
TPI promoter
Good
pET32-GYP5(8-892)
(or pET32-pep1)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r3)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Poorly
expressed
pY212-GYP5-6H(8-892)
(or pY212-pep1)
(yeast shuttle vector)
GYP5 containing frag-
ment from pET32-pep1
NcoI-SalI digested
pYX212-6H
from pY212-pep0
NcoI-SalI digested
C-terminus
6xHis-Tag.
2µ, URA3,
TPI promoter
Good
pET30-GYP5(400-892)A
(or pET30-pep2A)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r3)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Good
pET30-GYP5(400-892)B
(or 30-pep2B)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r3)
NcoI-NotI digested
pET30a
NcoI-NotI digested
N-terminus
6xHis-Tag,
S-Tag
Good
pET32-GYP5(400-892)
(or pET32-pep2)
GYP5 containing
fragment from
pET30-pep2B
NcoI-XhoI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pY212-GYP5-6H(400-892)
(or pY212-pep2)
(yeast shuttle vector)
GYP5 containing
fragment from
pET32-pep2
NcoI-SalI digested
pYX212-6H from
pY212-pep0
NcoI-SalI digested
C-terminus
6xHis-Tag.
2µ, URA3,
TPI promoter
Good
pET30-GYP5(429-892)A
(or pET30-pep3A)
PCR fragment from
genomic DNA
(GYP5_f3/GYP5_r3)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6His-Tag.
Good
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pET30-GYP5(429-892)B
(or pET30-pep3B)
PCR fragment from
genomic DNA
(GYP5_f3/GYP5_r3)
NcoI-NotI digested
pET30a
NcoI-NotI digested
N-terminus
6xHis-Tag,
S-Tag
Good
pET32-GYP5(429-892)
(or pET32-pep3)
PCR fragment from
genomic DNA
(GYP5_f3/GYP5_r3)
NcoI-NotI digeste
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pET30-GYP5(451-892)A
(or pET30-pep4A)
PCR fragment from
genomic DNA
(GYP5_f4/GYP5_r3)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6His-Tag
Good
pET32-GYP5(451-892)
(or pET32-pep4)
PCR fragment from
genomic DNA
(GYP5_f4/GYP5_r3)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pET30-GYP5(8-633)A
(or pET30-pep5A)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r2)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6His-Tag.
Good
pET32-GYP5(8-633)
(or pET32-pep5)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r2)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag.
Good
pET30-GYP5(400-633)A
(or pET30-pep6A)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r2)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6His-Tag
Good
pET30-GYP5(400-633)B
(or pET30-pep6B)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r2)
NcoI-NotI digested
pET30a
NcoI-NotI digested
N-terminus
6xHis-Tag,
S-Tag
Good
pET32-GYP5(400-633)
(or pET32-pep6)
PCR fragment
from genomic DNA
(GYP5_f2/GYP5_r2)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pET30-GYP5(429-633)A
(or pET30-pep7A)
PCR fragment from
genomic DNA
(GYP5_f3/GYP5_r2).
NdeI-SalI digested.
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Good
pET30-GYP5(429-633)B
(or pET30-pep7B)
PCR fragment from
genomic DNA
(GYP5_f3/GYP5_r2)
NcoI-NotI digested
pET30a
NcoI-NotI digested
N-terminus
6xHis-Tag,
S-Tag
Good
pET32-GYP5(429-633)
(or pET32-pep7)
PCR fragment from
genomic DNA
(GYP5_f3/GYP5_r2)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pET30-GYP5(451-633)A
(or pET30-pep8A)
PCR fragment from
genomic DNA
(GYP5_f4/GYP5_r2).
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Good
pET30-GYP5(451-633)B
(or pET30-pep8B)
PCR fragment from
genomic DNA
(GYP5_f4/GYP5_r2)
NcoI-NotI digested
pET30a
NcoI-NotI digested
N-terminus
6xHis-Tag,
S-Tag
Good
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pET32-GYP5(451-633)
(or pET32-pep8)
PCR fragment from
genomic DNA
(GYP5_f4/GYP5_r2)
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pET30-GYP5(8-759)A
(or pET30-pep9A)
PCR fragment from
genomic DNA
(GYP5_f1/GYP5_r4).
NdeI-SalI digested.
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Moderately
good
pET30-GYP5(400-759)A
(or pET30-pep10A)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r4)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Good
pET30-GYP5(400-786)A
(or pET30-pep14A)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r5)
NdeI-SalI digested
pET30a
NdeI-XhoI digested
C-terminus
6xHis-Tag
Good
pET32-GYP5(400-786)
(or pET32-pep14)
PCR fragment from
genomic DNA
(GYP5_f2/GYP5_r5).
NcoI-NotI digested
pET32a
NcoI-NotI digested
N-terminus
Trx-Tag,
6xHis-Tag,
S-Tag
Good
pET30-GYP5R496K(400-892)A
(or pET30-pep2AR496K)
R496K mutation induced in pET30-pep2A using the primers
GYP5-R/K_f and GYP5-R/K_r
pET30-GYP5R496A(400-892)A
(or pET30-pep2AR496A)
R496A mutation induced in pET30-pep2A using the primers
GYP5-R/A_f and GYP5-R/A_r
YPT1 Q67L construct
pET12c-YPT1Q67L point mutation induced in pET12c-YPT1 using the primers YPT1-Q/L_f and YPT1-Q/L_r
Yeast SEC24 family constructs
Construct Insertpreparation
Vector
preparation Features
Prot.
expression
pKT-SEC24
(yeast shuttle vector)
PCR fragment from
genomic DNA
(SEC24_f0/SEC24_r0)
XmaI/XbaI digested.
pEG(KT)
XmaI/XbaI
digested.
N-terminus
GST-Tag;
2µ, URA3, GAL1
Moderately
good
pKT-SEC24-6H-2MYC
(yeast shuttle vector)
PCR fragment from ADY4
genomic DNA
(SEC24_f0/ TAGuniv_r1)
XmaI/XbaI digested.
pEG(KT)
XmaI/XbaI
digested
N-terminus GST-
Tag; C-terminus
6xHis-2MYC; 2µ,
URA3, GAL1
Moderately
good
pY243-SEC24
(yeast shuttle vector)
SEC24 containing frag-
ment from pKT-SEC24
AvrII/XhoI digested
pYX243
AvrII/XhoI
digested
2µ, LEU2, GAL1 Good
pY243-SEC24-6H-2MYC
(yeast shuttle vector)
SEC24 containing fragment
from pKT-SEC24-6H-
2MYC, AvrII/XhoI digested
pYX243
AvrII/XhoI
digested
C-terminus
6His-2MYC;
2µ, LEU2, GAL1
Good
pTT-SEC24(174-330)
PCR fragment from
genomic DNA
(SEC24_f5/SEC24_r6).
XmaI/XhoI digested
pGEX-TT
XmaI/XhoI
digested
N-terminus
GST-Tag
Bad
pTT-SEC24C231S(174-330)
(pTT-SEC24m)
PCR fragment from
pEG-SEC24NC231S
(SEC24_f5/SEC24_r6)
XmaI/XhoI digested.
pGEX-TT
XmaI/XhoI
digested.
N-terminus
GST-Tag
Bad
Appendix 129
pTT-
SEC24NC231S-C234S(174-330)
(pTT-SEC24m2)
PCR fragment from
pEG-SEC24NC231S-C234S
(SEC24_f5/SEC24_r6)
XmaI/XhoI digested
pGEX-TT
XmaI/XhoI
digested.
N-terminus
GST-Tag
Bad
pMAL-SEC24(174-330)
SEC24 containing fragment
from pTT-SEC24(174-330)
BamHI/HindIII digested
pMAL-c2
BamHI/HindIII
digested
N-terminus
MBP-Tag
Good
pMAL-
SEC24C231S(174-330)
SEC24 containing fragment
from pTT-SEC24m
BamHI/HindIII digested
pMAL-c2
BamHI/HindIII
digested.
N-terminus
MBP-Tag
Good
pMAL-
SEC24NC231S-C234S(174-330)
SEC24 containing fragment
from pTTSEC24m2
BamHI/HindIII digested
pMAL-c2
BamHI/HindIII
digested
N-terminus
MBP-Tag
Good
pET32-SEC24(174-330)
SEC24 containing fragment
from pTT-SEC24m
BamHI/HindIII digested
pET32
BamHI/HindIII
digested.
N-terminus Trx-
Tag, 6xHis-Tag,
S-Tag
Good
pET32-
SEC24C231S(174-330)
SEC24 containing fragment
from pTT-SEC24m
BamHI/HindIII digested
pET32
BamHI/HindIII
digested.
N-terminus
Trx-Tag, 6xHis-
Tag, S-Tag
Good
pET32-
SEC24NC231S-C234S(174-330)
SEC24 containing fragment
from pTT-SEC24m2
BamHI/HindIII digested
pET32
BamHI/HindIII
digested.
N-terminus
Trx-Tag, 6xHis-
Tag,S-Tag
Good
pKT-SFB2
(yeast shuttle vector)
PCR fragment from
genomic DNA
(SFB2_f0/SFB2_r0).
XmaI/XbaI digested
pEG(KT)
XmaI/XbaI
digested
N-terminus
GST-Tag;
2µ, URA3, GAL1
Moderately
good
pY243-SFB2
(yeast shuttle vector)
SFB2 containing frag-
ment from pKT-SFB2.
AvrII/XhoI digested.
pYX243
AvrII/XhoI
digested
2µ, LEU2,GAL1
pY243-SFB2-6H-2MYC
(yeast shuttle vector)
PCR fragment from
ADY1 genomic DNA
(SFB2_f0/TAGuniv_r1)
AvrII/XhoI digested.
pYX243
AvrII/XhoI
digested.
C-terminus
6xHis-2MYC;
2µ, LEU2, GAL1
Good
pRS325-SFB3
(yeast shuttle vector)
PCR fragment from
genomic DNA
(SFB3_f1/SFB3_r4)
XhoI-BamHI digested
pRS326
XhoI-BamHI
digested.
2µ, LEU2
pKT-SFB3-6H-3HA
(yeast shuttle vector)
PCR fragment from
ADY9 genomic DNA
(SFB3_f0/TAGuniv_r1)
XmaI/XbaI digested
pEG(KT)
XmaI/XbaI
digested
N-terminus GST-
Tag; C-terminus,
6xHis-3HA; 2µ,
URA3, GAL1
Moderately
good
pTT-SFB3
PCR fragment from
genomic DNA
(SFB3_f0/ SFB3_r0.Xh)
XmaI/XhoI digested
pGEX-TT
XmaI/XhoI
digested.
N-terminus
GST-Tag
Bad
pY243-SFB3
(yeast shuttle vector)
SFB3 containing
fragment from pTT-SFB3
AvrII/XhoI digested
pYX243
AvrII/XhoI
digested
2µ, LEU2, GAL1
pY243-SFB3-6H-3HA
(yeast shuttle vector)
SFB3 containing fragment
from pKT-SFB3-6H-3HA
AvrII/XhoI digested
pYX243
AvrII/XhoI
digested
C-terminus
6xHis-3HA;
2µ, LEU2, GAL1
Moderately
good
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Human SEC24C constructs
Construct Insertpreparation
Vector
preparation
Features Prot.
expression
pQE30-
KIAA0079(2-102)
(fragment-1)
PCR fragment from KIAA0079
(hSEC24_f1/hSEC24_r2)
BamHI/HindIII digested
pQE30
BamHI/HindIII
digested
N-terminus
6His-Tag
Bad
pQE30-
KIAA0079(363-522)
(fragment-2)
PCR fragment from KIAA0079
(hSEC24_f3/hSEC24_r4)
BamHI/HindIII digested
pQE30
BamHI/HindIII
digested
N-terminus
6His-Tag
Good
pQE50-
KIAA0079(363-522)
(fragment-2)
PCR fragment from KIAA0079
(hSEC24_f3/hSEC24_r46H)
BamHI/HindIII digested
pQE50
BamHI/HindIII
digested
C-terminus
6His-Tag
Good
pMAL-
KIAA0079(363-522)
(fragment-2)
PCR fragment from KIAA0079
(hSEC24_f3/hSEC24_r4)
BamHI/HindIII digested
pMAL-c2
BamHI/HindIII
digested
N-terminus
MBP-Tag
Good
pQE30-
KIAA0079(570-715)
(fragment-3)
PCR fragment from KIAA0079
(hSEC24_f5/hSEC24_r6).
BamHI/HindIII digested
pQE30
BamHI/HindIII
digested
N-terminus
6His-Tag
Bad
pQE30-
KIAA0079(635-827)
(fragment-4)
PCR fragment from KIAA0079
(hSEC24_f7/hSEC24_r8).
BamHI/HindIII digested
pQE30
BamHI/HindIII
digested.
N-terminus
6His-Tag
Bad
pQE30-
KIAA0079(747-992)
(fragment-5)
PCR fragment from KIAA0079
(hSEC24_f9/hSEC24_r10)
BamHI/HindIII digested
pQE30
BamHI/HindIII
digested.
N-terminus
6His-Tag
Good
pMAL-
KIAA0079(747-992)
(fragment-5)
PCR fragment from KIAA0079
(hSEC24_f3/hSEC24_r4)
BamHI/HindIII digested
pMAL-c2
BamHI/HindIII
digested.
N-terminus
MBP-Tag
Good
t-SNAREs constructs
pTT-VAM3(1-261)
PCR fragment from genomic
DNA (VAM3_f/VAM3_r)
NcoI/XhoI digested.
pGEX-TT
NcoI/XhoI
digested.
N-terminus
GST-Tag
Moderately
good
pTT-SSO1(2-264)
PCR fragment from genomic
DNA (SSO1_f/SSO1_r)
XbaI/XhoI digested
pGEX-TT
XbaI/XhoI
digested.
N-terminus
GST-Tag
Good
pTT-SSO2(1-267)
PCR fragment from genomic
DNA (SSO2_f/SSO2_r)
NcoI/XhoI digested
pGEX-TT
NcoI/XhoI
digested.
N-terminus
GST-Tag.
Good
pTT-TLG1(1-204)
PCR fragment from genomic
DNA (TLG1_f/TLG1_r)
NcoI/XhoI digested
pGEX-TT
NcoI/XhoI
digested
N-terminus
GST-Tag.
Good
pTT-TLG2(1-317)
PCR fragment from genomic
DNA (TLG2_f/TLG2_r)
NcoI/XhoI digested
pGEX-TT
NcoI/XhoI
digested
N-terminus
GST-Tag
Good
7.3  Oligonucleotides
Oligonucleotides used in this work were custom-synthesized by Eurogentec
company (Belgium) or by NAPS company (Göttingen, Germany).  Here is a list with
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the primer used, note that "f" or "r" indicate whether a primer is in the "forward" or in
the "reverse" direction of a sequence.
Table 7.7
Name Sequence Peculiarities
GYP5-specific oligonucleotides
GYP5_f0 5’-ATT ACG AGG GCT TAT TCA GAA G-3’
GYP5_f1 5’-CG GGA TCC CAT ATG GCC ATG GAG AAAAAT ACA GAT ACG ATC GCC-3’
BamHI, NdeI, NcoI under-
lined; in bold aa n° 8
GYP5_f2 5'-CG GGA TCC CAT ATG GCC ATG GAG AACTTG TCC GAG TAT AAC GAA G-3'
BamHI, NdeI, NcoI under-
lined; in bold aa n° 400
GYP5_f3 5'-CG GGA TCC CAT ATG GCC ATG GTA GTTATT GAT TAT GCT ACA GTG GC-3'
BamHI, NdeI, NcoI under-
lined; in bold aa n° 429
GYP5_f4 5'-CG GGA TCC CAT ATG GCC ATG GGG ATACCA CCA CAA  ATT CGA GG-3'
BamHI, NdeI, NcoI under-
lined; in bold aa n° 451
GYP5_Seq.f0 5'-TTT GGA TCG AAC GTA ATT GA-3' Sequencing primer
GYP5_Seq.f1 5'-CAA CGC CAT CAG ACC AAT AT-3' Sequencing primer
GYP5_Seq.f2 5'-GGA TGT GCA AGC CCC AAA-3' Sequencing primer
GYP5_Seq.f3 5'-CCC AGA AAG GTC GTC AGA A-3' Sequencing primer
GYP5_Seq.f4 5'-TTC CAC CGC CAC TAG AGG A-3' Sequencing primer
GYP5_Seq.f5 5'-TTG TCC GAG TAT AAC GAA GTG-3' Sequencing primer
GYP5_Seq.f6 5'-GCC GAG GAC AAA ATG GAG T-3' Sequencing primer
GYP5_Seq.f7 5'-TCA CCT TCT TTG TAC AAT CGC T-3' Sequencing primer
GYP5_Seq.f8 5'-TCT TTT CGT TCA TGA TGC AAT-3' Sequencing primer
GYP5_Seq.r0 5'-GTG GAT GTA CGG GTG AAA ATA-3' Sequencing primer
GYP5_Mf 5'-TGG CAG CTG ATG GCG AAT-3' Sequencing primer
GYP5_Mr 5'-GAA CCC CAT GCC TTG CGT-3' Sequencing primer
GYP5_r0 5'-GGA AAC AAA AAC CCA ACA CAT-3'
GYP5_r1 5'-T TTC CCG GGC GGC CGC TTA GTC GACATG GGC TTC TAA ATT TTC TGG TTC-3'
XmaI, NotI, SalI underl-
ined; in bold STOP
codon and aa n° 448
GYP5_r16H
5'-T CCC CCC GGG TTA GTG ATG ATG ATG
GTG GTG GTC GAC ATG GGC TTC TAA ATT
TTC TGG TTC-3'
XmaI, SalI underlined. 6xHis
double underlined; in bold
STOP codon and aa n° 448.
GYP5_r2 5'-T TTC CCG GGC GGC CGC TTA GTC GACTTC AAT ACC CTC TAC GAA TAC AAT ATC-3'
XmaI, NotI, SalI under-
lined; in bold STOP
codon and aa n° 633.
GYP5_r3 5'-T TTC CCG GGC GGC CGC TTA GTC GACTTT TTT AAA ACC AGT CCA GCC TTT C-3'
XmaI, NotI, SalI under-
lined.  In bold STOP
codon and aa n° 892.
GYP5_r4 5'-T TTC CCG GGC GGC CGC TTA GTC GACTTC TAG CTT CTG CGC CTC TCT TTG-3'
XmaI, NotI, SalI under-
lined; in bold STOP
codon and aa n° 759
GYP5_r5 5'-T TTC CCG GGC GGC CGC TTA GTC GACCAG CAT CTC CAT ATT CAA TCT GTT CT-3'
XmaI, NotI, SalI under-
lined; in bold STOP
codon and aa n° 786
GYP5-R/K_f 5'-A CGT AGA GAT TTA AGG AAA ACG AAG TTTGTG GCC GAG GAC-3'
R496K mutation bold and
underlined
GYP5-R/K_r 5'-GTC CTC GGC CAC AAA CTT CGT TTT CCTTAA ATC TCT ACG T-3'
R496K mutation bold and
underlined
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GYP5-R/A_f 5’-A CGT AGA GAT TTA AGG GCA ACG AAGTTT GTG GCC GAG GAC-3’
R496A mutation bold
and underlined
GYP5-R/A_r 5’-GTC CTC GGC CAC AAA CTT CGT TGC CCTTAA ATC TCT ACG T-3’
R496A mutation bold and
underlined
GYP5-SeqM.f 5’-GGC AGC TGA TGG CGA ATT-3’ Sequencing primer
GYP5-SeqM.r 5’-GAA CCC CAT GCC TTG CGT-3’ Sequencing primer
GYP1, GYP7, GYP8 oligonucleotides
GYP1_f0 5’-ACA ACA ACA ACC ACC AAT ACC-3’
GYP1_r0 5’-CAC GTT CCT CAG GAT TTA TGA-3’
GYP7_f0 5’-TAT GGG GCA AAG TTC TGC TCT AT-3’
GYP7_r0 5’-CGG ATG TAT TGA TGA TTA TGT GG-3’
GYP8_f0 5’-GCA AAT GAC ATA GAA CAA GCC A-3’
GYP8_r0 5’-GCA GCG AAT TTT AAA GAA GCA-3’
YPT1-specific oligonucleotides
YPT1_f0 5’-GCA CCA GTT TTG AGG ATA T-3’
YPT1_f1 5’-GAT TAC CTG TTC AAA CTG CTG T-3’
YPT1_f1b 5’-T TCG GAC GAC ACA TAT ACC AA-3’
YPT1_f2 5’-GAA CTG GAC GGC AAG ACT G-3’
YPT1_r0 5’-TAT GTT CTC GCG TGT GTC TTA-3’
YPT1_r0b 5’-CGC TTC CCC ACA CAT TTT G-3’
YPT1_r1 5’-CCA CAT CTT CAC GCC GTT-3’
YPT1_r1b 5’-T CTC TTG CAG CCA CAT CTT CA-3’
YPT1-Q/L_f 5’-CAG ATT TGG GAC ACT GCA GGT CTA GAACGT TTC CGT ACT ATC ACT-3’
Q67L mutation bold and
underlined
YPT1-Q/L_r 5’-AGT GAT AGT ACG GAA ACG TTC TAG ACCTGC AGT GTC CCA AAT CTG-3’
Q67L mutation bold and
underlined
Yeast Sec24 family oligonucleotides
SEC24_f0 5’-TG GCC CCG GGA CCT AGG ATG TCT CATCAC AAG AAA CGT G-3’
XmaI, AvrII underlined; in
bold aa n° 1
SEC24_f3 5'-GGG AAG TTG CAA CGC TAA G-3'
SEC24_f5 5'-TG GCC CCG GGT CCT AGG TTG TCC AATGCG TCT CCA GAT TAT-3'
XmaI, AvrII underlined; in
bold aa n° 174
SEC24_r0 5'-GC TCT AGA TTA TTA TTT GCT AAT TCT GGC TTTCA-3'
XbaI, underlined. In bold
STOP codon.
SEC24_r6 5'-CCG CTC GAG TTA TTA CAA AAG GGT GTTGAT GGT AGT GGC-3'
XhoI, underlined; in bold
STOP codon and aa n° 330
SFB2-f0 5'-TG GCC CCG GGA CCT AGG ATG TCT CATCAT AAG AAG AGG GTG-3'
XmaI, AvrII underlined. In
bold aa n° 1
SFB2-f3 5'-CGC CAA CCT AAA CTC CGA A-3'
SFB2_r0 5'-GC TCT AGA TTA TTA TCT GTT GAT ACTAGT CTT CAT ACT-3'
XbaI, underlined; in bold
STOP codon
SFB3_f0 5'-TG GCC CCG GGA CCT AGG ATG TCT CAGCAG AAT ATT TTG GC-3'
XmaI, AvrII underlined; in
bold aa n° 1
SFB3_f1 5'-CCG CTC GAG CCG ATT TTG TTG GTG TTG TTT ATT-3' XhoI underlined
SFB3-f3 5'-ACA AGA CCG TCA ACA GAA TCG-3'
SFB3-f5 5'-G GGT GAA GGT GTC AGG TCA T-3'
SFB3_r0 5'-GC TCT AGA TTA GGA GGC TCA AAA CTGCAC AAA-3'
XbaI, underlined; in bold
STOP codon
SFB3_r0.Xh 5'-CCG CTC GAG TTA GGA GGC TCA AAA CTGCAC AAA-3'
XhoI underlined; in bold
STOP codon
SFB3_r2 5'-A GTA GTA CTG TTC CAC AGA TAG CC-3'
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SFB3_r4 5’-CGG GAT CCT GCA AGA TTT ACC AGA AGACAG TC-3’
BamHI underlined
SFB3_r6 5’-GGT TCC TGT TTT TAT TTT ACT-3’
SFB3_Seq1f 5’-GAA ATG CGC GTG TCC GTA A-3’ Sequencing primer
SFB3_Seq2f 5’-CA GCG CTC CTT GAT GAA-3’ Sequencing primer
SFB3_Seq3f 5’-AC AAC ATC CCC GAA AGT GAA-3’ Sequencing primer
SFB3_Seq4f 5’-GC AGT AAC TCA TCA ACG CAA-3’ Sequencing primer
SFB3_Seq5f 5’-CCT GAG ACG GGC ACT AGT AT-3’ Sequencing primer
SFB3_Seq6r 5’-CC GCC ACT AAT CAA CTC CT-3’ Sequencing primer
SFB3_Seq7r 5’-G GGG TGT AGT GTA GGG TGA-3’ Sequencing primer
SFB3_Seq8f 5’-G AGT CAA GAG CGA TTC GGT-3’ Sequencing primer
SFB3_Seq9r 5’-CAA AGG CGT ACC ATC CAT T-3’ Sequencing primer
SFB3_Seq10f 5’-A GTC GAT TTC TTG GTG CCA-3’ Sequencing primer
SFB3_Seq11f 5’-CC GGA AAC TCG ATG AAA AT-3’ Sequencing primer
SFB3_Seq12r 5’-GGT ACT TTG AGC GTT TGG C-3’ Sequencing primer
SFB3_Seq13r 5’-CCT CAA CAA GAC TAA CGG CA-3’ Sequencing primer
Human SEC24c-specific oligonucleotides
hSEC24_f1 5’-CGC GGA TCC AAC GTC AAC CAG TCA GTTCCA CCT-3’
BamHI underlined;
in bold aa n° 2
hSEC24_f3 5'-CGC GGA TCC GTG AAA GAC CAA GGG AATGCA AGT-3'
BamHI underlined;
in bold aa n° 363
hSEC24_f5 5'-CGC GGA TCC ATG ATG GTT GTG TCT GATGTG GCT-3'
BamHI underlined;
in bold aa n° 570
hSEC24_f7 5'-CGC GGA TCC TGT GCA GGG AAG CTC TTTCTA TTC-3'
BamHI underlined;
in bold aa n° 635
hSEC24_f9 5'-CGC GGA TCC GTT GGC TTT GAT GCT GTGATG CGG-3'
BamHI underlined;
in bold aa n° 747
hSEC24_r2 5'-CCG AAG CTT TTA TTG CAT CTG AAC AGTGGA GCT TGG-3'
HindIII, underlined; in bold
STOP codon and aa n° 102
hSEC24_r4 5'-CCC AAG CTT TTA GAG CCT AAC AAG ACCAGT CCT GAT -3'
HindIII, underlined; in bold
STOP codon and aa n° 522
hSEC24_r46H 5'-CCC AAG CTT TTA GTG ATG GTG ATG GTGATG GAG CCT AAC AAG ACC AGT CCT GAT-3'
HindIII, underlined; in bold
STOP codon and aa n° 522
6-His double underlined.
hSEC24_r6 5'-TTT AAG CTT TTA GAG CTG GGG CAC AACAGA GAG TGT-3'
HindIII, underlined; in bold
STOP codon and aa n° 715
hSEC24_r8 5'-GCG AAG CTT TTA CAG ATT ATG GAT GCGGAG CCG ACG-3'
HindIII, underlined; in bold
STOP codon and aa n° 827
hSEC24_r10 5'-GCG AAG CTT TTA CCA GAG GAA GAG GTTGAG CCC ATT-3'
HindIII, underlined; in bold
STOP codon and aa n° 992
t-SNAREs  oligonucleotides
VAM3_f 5'-CTT GCC ATG GTT GAG ATT ATG TCC TTT TTCGA-3'
NcoI underlined; in bold
aa n° 1
VAM3_r 5'-CGG CTC GAG TTA TTT GTT ACG GTC CCTCTG ATG-3'
XhoI, underlined; in bold
STOP codon and aa n° 261
SSO1_f 5'-T GCT CTA GAG AGT TAT AAT AAT CCG TACCAG-3'
XbaI underlined; in bold
aa n° 2
SSO1_r 5'-CCG CTC GAG TTA AAT CTT GTT CTT TCTTGC TTT TC-3'
XhoI, underlined; in bold
STOP codon and aa n° 264
SSO2_f 5'-CAA GCC ATG GCA ATG AGC AAC GCT AATCCT TA-3'
NcoI underlined; in bold
amino acid n° 1
SSO2_r 5'-CCG CTC GAG TTA TTT GTT TTT TCT TGCTTT TCT GG-3'
XhoI, underlined; in bold
STOP codon and aa n° 267
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TLG1_f 5’-CAT GCC ATG GAA ATG AAC AAC AGT GAA GATCCG-3’
NcoI underlined; in bold
amino acid n° 1
TLG1_r 5'-CCG CTC GAG TTA ATC GTC GTA TTT TTCTTT ATT TT-3'
XhoI, underlined; in bold
STOP codon and aa n° 204
TLG2_f 5'-CAT GCC ATG GCA AAC ATG TTT AGA GATAGA ACT A-3'
NcoI underlined; in bold
amino acid n° 1
TLG2_r 5'-CCG CTC GAG TTA TTT ACA TTT TTG AGTTCT CTT CTG-3'
XhoI, underlined; in bold
STOP codon and aa n° 317
Vectors-specific oligonucleotides
Tag.univ_r1 5'-C CCC TCG AGG CAA GCT AAA CAG ATC-3' Anneals inside loxP-kanMX;XhoI underlined
Tag.univ_r2 5'-G GGG ATC CTA TAG GGA GAC CGG CAGATC-3'
Anneals after kanMX-loxP;
BamHI underlined
pU-f0 5'-AAC GCG GCT ACA ATT AAT AC-3' For pU vectors
pU-r0 5'-AT TCT GGG CCT CCA TGT C-3' Anneals inside loxP-kanMX
pU-r2 5’-GG ATG TAT GGG CTA AAT G-3’ Anneals inside loxP-kanMX
pU-r4 5'-CTA TAG GGA GAC CGG CAG ATC-3' Anneals after kanMX-loxP
6H-f 5'-CAC CAC CAT CAT CAT CAC G-3' For pUtag vectors
TL15_f 5'-C CTC GAC ATC ATC TGC CC-3' Anneals inside kanMX
TL20_r 5'-CCC ATG GTT GTT TAT GTT CG-3' Anneals inside kanMX
MYC-f 5'-GAA CAA AAG CTT ATT TCT GAA-3'
HA-f 5'-TAC CCA TAC GAC GTC CCA GAC-3'
VSV-f 5'-TAC ACT GAC ATT GAA ATG AAT-3'
TPI-f 5'-AGG GAA TAT AAA GGG CAG CA-3' For sequencing inserts inpYX112  and pYX212
pYX243_f 5'-CGG TTT GTA TTA CTT CTT ATT C-3' for sequencing inserts inpYX143 and pYX243
pYX_r 5'-AAA GGG ATG TAT CGG TCA GTC A-3' For sequencing inserts inpYX vectors
pET30_Seqf 5'-TGA AAG AAA CCG CTG CTG C-3' For sequencing inserts in pET30
pET30_f 5'-CCG GCG TAG AGG ATC GAG A -3' For pET30 and pET32
pET30_r 5'-GAG CCG TTT AGA GGC CCC A-3' For pET30 and pET32
pET32_Seqf 5'-GAA AGA AAC CGC TGC TGC T-3' For sequencing inserts in pET32
GST_f 5'-GCA AGT ATA TAG CAT GGC C-3' For sequencing inserts inpGEX-TT and pEG(KT)
TT_f1 5'-GAC CAT CCT CCA AAA TCG G-3' For sequencing inserts inpGEX-TT and pEG(KT)
TT_r2 5'-GAG GCA GAT CGT CAG TCA G-3' For sequencing inserts inpGEX-TT and pEG(KT)
pMAL_f 5'-GGT CGT CAG ACT GTC GAT GAA GCC-3' For sequencing inserts in pMAL
pMAL_r 5'-CGC CAG GGT TTT CCC AGT CAC GAC-3' For sequencing inserts in pMAL
pQE_f 5'-GAA TTC ATT AAA GAG GAG AAA-3' For sequencing inserts inpQE vectors
pQE_r 5'-CAT TAC TG ATC TAT CAA CAG G-3' For sequencing inserts inpQE30, pQE50
oligonucleotides for PCR mediated gene deletion
GYP5DEL_f1
5'-ACA GCT CCT ACC ACC AGT GTA AAG TAG AAC
GTT AAT AGA GCA TCC CAC CAC CAT CAT CAT
CAC-3'
For GYP5 deletion, it anneals
(underlined sequence)
with pUtag vectors
GYP5DEL_r
=Gyp5-tag_r2
5'-CAA CAA CAT TGT CTA AAC GAG TCG TGA TGC
ATT TTT TAA CAC ACT ATA GGG AGA CCG GCA
GAT C-3'
For GYP5 deletion, it anneals
(underlined sequence)
with pUtag vectors
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GYP1DEL_f
5’-AAC AAC CAC CAA TAC CGA CCA CTT AAT
AAA AGT AAC CAT ATA GCT TAA TGA GTC GAC
AAC CCT-3’
For GYP1 deletion, it
anneals (underlined seq.)
with pU6H3HA
GYP1DEL_r
5’-GAG ATT TTT GTT TTA TAT TAT TAC ATA
CTA TAC AGT AAG TAA ACT ATA GGG AGA
CCG GCA GAT C-3’
For GYP1 deletion, it
anneals (underlined seq.)
with pU6H3HA
GYP8DEL_f
= SA170
5’-AAT ACG ATG CCA TTA AGG TCA TTA TTT CAT
ACT AAT CAG AGT CAG CTG AAG CTT CGT ACG C-3’
For GYP8 deletion, it anneals
(underlined seq.) with pUG6
GYP8DEL_r 5’-CTA TCT AGT TGG ATG CCC CAG TTT CAA AAT GTCCCT AAT CGG GCA TAG GCC ACT AGT GGA TCT G-3’
For GYP8 deletion, it anneals
(underlined seq.) with pUG6
SA88_f 5’-CAT CCC CTG ATG AGT AAG ATA CTA TTCTGC AAA TCT CAG CTG AAG CTT CGT ACG C-3’
For GYP7 deletion, it anneals
(underlined seq.) with pUG6
SA89_r 5’-CCA CTA TTT AAC GGA ATT TTT GCT CCT TTGCCC  TTC  GCA TAG GCC ACT AGT GGA TCT -3’
For GYP7 deletion, it anneals
(underlined seq.) with pUG6
oligonucleotides for PCR mediated epitope tagging
GYP5-tag_fa
5’-AAA GGG AGG AAA GGC TGG ACT GGT TTT
AAA AAA GTT GTT AAA TCC CAC CAC CAT CAT
CAT CAC-3’
For GYP5 tagging, it anneals
(underlined sequence)
with pUtag vectors
GYP5-tag_r2
5’-CAA CAA CAT TGT CTA AAC GAG TCG TGA TGC
ATT TTT TAA CAC ACT ATA GGG AGA CCG GCA
GAT C-3’
For GYP5 tagging, it anneals
(underlined sequence)
with pUtag vectors
SEC23-tag_f1
5’-TTC ATG ACT CAC TTA CAA CAA GTA GCC
GTC TCT GGT CAG GCA TCC CAC CAC CAT
CAT CAT CAC-3’
For SEC23 tagging, it anneals
(underlined sequence)
with pUtag vectors
SEC23-tag_r4
5’-GGA AAA TTC TTG CAC GCG CAA TGG ACT GAA
CAG GCC TTA TAT ACT ATA GGG AGA CCG GCA
GAT C-3’
For SEC23 tagging, it anneals
(underlined sequence)
with pUtag vectors
SEC24-tag_f1
5’-TAC AGA GAA TTC TTA CAA ATC ATG AAA
GCC AGA ATT AGC AAA TCC CAC CAC CAT CAT
CAT CAC-3’
For SEC24 tagging, it anneals
(underlined sequence)
with pUtag vectors
SEC24-tag_r2
5’-AAC TGT TCA ATA TAC ATA ATA TAA TTG
GAA AGC AAA AAT GCA ACT ATA GGG AGA
CCG GCA GAT C-3’
For SEC24 tagging, it anneals
(underlined sequence)
with pUtag vectors
SFB2-tag_f1
5’-TAT AGA GAA TAC TTA CAG AGT ATG AAG
ACT AGT ATC AAC AGA TCC CAC CAC CAT
CAT CAT CAC-3'
For SFB2 tagging, It anneals
(underlined sequence)
with pUtag vectors
SFB2-tag_r6
5'-CGA TTT ACT TTT ATT TCT ATC TGT ATT GTA
TAT CAA AAT CTA ACT ATA GGG AGA CCG GCA
GAT C-3’
For SFB2 tagging, It anneals
(underlined sequence)
with pUtag vectors
SFB3-tag_f1
5'-GCC GCA ACT CAC GAA AAT ATC CAT CAA
AAA TTT GTG CAG TTT TCC CAC CAC CAT CAT
CAT CAC-3'
For SFB3 tagging, It anneals
(underlined sequence)
with pUtag vectors
SFB3-tag_r4
5'-TCC TAT GTA GAA TTT CAC CCT TTC TCT GCC
AGC GTT TCA CAT ACT ATA GGG AGA CCG GCA
GAT C-3'
For SFB3 tagging, It anneals
(underlined sequence)
with pUtag vectors
7.4  Antibodies
Antibodies against different proteins or epitopes were produced according to
standard procedures in rabbits.
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7.4.1  Primary antibodies
Table 7.8
Antibody source
Rabbit anti-KIAA0079-2 (anti-hSec24c-2), polyclonal
Antigen: 6xHis recombinant hSec24cp(363-522) This work
Rabbit anti-KIAA0079-5 (anti-hSec24c-5), polyclonal
Antigen: 6xHis recombinant hSec24cp(570-992) This work.
Rabbit anti-Sec24p, polyclonal (Peng et al., 1999)
Rabbit anti-Sec23p, polyclonal Dr. R. Peng, this Department
Rabbit anti-Sly1p, polyclonal This department
Rabbit anti-Emp47, polyclonal Dr. S. Schröder, this Department
Rabbit anti-Kar2p, polyclonal (Benli et al., 1996)
Rabbit anti-Bos1p, polyclonal This department
Rabbit anti-Sed5p, polyclonal Dr. R. Grabowski this Department
Rabbit anti-Gyp1, polyclonal Dr. S. Albert, this Department
Rabbit anti-Ypt1p, polyclonal Dr. X. Yang, this Department
Rabbit anti-Sec61p, polyclonal
Rabbit anti-Hxk2p, polyclonal Prof. H. Riezman, Univ. of Basel
Rabbit anti-Gas1p, polyclonal Prof. H. Riezman, Univ. of Basel
Rabbit anti-CPY, polyclonal This Department, (Benli et al., 1996)
Rabbit anti-ALP, polyclonal This Department, (Benli et al., 1996)
Rabbit anti-GST, polyclonal Pharmacia (Freiburg, Germany)
Mouse anti-6xhis, monoclonal Gibco (Karlsruhe, Germany)
Mouse anti-HA (12CA5), monoclonal Roche (Mannheim, Germany)
Mouse anti-VSV-G (P5D4), monoclonal Roche (Mannheim, Germany)
Mouse anti-c-myc (9E10), monoclonal Santa Cruz Biotech. (USA)
Rabbit anti-c-myc, polyclonal Santa Cruz Biotech. (USA)
Mouse anti-calnexin (AF18), monoclonal DIANOVA, Hamburg, Germany
Mouse anti-PDI (RL77), monoclonal DIANOVA, Hamburg, Germany
Mouse anti-β1 and β1-adaptins (100/1), monoclonal Sigma,  Deisenhofen, Germany
Mouse anti-Golgi 58K (58K-9), monoclonal Sigma,  Deisenhofen, Germany
7.4.2  Secondary antibodies
Table 7.9
Antibody source
Sheep anti-mouse-IgG, HRP conjugated. Amersham-Buchler(Braunschweig, Germany)
Donkey anti-rabbit-IgG, HRP conjugated Amersham-Buchler
Anti-mouse-IgG, Cy3 conjugated Dianova (Hamburg, Germany)
Anti-rabbit-IgG, Cy3 conjugated Dianova
Anti-mouse-IgG, Rhodamine Red-X conjugated Dianova
Anti-mouse-IgG, Rhodamine Red-X conjugated Dianova
goat anti-rabbit IgG, Oregon Green 488 conjugated Molecular Probe Inc. (Leiden,The Netherlands)
goat anti-rabbit IgG, Oregon Green 488 conjugated Molecular Probe Inc.
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8  ABBREVIATION
aa amino acid
ALP alkaline phosphatase
APS ammoniumpersulfate
ARF ADP-ribosylation factor
ARS autonomous replication sequences
3-AT 3 amino 1,2,4 triazol
ATCC American Type Culture Collection
BSA bovine serum albumin
CEN centromere elements
COPI/II coatamer protein complex I/II
CPY carboxypeptidase Y
Cy3 indigocarbocyanine
Dept. Department
dH2O deionized H2O
DIC differential interference contrast
dsDNA double strand DNA
DTT dithiothreitol
ECL enhanced chemiluminescence
EDTA ethylenediaminetetraacetic acid
EEA1 early endosome associated protein
ER endoplasmic reticulum
ERGIC ER Golgi intermediate compartment
FCS foetal calf serum
FM 4-64 N-(3-triethylammmoniumpropyl)-4-
(p-diethylaminophenylhexatrienyl)
pyridinium dibromide
5-FOA 5-fluoroorotic acid
FPLC fast protein liquid chromatography
g gram
g gravity
GAP GTPase activating protein
Gap1 general amino acid permease
Gas1p glycophospholipid-anchored
surface protein
GDI GDP dissociation inhibitor
GDP guanosine diphosphate
GEF guanine nucleotide exchange factor
GMP guanosine monophosphate
GMP-PNP  5’-guanylyl imidodiphosphate
GPI glycosyl phosphatidyl inositol
GST glutathione S-transferase
GTP guanosine triphosphate
h hour(s)
HA influenza virus hemagglutinin epitope
HEPES N-(2-Hydroxyethyl)piperazine-N’-
(2-ethanesulfonic acid)
HP high performance
HPLC high performance liquid
chromatography
HR high resolution
HRP horseradish peroxidase
Ig immunoglobulin
IPTG isopropylthio-ß-D-galactoside
Iss1 interacting with sec-sixteen
kcat catalytic rate constant
kDa kilo Dalton
km Michaelis constant
KOAc potassium acetate
l litre
LiOAc lithium acetate
Lma1 low molecular weight activity
Lst1 lethal with sec-thirteen
m meter
M molar (mol x l-1)
mA milli Amper
MBP maltose binding protein
2-ME β−mercaptoethanol
Abbreviation138
mg milligram (10-3g)
µg microrgram (10-6g)
MgOAc magnesium acetate
min minute(s)
ml millilitre (10-3 l)
µl microlitre (10-6 l)
µm micrometer (10-6 m)
mM millimolar (10-3 M)
µM micromolar (10-6 M)
MPI Max Planck Insitute
MYC c-myc epitope
NaOAc sodium acetate
Ni-NTA nickel-nitrilotriacetic acid
nm nanometer (10-9m)
NSF N-ethylmaleimide sensitive fusion
OD optical density
ON overnight
ORF open reading frame
ori origin of replication
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PCR polymerase chain reaction
PES polyethylene sodium sulfonate
pI isoelectric point
Pma1 plasma membrane ATPase
PMSF phenyl methyl sulfonyl fluoride
Rab rat brain
Ras rat sarcoma
Rnase ribonuclease
Rpm rotation per minute
RT room temperature
SD synthetic dextrose
SDS sodium dodecyl sulfate
Sfb Sed-five bynding
SMM semi-minimal medium
SNAP soluble NSF attachment protein
SNARE SNAP receptor
ssDNA single strand DNA
tab. tablet
TBS tris buffered saline
TCA thrichloroacetic acid
TEF translation elongation factor
TEMED 1,2-bis-(dimethylamino)-ethane
tER transitional ER
TGN trans-Golgi network
TPI tris phosphate isomerase
TRAPP transport protein particle
Tris tris(hydroxymethyl)aminomethane
Trx thioredoxin
YEPG yeast extract, peptone, glucose
VAMP vesicle associated membrane protein
VSV vesicular stomatitis virus
glycoprotein epitope
VTCS vesicular tubular clusters
v/v volume/volume
w/o without
wt wild type
w/v weight/volume
Ø diameter
--------------------------------------------------------
Amino acids abbreviations:
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Cysteine Cys C
Glutamic acid Glu E
Glutamine Gln Q
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Valine Val V
Abbreviation 139
Species abbreviations:
A. gossypii Ashibya gossypii
A. thaliana Arabidopsis thaliana
C. elegans Caenorhabditis elegans
D. melanogaster Drosophila melanogaster
E. coli Escherichia coli
H. sapiens  Homo sapiens
S. cerevisiae Saccharomyces cerevisiae
S. pombe Schizosaccharomyces pombe
X. laevis Xenopus laevis
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